AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|RACE|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-14|3.4|3.8|3.6|1949|Incidence|54370170|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|3.5|3.8|3.7|1999|Incidence|54659806|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|3.6|4.0|3.8|2166|Incidence|57293473|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|3.5|3.8|3.6|2117|Incidence|58853101|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|3.4|3.7|3.5|2142|Incidence|60910921|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|3.6|3.9|3.8|2321|Incidence|61011791|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|3.7|3.8|3.8|11662|Incidence|305851887|All Races|Male and Female|Acute Lymphocytic|2004-2008|||
0-14|3.5|3.8|3.7|2264|Incidence|60953039|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|3.6|3.9|3.8|2326|Incidence|61022964|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|3.7|4.0|3.8|2371|Incidence|61294588|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|3.6|3.9|3.8|2380|Incidence|61569505|All Races|Male and Female|Acute Lymphocytic|2008|||
0-14|0.6|0.8|0.7|374|Incidence|54370170|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.5|0.7|0.6|323|Incidence|54659806|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.6|0.7|0.7|386|Incidence|57293473|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.6|0.7|0.7|399|Incidence|58853101|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.6|0.7|0.6|392|Incidence|60910921|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.6|0.8|0.7|424|Incidence|61011791|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.6|0.7|0.7|2054|Incidence|305851887|All Races|Male and Female|Acute Myeloid|2004-2008|||
0-14|0.6|0.7|0.6|391|Incidence|60953039|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.6|0.7|0.7|412|Incidence|61022964|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.6|0.7|0.7|406|Incidence|61294588|All Races|Male and Female|Acute Myeloid|2007|||
0-14|0.6|0.7|0.7|421|Incidence|61569505|All Races|Male and Female|Acute Myeloid|2008|||
0-14|14.3|14.9|14.6|7914|Incidence|54370170|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|14.5|15.2|14.9|8106|Incidence|54659806|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|15.2|15.8|15.5|8894|Incidence|57293473|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|15.0|15.6|15.3|9034|Incidence|58853101|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|14.7|15.3|15.0|9175|Incidence|60910921|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|15.4|16.1|15.7|9673|Incidence|61011791|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|15.4|15.6|15.5|47885|Incidence|305851887|All Races|Male and Female|All Cancer Sites Combined|2004-2008|||
0-14|15.0|15.6|15.3|9395|Incidence|60953039|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|15.1|15.7|15.4|9498|Incidence|61022964|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|15.3|15.9|15.6|9685|Incidence|61294588|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|15.1|15.8|15.5|9634|Incidence|61569505|All Races|Male and Female|All Cancer Sites Combined|2008|||
0-14|0.7|0.8|0.7|403|Incidence|54370170|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.6|0.8|0.7|373|Incidence|54659806|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.6|0.8|0.7|411|Incidence|57293473|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.6|0.8|0.7|422|Incidence|58853101|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.6|0.8|0.7|424|Incidence|60910921|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.7|0.8|0.7|453|Incidence|61011791|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.7|0.7|0.7|2147|Incidence|305851887|All Races|Male and Female|Bones and Joints|2004-2008|||
0-14|0.6|0.8|0.7|420|Incidence|60953039|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.7|0.8|0.7|439|Incidence|61022964|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.6|0.8|0.7|421|Incidence|61294588|All Races|Male and Female|Bones and Joints|2007|||
0-14|0.6|0.8|0.7|414|Incidence|61569505|All Races|Male and Female|Bones and Joints|2008|||
0-14|3.1|3.4|3.2|1752|Incidence|54370170|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|3.2|3.5|3.4|1837|Incidence|54659806|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|3.1|3.4|3.3|1883|Incidence|57293473|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|3.3|3.6|3.5|2030|Incidence|58853101|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|3.1|3.4|3.3|1994|Incidence|60910921|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|3.3|3.6|3.5|2124|Incidence|61011791|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|3.3|3.4|3.4|10324|Incidence|305851887|All Races|Male and Female|Brain and Other Nervous System|2004-2008|||
0-14|3.1|3.4|3.2|1984|Incidence|60953039|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|3.2|3.5|3.3|2043|Incidence|61022964|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|3.3|3.6|3.4|2119|Incidence|61294588|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|3.2|3.5|3.3|2054|Incidence|61569505|All Races|Male and Female|Brain and Other Nervous System|2008|||
0-14|0.5|0.6|0.5|297|Incidence|54370170|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|0.5|0.7|0.6|325|Incidence|54659806|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|0.5|0.7|0.6|341|Incidence|57293473|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|0.5|0.6|0.6|328|Incidence|58853101|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|0.5|0.7|0.6|360|Incidence|60910921|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|0.5|0.6|0.5|329|Incidence|61011791|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|0.6|0.6|0.6|1764|Incidence|305851887|All Races|Male and Female|Hodgkin Lymphoma|2004-2008|||
0-14|0.5|0.7|0.6|366|Incidence|60953039|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|0.6|0.7|0.6|373|Incidence|61022964|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|0.5|0.6|0.5|324|Incidence|61294588|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|0.6|0.7|0.6|372|Incidence|61569505|All Races|Male and Female|Hodgkin Lymphoma|2008|||
0-14|0.8|0.9|0.8|453|Incidence|54370170|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.8|1.0|0.9|483|Incidence|54659806|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.8|1.0|0.9|502|Incidence|57293473|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.8|0.9|0.8|499|Incidence|58853101|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.8|0.9|0.9|526|Incidence|60910921|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.7|0.9|0.8|506|Incidence|61011791|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.8|0.9|0.8|2633|Incidence|305851887|All Races|Male and Female|Kidney and Renal Pelvis|2004-2008|||
0-14|0.8|0.9|0.8|518|Incidence|60953039|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.8|0.9|0.8|520|Incidence|61022964|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.8|0.9|0.9|539|Incidence|61294588|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|0.8|0.9|0.9|550|Incidence|61569505|All Races|Male and Female|Kidney and Renal Pelvis|2008|||
0-14|4.4|4.8|4.6|2495|Incidence|54370170|All Races|Male and Female|Leukemia|1999|||
0-14|4.4|4.8|4.6|2505|Incidence|54659806|All Races|Male and Female|Leukemia|2000|||
0-14|4.7|5.0|4.9|2771|Incidence|57293473|All Races|Male and Female|Leukemia|2001|||
0-14|4.5|4.9|4.7|2764|Incidence|58853101|All Races|Male and Female|Leukemia|2002|||
0-14|4.3|4.7|4.5|2737|Incidence|60910921|All Races|Male and Female|Leukemia|2003|||
0-14|4.7|5.0|4.9|2986|Incidence|61011791|All Races|Male and Female|Leukemia|2004|||
0-14|4.7|4.9|4.8|14875|Incidence|305851887|All Races|Male and Female|Leukemia|2004-2008|||
0-14|4.5|4.9|4.7|2893|Incidence|60953039|All Races|Male and Female|Leukemia|2005|||
0-14|4.6|5.0|4.8|2968|Incidence|61022964|All Races|Male and Female|Leukemia|2006|||
0-14|4.7|5.0|4.8|3005|Incidence|61294588|All Races|Male and Female|Leukemia|2007|||
0-14|4.7|5.0|4.8|3023|Incidence|61569505|All Races|Male and Female|Leukemia|2008|||
0-14|0.8|1.0|0.9|481|Incidence|54370170|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.8|1.0|0.9|506|Incidence|54659806|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.8|1.0|0.9|519|Incidence|57293473|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.8|1.0|0.9|529|Incidence|58853101|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.8|1.0|0.9|545|Incidence|60910921|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.9|1.0|0.9|575|Incidence|61011791|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.9|1.0|0.9|2835|Incidence|305851887|All Races|Male and Female|Non-Hodgkin Lymphoma|2004-2008|||
0-14|0.8|1.0|0.9|556|Incidence|60953039|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.8|1.0|0.9|546|Incidence|61022964|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.9|1.1|1.0|595|Incidence|61294588|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|0.8|1.0|0.9|563|Incidence|61569505|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|||
0-14|2.8|3.1|2.9|1575|Incidence|54370170|All Races|Male and Female|Other|1999|||
0-14|2.7|3.0|2.9|1560|Incidence|54659806|All Races|Male and Female|Other|2000|||
0-14|3.2|3.5|3.3|1907|Incidence|57293473|All Races|Male and Female|Other|2001|||
0-14|3.0|3.3|3.2|1869|Incidence|58853101|All Races|Male and Female|Other|2002|||
0-14|3.1|3.4|3.3|2008|Incidence|60910921|All Races|Male and Female|Other|2003|||
0-14|3.2|3.5|3.4|2093|Incidence|61011791|All Races|Male and Female|Other|2004|||
0-14|3.2|3.3|3.3|10230|Incidence|305851887|All Races|Male and Female|Other|2004-2008|||
0-14|3.2|3.4|3.3|2049|Incidence|60953039|All Races|Male and Female|Other|2005|||
0-14|3.1|3.4|3.2|2019|Incidence|61022964|All Races|Male and Female|Other|2006|||
0-14|3.1|3.4|3.3|2052|Incidence|61294588|All Races|Male and Female|Other|2007|||
0-14|3.1|3.3|3.2|2017|Incidence|61569505|All Races|Male and Female|Other|2008|||
0-14|0.8|0.9|0.8|458|Incidence|54370170|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.9|1.0|0.9|517|Incidence|54659806|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.9|1.1|1.0|560|Incidence|57293473|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.9|1.1|1.0|593|Incidence|58853101|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.9|1.0|0.9|581|Incidence|60910921|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.9|1.1|1.0|607|Incidence|61011791|All Races|Male and Female|Soft Tissue|2004|||
0-14|1.0|1.0|1.0|3077|Incidence|305851887|All Races|Male and Female|Soft Tissue|2004-2008|||
0-14|0.9|1.1|1.0|609|Incidence|60953039|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.9|1.0|1.0|590|Incidence|61022964|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.9|1.1|1.0|630|Incidence|61294588|All Races|Male and Female|Soft Tissue|2007|||
0-14|0.9|1.1|1.0|641|Incidence|61569505|All Races|Male and Female|Soft Tissue|2008|||
0-14|0.3|0.4|0.3|194|Mortality|59955368|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|0.3|0.4|0.4|234|Mortality|60300602|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|0.3|0.4|0.3|208|Mortality|60566200|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|0.3|0.4|0.4|217|Mortality|60764336|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|0.4|0.5|0.4|246|Mortality|60910921|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|0.3|0.4|0.3|202|Mortality|61011791|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|0.3|0.3|0.3|952|Mortality|305851887|All Races|Male and Female|Acute Lymphocytic|2004-2008|||
0-14|0.3|0.4|0.3|188|Mortality|60953039|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|0.2|0.3|0.3|174|Mortality|61022964|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|0.3|0.4|0.3|212|Mortality|61294588|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|0.2|0.3|0.3|176|Mortality|61569505|All Races|Male and Female|Acute Lymphocytic|2008|||
0-14|0.2|0.3|0.2|141|Mortality|59955368|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.2|0.3|0.2|145|Mortality|60300602|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.2|0.3|0.3|157|Mortality|60566200|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.2|0.3|0.2|131|Mortality|60764336|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.2|0.3|0.2|142|Mortality|60910921|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.2|0.3|0.2|147|Mortality|61011791|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.2|0.2|0.2|664|Mortality|305851887|All Races|Male and Female|Acute Myeloid|2004-2008|||
0-14|0.2|0.3|0.2|137|Mortality|60953039|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.2|0.2|0.2|124|Mortality|61022964|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.2|0.2|0.2|129|Mortality|61294588|All Races|Male and Female|Acute Myeloid|2007|||
0-14|0.2|0.2|0.2|127|Mortality|61569505|All Races|Male and Female|Acute Myeloid|2008|||
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|2.4|2.7|2.5|1526|Mortality|60300602|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|2.3|2.6|2.5|1494|Mortality|60566200|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|2.4|2.7|2.5|1548|Mortality|60764336|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|2.4|2.7|2.5|1543|Mortality|60910921|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|2.3|2.6|2.5|1492|Mortality|61011791|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|2.3|2.4|2.3|7053|Mortality|305851887|All Races|Male and Female|All Cancer Sites Combined|2004-2008|||
0-14|2.3|2.5|2.4|1452|Mortality|60953039|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|2.1|2.4|2.2|1360|Mortality|61022964|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|2.2|2.4|2.3|1395|Mortality|61294588|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|2.1|2.3|2.2|1354|Mortality|61569505|All Races|Male and Female|All Cancer Sites Combined|2008|||
0-14|0.1|0.2|0.1|82|Mortality|59955368|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.1|0.2|0.1|83|Mortality|60300602|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.1|0.2|0.1|88|Mortality|60566200|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.1|0.2|0.1|85|Mortality|60764336|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.1|0.2|0.1|82|Mortality|60910921|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.1|0.2|0.1|75|Mortality|61011791|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.1|0.1|0.1|345|Mortality|305851887|All Races|Male and Female|Bones and Joints|2004-2008|||
0-14|0.1|0.2|0.1|88|Mortality|60953039|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.1|0.1|0.1|59|Mortality|61022964|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.1|0.1|0.1|61|Mortality|61294588|All Races|Male and Female|Bones and Joints|2007|||
0-14|0.1|0.1|0.1|62|Mortality|61569505|All Races|Male and Female|Bones and Joints|2008|||
0-14|0.7|0.8|0.7|431|Mortality|59955368|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|0.7|0.8|0.7|440|Mortality|60300602|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|0.6|0.8|0.7|416|Mortality|60566200|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|0.7|0.8|0.8|463|Mortality|60764336|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|0.7|0.8|0.8|458|Mortality|60910921|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|0.7|0.8|0.7|446|Mortality|61011791|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|0.7|0.7|0.7|2149|Mortality|305851887|All Races|Male and Female|Brain and Other Nervous System|2004-2008|||
0-14|0.6|0.8|0.7|426|Mortality|60953039|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|0.6|0.8|0.7|422|Mortality|61022964|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|0.6|0.8|0.7|426|Mortality|61294588|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|0.6|0.8|0.7|429|Mortality|61569505|All Races|Male and Female|Brain and Other Nervous System|2008|||
0-14|~|~|~|~|Mortality|59955368|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|~|~|~|~|Mortality|60300602|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|~|~|~|~|Mortality|60566200|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|~|~|~|~|Mortality|60764336|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|~|~|~|~|Mortality|60910921|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|~|~|~|~|Mortality|61011791|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|0.0|0.0|0.0|26|Mortality|305851887|All Races|Male and Female|Hodgkin Lymphoma|2004-2008|||
0-14|~|~|~|~|Mortality|60953039|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|~|~|~|~|Mortality|61022964|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|~|~|~|~|Mortality|61294588|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|~|~|~|~|Mortality|61569505|All Races|Male and Female|Hodgkin Lymphoma|2008|||
0-14|0.1|0.1|0.1|54|Mortality|59955368|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.1|0.1|0.1|46|Mortality|60300602|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.1|0.1|0.1|58|Mortality|60566200|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.1|0.1|0.1|42|Mortality|60764336|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.1|0.1|0.1|54|Mortality|60910921|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.1|0.1|0.1|51|Mortality|61011791|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.1|0.1|0.1|230|Mortality|305851887|All Races|Male and Female|Kidney and Renal Pelvis|2004-2008|||
0-14|0.1|0.1|0.1|54|Mortality|60953039|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.1|0.1|0.1|43|Mortality|61022964|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.0|0.1|0.1|36|Mortality|61294588|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|0.1|0.1|0.1|46|Mortality|61569505|All Races|Male and Female|Kidney and Renal Pelvis|2008|||
0-14|0.7|0.8|0.8|451|Mortality|59955368|All Races|Male and Female|Leukemia|1999|||
0-14|0.7|0.9|0.8|490|Mortality|60300602|All Races|Male and Female|Leukemia|2000|||
0-14|0.8|0.9|0.8|503|Mortality|60566200|All Races|Male and Female|Leukemia|2001|||
0-14|0.7|0.8|0.7|441|Mortality|60764336|All Races|Male and Female|Leukemia|2002|||
0-14|0.8|0.9|0.8|505|Mortality|60910921|All Races|Male and Female|Leukemia|2003|||
0-14|0.7|0.8|0.7|455|Mortality|61011791|All Races|Male and Female|Leukemia|2004|||
0-14|0.7|0.7|0.7|2126|Mortality|305851887|All Races|Male and Female|Leukemia|2004-2008|||
0-14|0.6|0.8|0.7|417|Mortality|60953039|All Races|Male and Female|Leukemia|2005|||
0-14|0.6|0.7|0.7|411|Mortality|61022964|All Races|Male and Female|Leukemia|2006|||
0-14|0.7|0.8|0.7|441|Mortality|61294588|All Races|Male and Female|Leukemia|2007|||
0-14|0.6|0.7|0.7|402|Mortality|61569505|All Races|Male and Female|Leukemia|2008|||
0-14|0.1|0.1|0.1|55|Mortality|59955368|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.1|0.1|0.1|55|Mortality|60300602|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.0|0.1|0.1|40|Mortality|60566200|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.1|0.2|0.1|74|Mortality|60764336|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.1|0.1|0.1|50|Mortality|60910921|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.1|0.1|0.1|44|Mortality|61011791|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.1|0.1|0.1|222|Mortality|305851887|All Races|Male and Female|Non-Hodgkin Lymphoma|2004-2008|||
0-14|0.1|0.1|0.1|55|Mortality|60953039|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.1|0.1|0.1|44|Mortality|61022964|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.0|0.1|0.1|40|Mortality|61294588|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|0.0|0.1|0.1|39|Mortality|61569505|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|||
0-14|0.5|0.6|0.5|328|Mortality|59955368|All Races|Male and Female|Other|1999|||
0-14|0.5|0.6|0.6|333|Mortality|60300602|All Races|Male and Female|Other|2000|||
0-14|0.4|0.6|0.5|297|Mortality|60566200|All Races|Male and Female|Other|2001|||
0-14|0.5|0.6|0.6|342|Mortality|60764336|All Races|Male and Female|Other|2002|||
0-14|0.5|0.6|0.5|311|Mortality|60910921|All Races|Male and Female|Other|2003|||
0-14|0.5|0.6|0.5|317|Mortality|61011791|All Races|Male and Female|Other|2004|||
0-14|0.5|0.5|0.5|1523|Mortality|305851887|All Races|Male and Female|Other|2004-2008|||
0-14|0.5|0.6|0.5|318|Mortality|60953039|All Races|Male and Female|Other|2005|||
0-14|0.4|0.5|0.5|296|Mortality|61022964|All Races|Male and Female|Other|2006|||
0-14|0.4|0.6|0.5|306|Mortality|61294588|All Races|Male and Female|Other|2007|||
0-14|0.4|0.5|0.5|286|Mortality|61569505|All Races|Male and Female|Other|2008|||
0-14|0.1|0.2|0.1|87|Mortality|59955368|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.1|0.1|0.1|71|Mortality|60300602|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.1|0.2|0.1|86|Mortality|60566200|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.1|0.2|0.2|95|Mortality|60764336|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.1|0.2|0.1|78|Mortality|60910921|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.1|0.2|0.2|98|Mortality|61011791|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.1|0.2|0.1|432|Mortality|305851887|All Races|Male and Female|Soft Tissue|2004-2008|||
0-14|0.1|0.2|0.1|83|Mortality|60953039|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.1|0.2|0.1|80|Mortality|61022964|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.1|0.2|0.1|82|Mortality|61294588|All Races|Male and Female|Soft Tissue|2007|||
0-14|0.1|0.2|0.1|89|Mortality|61569505|All Races|Male and Female|Soft Tissue|2008|||
0-19|2.5|2.8|2.7|940|Incidence|35359689|All Races|Female|Acute Lymphocytic|1999|2.5|2.8|2.7
0-19|2.7|3.0|2.9|1012|Incidence|35585399|All Races|Female|Acute Lymphocytic|2000|2.7|3.0|2.8
0-19|2.8|3.1|2.9|1089|Incidence|37294501|All Races|Female|Acute Lymphocytic|2001|2.7|3.1|2.9
0-19|2.6|2.9|2.7|1041|Incidence|38330396|All Races|Female|Acute Lymphocytic|2002|2.6|2.9|2.7
0-19|2.5|2.8|2.7|1054|Incidence|39731700|All Races|Female|Acute Lymphocytic|2003|2.5|2.8|2.7
0-19|2.6|2.9|2.7|1099|Incidence|39908757|All Races|Female|Acute Lymphocytic|2004|2.6|2.9|2.8
0-19|2.8|2.9|2.8|5737|Incidence|201197585|All Races|Female|Acute Lymphocytic|2004-2008|2.8|2.9|2.9
0-19|2.6|2.9|2.7|1106|Incidence|40041255|All Races|Female|Acute Lymphocytic|2005|2.6|2.9|2.8
0-19|2.7|3.0|2.8|1139|Incidence|40202922|All Races|Female|Acute Lymphocytic|2006|2.7|3.0|2.8
0-19|2.7|3.1|2.9|1179|Incidence|40435594|All Races|Female|Acute Lymphocytic|2007|2.8|3.1|2.9
0-19|2.8|3.1|3.0|1214|Incidence|40609057|All Races|Female|Acute Lymphocytic|2008|2.8|3.2|3.0
0-19|0.6|0.8|0.7|241|Incidence|35359689|All Races|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.6|225|Incidence|35585399|All Races|Female|Acute Myeloid|2000|0.6|0.7|0.6
0-19|0.6|0.8|0.7|248|Incidence|37294501|All Races|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|258|Incidence|38330396|All Races|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|249|Incidence|39731700|All Races|Female|Acute Myeloid|2003|0.6|0.7|0.6
0-19|0.5|0.7|0.6|245|Incidence|39908757|All Races|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.7|1343|Incidence|201197585|All Races|Female|Acute Myeloid|2004-2008|0.6|0.7|0.7
0-19|0.6|0.7|0.6|262|Incidence|40041255|All Races|Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|285|Incidence|40202922|All Races|Female|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.7|0.7|271|Incidence|40435594|All Races|Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|280|Incidence|40609057|All Races|Female|Acute Myeloid|2008|0.6|0.8|0.7
0-19|14.5|15.3|14.9|5249|Incidence|35359689|All Races|Female|All Cancer Sites Combined|1999|14.4|15.3|14.8
0-19|15.0|15.8|15.4|5466|Incidence|35585399|All Races|Female|All Cancer Sites Combined|2000|15.0|15.8|15.4
0-19|15.7|16.5|16.1|6018|Incidence|37294501|All Races|Female|All Cancer Sites Combined|2001|15.7|16.5|16.1
0-19|15.2|16.0|15.6|5989|Incidence|38330396|All Races|Female|All Cancer Sites Combined|2002|15.2|16.0|15.6
0-19|15.6|16.4|16.0|6376|Incidence|39731700|All Races|Female|All Cancer Sites Combined|2003|15.7|16.4|16.0
0-19|15.9|16.7|16.3|6530|Incidence|39908757|All Races|Female|All Cancer Sites Combined|2004|16.0|16.8|16.4
0-19|16.0|16.3|16.2|32828|Incidence|201197585|All Races|Female|All Cancer Sites Combined|2004-2008|16.1|16.5|16.3
0-19|15.8|16.6|16.2|6532|Incidence|40041255|All Races|Female|All Cancer Sites Combined|2005|15.9|16.7|16.3
0-19|15.5|16.2|15.8|6429|Incidence|40202922|All Races|Female|All Cancer Sites Combined|2006|15.6|16.4|16.0
0-19|16.0|16.7|16.4|6687|Incidence|40435594|All Races|Female|All Cancer Sites Combined|2007|16.1|16.9|16.5
0-19|15.8|16.6|16.2|6650|Incidence|40609057|All Races|Female|All Cancer Sites Combined|2008|16.0|16.8|16.4
0-19|0.7|0.9|0.8|276|Incidence|35359689|All Races|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|282|Incidence|35585399|All Races|Female|Bones and Joints|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|309|Incidence|37294501|All Races|Female|Bones and Joints|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|294|Incidence|38330396|All Races|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|0.9|0.8|337|Incidence|39731700|All Races|Female|Bones and Joints|2003|0.8|0.9|0.8
0-19|0.8|1.0|0.9|355|Incidence|39908757|All Races|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1620|Incidence|201197585|All Races|Female|Bones and Joints|2004-2008|0.8|0.8|0.8
0-19|0.7|0.9|0.8|322|Incidence|40041255|All Races|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|323|Incidence|40202922|All Races|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|305|Incidence|40435594|All Races|Female|Bones and Joints|2007|0.7|0.8|0.8
0-19|0.7|0.9|0.8|315|Incidence|40609057|All Races|Female|Bones and Joints|2008|0.7|0.9|0.8
0-19|2.6|2.9|2.7|969|Incidence|35359689|All Races|Female|Brain and Other Nervous System|1999|2.6|2.9|2.7
0-19|2.6|3.0|2.8|999|Incidence|35585399|All Races|Female|Brain and Other Nervous System|2000|2.6|3.0|2.8
0-19|2.7|3.0|2.8|1056|Incidence|37294501|All Races|Female|Brain and Other Nervous System|2001|2.7|3.0|2.8
0-19|2.6|2.9|2.8|1057|Incidence|38330396|All Races|Female|Brain and Other Nervous System|2002|2.6|2.9|2.8
0-19|2.7|3.1|2.9|1154|Incidence|39731700|All Races|Female|Brain and Other Nervous System|2003|2.7|3.1|2.9
0-19|2.9|3.2|3.1|1225|Incidence|39908757|All Races|Female|Brain and Other Nervous System|2004|2.9|3.2|3.1
0-19|2.9|3.0|2.9|5914|Incidence|201197585|All Races|Female|Brain and Other Nervous System|2004-2008|2.9|3.0|2.9
0-19|2.7|3.0|2.9|1150|Incidence|40041255|All Races|Female|Brain and Other Nervous System|2005|2.7|3.0|2.9
0-19|2.7|3.0|2.8|1143|Incidence|40202922|All Races|Female|Brain and Other Nervous System|2006|2.7|3.0|2.8
0-19|2.9|3.2|3.1|1236|Incidence|40435594|All Races|Female|Brain and Other Nervous System|2007|2.9|3.2|3.1
0-19|2.7|3.0|2.8|1160|Incidence|40609057|All Races|Female|Brain and Other Nervous System|2008|2.7|3.0|2.9
0-19|1.0|1.2|1.1|374|Incidence|35359689|All Races|Female|Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|429|Incidence|35585399|All Races|Female|Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.3|1.2|449|Incidence|37294501|All Races|Female|Hodgkin Lymphoma|2001|1.1|1.3|1.2
0-19|1.1|1.3|1.2|467|Incidence|38330396|All Races|Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.1|1.3|1.2|464|Incidence|39731700|All Races|Female|Hodgkin Lymphoma|2003|1.1|1.3|1.2
0-19|1.1|1.3|1.2|473|Incidence|39908757|All Races|Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.1|1.2|1.2|2423|Incidence|201197585|All Races|Female|Hodgkin Lymphoma|2004-2008|1.2|1.3|1.2
0-19|1.1|1.3|1.2|494|Incidence|40041255|All Races|Female|Hodgkin Lymphoma|2005|1.1|1.3|1.2
0-19|1.1|1.3|1.2|478|Incidence|40202922|All Races|Female|Hodgkin Lymphoma|2006|1.1|1.3|1.2
0-19|1.0|1.2|1.1|453|Incidence|40435594|All Races|Female|Hodgkin Lymphoma|2007|1.0|1.2|1.1
0-19|1.2|1.4|1.3|525|Incidence|40609057|All Races|Female|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|0.6|0.8|0.7|254|Incidence|35359689|All Races|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|259|Incidence|35585399|All Races|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|279|Incidence|37294501|All Races|Female|Kidney and Renal Pelvis|2001|0.7|0.8|0.7
0-19|0.6|0.8|0.7|255|Incidence|38330396|All Races|Female|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.7|0.9|0.8|308|Incidence|39731700|All Races|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|270|Incidence|39908757|All Races|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1495|Incidence|201197585|All Races|Female|Kidney and Renal Pelvis|2004-2008|0.7|0.8|0.7
0-19|0.6|0.8|0.7|296|Incidence|40041255|All Races|Female|Kidney and Renal Pelvis|2005|0.7|0.8|0.7
0-19|0.6|0.8|0.7|283|Incidence|40202922|All Races|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|323|Incidence|40435594|All Races|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|323|Incidence|40609057|All Races|Female|Kidney and Renal Pelvis|2008|0.7|0.9|0.8
0-19|3.4|3.8|3.6|1285|Incidence|35359689|All Races|Female|Leukemia|1999|3.4|3.8|3.6
0-19|3.6|4.0|3.8|1347|Incidence|35585399|All Races|Female|Leukemia|2000|3.6|4.0|3.8
0-19|3.8|4.2|4.0|1480|Incidence|37294501|All Races|Female|Leukemia|2001|3.8|4.2|4.0
0-19|3.6|4.0|3.8|1453|Incidence|38330396|All Races|Female|Leukemia|2002|3.6|4.0|3.8
0-19|3.4|3.8|3.6|1434|Incidence|39731700|All Races|Female|Leukemia|2003|3.4|3.8|3.6
0-19|3.5|3.9|3.7|1486|Incidence|39908757|All Races|Female|Leukemia|2004|3.5|3.9|3.7
0-19|3.8|3.9|3.8|7801|Incidence|201197585|All Races|Female|Leukemia|2004-2008|3.8|4.0|3.9
0-19|3.6|3.9|3.8|1514|Incidence|40041255|All Races|Female|Leukemia|2005|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1574|Incidence|40202922|All Races|Female|Leukemia|2006|3.7|4.1|3.9
0-19|3.7|4.1|3.9|1601|Incidence|40435594|All Races|Female|Leukemia|2007|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1626|Incidence|40609057|All Races|Female|Leukemia|2008|3.8|4.2|4.0
0-19|0.6|0.8|0.7|250|Incidence|35359689|All Races|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|276|Incidence|35585399|All Races|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|296|Incidence|37294501|All Races|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|299|Incidence|38330396|All Races|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|291|Incidence|39731700|All Races|Female|Non-Hodgkin Lymphoma|2003|0.7|0.8|0.7
0-19|0.7|0.9|0.8|317|Incidence|39908757|All Races|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.8|0.8|1556|Incidence|201197585|All Races|Female|Non-Hodgkin Lymphoma|2004-2008|0.7|0.8|0.8
0-19|0.7|0.9|0.8|316|Incidence|40041255|All Races|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.7|301|Incidence|40202922|All Races|Female|Non-Hodgkin Lymphoma|2006|0.7|0.8|0.7
0-19|0.7|0.9|0.8|319|Incidence|40435594|All Races|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|0.7|0.8|0.7|303|Incidence|40609057|All Races|Female|Non-Hodgkin Lymphoma|2008|0.7|0.8|0.7
0-19|4.1|4.6|4.3|1527|Incidence|35359689|All Races|Female|Other|1999|4.1|4.5|4.3
0-19|4.1|4.5|4.3|1525|Incidence|35585399|All Races|Female|Other|2000|4.1|4.5|4.3
0-19|4.5|5.0|4.8|1780|Incidence|37294501|All Races|Female|Other|2001|4.6|5.0|4.8
0-19|4.4|4.9|4.6|1786|Incidence|38330396|All Races|Female|Other|2002|4.4|4.9|4.7
0-19|4.7|5.2|4.9|1978|Incidence|39731700|All Races|Female|Other|2003|4.8|5.2|5.0
0-19|4.7|5.1|4.9|1975|Incidence|39908757|All Races|Female|Other|2004|4.7|5.2|4.9
0-19|4.8|5.0|4.9|9929|Incidence|201197585|All Races|Female|Other|2004-2008|4.8|5.0|4.9
0-19|4.8|5.3|5.0|2050|Incidence|40041255|All Races|Female|Other|2005|4.9|5.3|5.1
0-19|4.5|4.9|4.7|1935|Incidence|40202922|All Races|Female|Other|2006|4.6|5.0|4.8
0-19|4.6|5.1|4.9|2003|Incidence|40435594|All Races|Female|Other|2007|4.7|5.2|5.0
0-19|4.5|5.0|4.7|1966|Incidence|40609057|All Races|Female|Other|2008|4.6|5.1|4.8
0-19|0.8|1.0|0.9|314|Incidence|35359689|All Races|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|349|Incidence|35585399|All Races|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|369|Incidence|37294501|All Races|Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|378|Incidence|38330396|All Races|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Incidence|39731700|All Races|Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.2|1.1|429|Incidence|39908757|All Races|Female|Soft Tissue|2004|1.0|1.2|1.1
0-19|1.0|1.1|1.0|2090|Incidence|201197585|All Races|Female|Soft Tissue|2004-2008|1.0|1.1|1.0
0-19|0.9|1.1|1.0|390|Incidence|40041255|All Races|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|392|Incidence|40202922|All Races|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|447|Incidence|40435594|All Races|Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|432|Incidence|40609057|All Races|Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|3.2|3.6|3.4|1262|Incidence|37188457|All Races|Male|Acute Lymphocytic|1999|3.2|3.6|3.4
0-19|3.2|3.6|3.4|1280|Incidence|37431805|All Races|Male|Acute Lymphocytic|2000|3.2|3.6|3.4
0-19|3.4|3.7|3.5|1381|Incidence|39251872|All Races|Male|Acute Lymphocytic|2001|3.3|3.7|3.5
0-19|3.3|3.7|3.5|1396|Incidence|40327357|All Races|Male|Acute Lymphocytic|2002|3.3|3.6|3.5
0-19|3.2|3.5|3.3|1386|Incidence|41753613|All Races|Male|Acute Lymphocytic|2003|3.1|3.5|3.3
0-19|3.5|3.9|3.7|1560|Incidence|41911213|All Races|Male|Acute Lymphocytic|2004|3.5|3.9|3.7
0-19|3.5|3.7|3.6|7668|Incidence|211139504|All Races|Male|Acute Lymphocytic|2004-2008|3.6|3.7|3.6
0-19|3.3|3.7|3.5|1485|Incidence|42031490|All Races|Male|Acute Lymphocytic|2005|3.4|3.7|3.5
0-19|3.5|3.8|3.6|1542|Incidence|42186878|All Races|Male|Acute Lymphocytic|2006|3.5|3.8|3.7
0-19|3.5|3.8|3.6|1555|Incidence|42421376|All Races|Male|Acute Lymphocytic|2007|3.5|3.9|3.7
0-19|3.4|3.7|3.5|1526|Incidence|42588547|All Races|Male|Acute Lymphocytic|2008|3.4|3.8|3.6
0-19|0.7|0.9|0.8|292|Incidence|37188457|All Races|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|251|Incidence|37431805|All Races|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|295|Incidence|39251872|All Races|Male|Acute Myeloid|2001|0.7|0.8|0.8
0-19|0.7|0.8|0.8|306|Incidence|40327357|All Races|Male|Acute Myeloid|2002|0.7|0.8|0.8
0-19|0.6|0.8|0.7|306|Incidence|41753613|All Races|Male|Acute Myeloid|2003|0.7|0.8|0.7
0-19|0.8|0.9|0.8|355|Incidence|41911213|All Races|Male|Acute Myeloid|2004|0.8|0.9|0.8
0-19|0.7|0.8|0.7|1566|Incidence|211139504|All Races|Male|Acute Myeloid|2004-2008|0.7|0.8|0.7
0-19|0.6|0.7|0.7|281|Incidence|42031490|All Races|Male|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|302|Incidence|42186878|All Races|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|303|Incidence|42421376|All Races|Male|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.7|0.8|0.8|325|Incidence|42588547|All Races|Male|Acute Myeloid|2008|0.7|0.9|0.8
0-19|16.4|17.3|16.9|6258|Incidence|37188457|All Races|Male|All Cancer Sites Combined|1999|16.4|17.2|16.8
0-19|16.7|17.6|17.2|6415|Incidence|37431805|All Races|Male|All Cancer Sites Combined|2000|16.7|17.6|17.1
0-19|17.3|18.2|17.7|6963|Incidence|39251872|All Races|Male|All Cancer Sites Combined|2001|17.3|18.2|17.7
0-19|17.7|18.5|18.1|7309|Incidence|40327357|All Races|Male|All Cancer Sites Combined|2002|17.7|18.5|18.1
0-19|16.7|17.5|17.1|7177|Incidence|41753613|All Races|Male|All Cancer Sites Combined|2003|16.8|17.6|17.2
0-19|17.8|18.6|18.2|7660|Incidence|41911213|All Races|Male|All Cancer Sites Combined|2004|17.9|18.7|18.3
0-19|17.8|18.2|18.0|38312|Incidence|211139504|All Races|Male|All Cancer Sites Combined|2004-2008|18.0|18.3|18.1
0-19|17.4|18.2|17.8|7548|Incidence|42031490|All Races|Male|All Cancer Sites Combined|2005|17.6|18.4|18.0
0-19|17.6|18.4|18.0|7660|Incidence|42186878|All Races|Male|All Cancer Sites Combined|2006|17.8|18.6|18.2
0-19|17.7|18.5|18.1|7748|Incidence|42421376|All Races|Male|All Cancer Sites Combined|2007|17.9|18.7|18.3
0-19|17.5|18.3|17.9|7696|Incidence|42588547|All Races|Male|All Cancer Sites Combined|2008|17.7|18.5|18.1
0-19|0.9|1.1|1.0|379|Incidence|37188457|All Races|Male|Bones and Joints|1999|0.9|1.1|1.0
0-19|0.8|1.0|0.9|352|Incidence|37431805|All Races|Male|Bones and Joints|2000|0.8|1.0|0.9
0-19|1.0|1.2|1.1|432|Incidence|39251872|All Races|Male|Bones and Joints|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|447|Incidence|40327357|All Races|Male|Bones and Joints|2002|1.0|1.2|1.1
0-19|0.9|1.0|0.9|397|Incidence|41753613|All Races|Male|Bones and Joints|2003|0.9|1.0|1.0
0-19|0.9|1.1|1.0|408|Incidence|41911213|All Races|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|1.0|1.0|1.0|2125|Incidence|211139504|All Races|Male|Bones and Joints|2004-2008|1.0|1.1|1.0
0-19|0.9|1.1|1.0|419|Incidence|42031490|All Races|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.2|1.1|462|Incidence|42186878|All Races|Male|Bones and Joints|2006|1.0|1.2|1.1
0-19|0.9|1.1|1.0|428|Incidence|42421376|All Races|Male|Bones and Joints|2007|0.9|1.1|1.0
0-19|0.9|1.1|1.0|408|Incidence|42588547|All Races|Male|Bones and Joints|2008|0.9|1.1|1.0
0-19|2.9|3.3|3.1|1147|Incidence|37188457|All Races|Male|Brain and Other Nervous System|1999|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1241|Incidence|37431805|All Races|Male|Brain and Other Nervous System|2000|3.1|3.5|3.3
0-19|3.0|3.3|3.1|1234|Incidence|39251872|All Races|Male|Brain and Other Nervous System|2001|3.0|3.3|3.1
0-19|3.3|3.7|3.5|1400|Incidence|40327357|All Races|Male|Brain and Other Nervous System|2002|3.3|3.7|3.5
0-19|2.9|3.3|3.1|1292|Incidence|41753613|All Races|Male|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1373|Incidence|41911213|All Races|Male|Brain and Other Nervous System|2004|3.1|3.5|3.3
0-19|3.1|3.3|3.2|6809|Incidence|211139504|All Races|Male|Brain and Other Nervous System|2004-2008|3.1|3.3|3.2
0-19|2.9|3.3|3.1|1300|Incidence|42031490|All Races|Male|Brain and Other Nervous System|2005|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1386|Incidence|42186878|All Races|Male|Brain and Other Nervous System|2006|3.1|3.5|3.3
0-19|3.1|3.4|3.2|1371|Incidence|42421376|All Races|Male|Brain and Other Nervous System|2007|3.1|3.4|3.2
0-19|3.1|3.4|3.2|1379|Incidence|42588547|All Races|Male|Brain and Other Nervous System|2008|3.1|3.4|3.2
0-19|1.2|1.4|1.3|480|Incidence|37188457|All Races|Male|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.2|1.4|1.3|474|Incidence|37431805|All Races|Male|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.2|1.4|1.3|515|Incidence|39251872|All Races|Male|Hodgkin Lymphoma|2001|1.2|1.4|1.3
0-19|1.1|1.4|1.2|503|Incidence|40327357|All Races|Male|Hodgkin Lymphoma|2002|1.1|1.4|1.2
0-19|1.2|1.4|1.3|557|Incidence|41753613|All Races|Male|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.1|1.3|1.2|518|Incidence|41911213|All Races|Male|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.3|1.4|1.3|2797|Incidence|211139504|All Races|Male|Hodgkin Lymphoma|2004-2008|1.3|1.4|1.3
0-19|1.3|1.5|1.4|581|Incidence|42031490|All Races|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.2|1.5|1.4|575|Incidence|42186878|All Races|Male|Hodgkin Lymphoma|2006|1.3|1.5|1.4
0-19|1.2|1.4|1.3|569|Incidence|42421376|All Races|Male|Hodgkin Lymphoma|2007|1.2|1.5|1.3
0-19|1.2|1.4|1.3|554|Incidence|42588547|All Races|Male|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|0.5|0.7|0.6|226|Incidence|37188457|All Races|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.6|0.8|0.7|247|Incidence|37431805|All Races|Male|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.6|253|Incidence|39251872|All Races|Male|Kidney and Renal Pelvis|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|270|Incidence|40327357|All Races|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|249|Incidence|41753613|All Races|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.7|0.6|275|Incidence|41911213|All Races|Male|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.6|1364|Incidence|211139504|All Races|Male|Kidney and Renal Pelvis|2004-2008|0.6|0.7|0.6
0-19|0.6|0.7|0.6|271|Incidence|42031490|All Races|Male|Kidney and Renal Pelvis|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.7|284|Incidence|42186878|All Races|Male|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|259|Incidence|42421376|All Races|Male|Kidney and Renal Pelvis|2007|0.5|0.7|0.6
0-19|0.6|0.7|0.6|275|Incidence|42588547|All Races|Male|Kidney and Renal Pelvis|2008|0.6|0.7|0.6
0-19|4.4|4.8|4.6|1699|Incidence|37188457|All Races|Male|Leukemia|1999|4.4|4.8|4.6
0-19|4.2|4.7|4.4|1659|Incidence|37431805|All Races|Male|Leukemia|2000|4.2|4.7|4.4
0-19|4.5|4.9|4.7|1842|Incidence|39251872|All Races|Male|Leukemia|2001|4.5|4.9|4.7
0-19|4.4|4.9|4.6|1870|Incidence|40327357|All Races|Male|Leukemia|2002|4.4|4.9|4.6
0-19|4.3|4.7|4.5|1863|Incidence|41753613|All Races|Male|Leukemia|2003|4.3|4.7|4.5
0-19|4.8|5.2|5.0|2099|Incidence|41911213|All Races|Male|Leukemia|2004|4.8|5.2|5.0
0-19|4.7|4.9|4.8|10173|Incidence|211139504|All Races|Male|Leukemia|2004-2008|4.7|4.9|4.8
0-19|4.4|4.8|4.6|1961|Incidence|42031490|All Races|Male|Leukemia|2005|4.5|4.9|4.7
0-19|4.6|5.0|4.8|2035|Incidence|42186878|All Races|Male|Leukemia|2006|4.6|5.0|4.8
0-19|4.6|5.0|4.8|2040|Incidence|42421376|All Races|Male|Leukemia|2007|4.6|5.0|4.8
0-19|4.5|4.9|4.7|2038|Incidence|42588547|All Races|Male|Leukemia|2008|4.6|5.0|4.8
0-19|1.3|1.5|1.4|517|Incidence|37188457|All Races|Male|Non-Hodgkin Lymphoma|1999|1.3|1.5|1.4
0-19|1.4|1.6|1.5|555|Incidence|37431805|All Races|Male|Non-Hodgkin Lymphoma|2000|1.4|1.6|1.5
0-19|1.3|1.5|1.4|561|Incidence|39251872|All Races|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.4
0-19|1.3|1.6|1.4|579|Incidence|40327357|All Races|Male|Non-Hodgkin Lymphoma|2002|1.3|1.6|1.4
0-19|1.3|1.5|1.4|588|Incidence|41753613|All Races|Male|Non-Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.3|1.6|1.4|604|Incidence|41911213|All Races|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.4|1.6|1.5|3164|Incidence|211139504|All Races|Male|Non-Hodgkin Lymphoma|2004-2008|1.4|1.6|1.5
0-19|1.4|1.7|1.5|649|Incidence|42031490|All Races|Male|Non-Hodgkin Lymphoma|2005|1.4|1.7|1.5
0-19|1.4|1.6|1.5|625|Incidence|42186878|All Races|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.7|1.5|647|Incidence|42421376|All Races|Male|Non-Hodgkin Lymphoma|2007|1.4|1.6|1.5
0-19|1.4|1.6|1.5|639|Incidence|42588547|All Races|Male|Non-Hodgkin Lymphoma|2008|1.4|1.6|1.5
0-19|3.8|4.2|4.0|1491|Incidence|37188457|All Races|Male|Other|1999|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1492|Incidence|37431805|All Races|Male|Other|2000|3.8|4.2|4.0
0-19|4.2|4.6|4.4|1728|Incidence|39251872|All Races|Male|Other|2001|4.2|4.6|4.4
0-19|4.3|4.7|4.5|1812|Incidence|40327357|All Races|Male|Other|2002|4.3|4.7|4.5
0-19|4.1|4.5|4.3|1812|Incidence|41753613|All Races|Male|Other|2003|4.1|4.5|4.3
0-19|4.4|4.8|4.6|1953|Incidence|41911213|All Races|Male|Other|2004|4.5|4.9|4.7
0-19|4.4|4.6|4.5|9660|Incidence|211139504|All Races|Male|Other|2004-2008|4.5|4.7|4.6
0-19|4.2|4.6|4.4|1898|Incidence|42031490|All Races|Male|Other|2005|4.3|4.7|4.5
0-19|4.1|4.5|4.3|1864|Incidence|42186878|All Races|Male|Other|2006|4.2|4.6|4.4
0-19|4.4|4.8|4.6|1992|Incidence|42421376|All Races|Male|Other|2007|4.5|4.9|4.7
0-19|4.3|4.7|4.5|1953|Incidence|42588547|All Races|Male|Other|2008|4.4|4.8|4.6
0-19|0.8|1.0|0.9|319|Incidence|37188457|All Races|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|395|Incidence|37431805|All Races|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|398|Incidence|39251872|All Races|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|428|Incidence|40327357|All Races|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|0.9|1.1|1.0|419|Incidence|41753613|All Races|Male|Soft Tissue|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|430|Incidence|41911213|All Races|Male|Soft Tissue|2004|0.9|1.1|1.0
0-19|1.0|1.1|1.0|2220|Incidence|211139504|All Races|Male|Soft Tissue|2004-2008|1.0|1.1|1.1
0-19|1.0|1.2|1.1|469|Incidence|42031490|All Races|Male|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|429|Incidence|42186878|All Races|Male|Soft Tissue|2006|0.9|1.1|1.0
0-19|0.9|1.1|1.0|442|Incidence|42421376|All Races|Male|Soft Tissue|2007|0.9|1.1|1.0
0-19|0.9|1.1|1.0|450|Incidence|42588547|All Races|Male|Soft Tissue|2008|1.0|1.2|1.1
0-19|2.9|3.2|3.0|2202|Incidence|72548146|All Races|Male and Female|Acute Lymphocytic|1999|2.9|3.2|3.0
0-19|3.0|3.3|3.2|2292|Incidence|73017204|All Races|Male and Female|Acute Lymphocytic|2000|3.0|3.3|3.1
0-19|3.1|3.4|3.2|2470|Incidence|76546373|All Races|Male and Female|Acute Lymphocytic|2001|3.1|3.4|3.2
0-19|3.0|3.2|3.1|2437|Incidence|78657753|All Races|Male and Female|Acute Lymphocytic|2002|3.0|3.2|3.1
0-19|2.9|3.1|3.0|2440|Incidence|81485313|All Races|Male and Female|Acute Lymphocytic|2003|2.9|3.1|3.0
0-19|3.1|3.4|3.2|2659|Incidence|81819970|All Races|Male and Female|Acute Lymphocytic|2004|3.1|3.4|3.2
0-19|3.2|3.3|3.2|13405|Incidence|412337089|All Races|Male and Female|Acute Lymphocytic|2004-2008|3.2|3.3|3.3
0-19|3.0|3.3|3.1|2591|Incidence|82072745|All Races|Male and Female|Acute Lymphocytic|2005|3.0|3.3|3.2
0-19|3.1|3.4|3.2|2681|Incidence|82389800|All Races|Male and Female|Acute Lymphocytic|2006|3.1|3.4|3.3
0-19|3.2|3.4|3.3|2734|Incidence|82856970|All Races|Male and Female|Acute Lymphocytic|2007|3.2|3.4|3.3
0-19|3.1|3.4|3.3|2740|Incidence|83197604|All Races|Male and Female|Acute Lymphocytic|2008|3.2|3.4|3.3
0-19|0.7|0.8|0.7|533|Incidence|72548146|All Races|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.7|476|Incidence|73017204|All Races|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|543|Incidence|76546373|All Races|Male and Female|Acute Myeloid|2001|0.7|0.8|0.7
0-19|0.7|0.8|0.7|564|Incidence|78657753|All Races|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.7|555|Incidence|81485313|All Races|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|600|Incidence|81819970|All Races|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.7|0.7|0.7|2909|Incidence|412337089|All Races|Male and Female|Acute Myeloid|2004-2008|0.7|0.7|0.7
0-19|0.6|0.7|0.7|543|Incidence|82072745|All Races|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|587|Incidence|82389800|All Races|Male and Female|Acute Myeloid|2006|0.7|0.8|0.7
0-19|0.6|0.7|0.7|574|Incidence|82856970|All Races|Male and Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.7|0.8|0.7|605|Incidence|83197604|All Races|Male and Female|Acute Myeloid|2008|0.7|0.8|0.7
0-19|15.6|16.2|15.9|11507|Incidence|72548146|All Races|Male and Female|All Cancer Sites Combined|1999|15.6|16.2|15.9
0-19|16.0|16.6|16.3|11881|Incidence|73017204|All Races|Male and Female|All Cancer Sites Combined|2000|16.0|16.6|16.3
0-19|16.7|17.3|17.0|12981|Incidence|76546373|All Races|Male and Female|All Cancer Sites Combined|2001|16.7|17.3|17.0
0-19|16.6|17.2|16.9|13298|Incidence|78657753|All Races|Male and Female|All Cancer Sites Combined|2002|16.6|17.2|16.9
0-19|16.3|16.9|16.6|13553|Incidence|81485313|All Races|Male and Female|All Cancer Sites Combined|2003|16.4|16.9|16.6
0-19|17.0|17.5|17.2|14190|Incidence|81819970|All Races|Male and Female|All Cancer Sites Combined|2004|17.1|17.6|17.3
0-19|17.0|17.2|17.1|71140|Incidence|412337089|All Races|Male and Female|All Cancer Sites Combined|2004-2008|17.1|17.4|17.3
0-19|16.7|17.3|17.0|14080|Incidence|82072745|All Races|Male and Female|All Cancer Sites Combined|2005|16.9|17.4|17.2
0-19|16.7|17.2|16.9|14089|Incidence|82389800|All Races|Male and Female|All Cancer Sites Combined|2006|16.8|17.4|17.1
0-19|16.9|17.5|17.2|14435|Incidence|82856970|All Races|Male and Female|All Cancer Sites Combined|2007|17.1|17.7|17.4
0-19|16.8|17.3|17.0|14346|Incidence|83197604|All Races|Male and Female|All Cancer Sites Combined|2008|17.0|17.5|17.2
0-19|0.8|1.0|0.9|655|Incidence|72548146|All Races|Male and Female|Bones and Joints|1999|0.8|1.0|0.9
0-19|0.8|0.9|0.9|634|Incidence|73017204|All Races|Male and Female|Bones and Joints|2000|0.8|0.9|0.9
0-19|0.9|1.0|1.0|741|Incidence|76546373|All Races|Male and Female|Bones and Joints|2001|0.9|1.0|1.0
0-19|0.9|1.0|0.9|741|Incidence|78657753|All Races|Male and Female|Bones and Joints|2002|0.9|1.0|0.9
0-19|0.8|1.0|0.9|734|Incidence|81485313|All Races|Male and Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.9|1.0|0.9|763|Incidence|81819970|All Races|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.9|0.9|0.9|3745|Incidence|412337089|All Races|Male and Female|Bones and Joints|2004-2008|0.9|0.9|0.9
0-19|0.8|1.0|0.9|741|Incidence|82072745|All Races|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.0|1.0|785|Incidence|82389800|All Races|Male and Female|Bones and Joints|2006|0.9|1.0|1.0
0-19|0.8|1.0|0.9|733|Incidence|82856970|All Races|Male and Female|Bones and Joints|2007|0.8|1.0|0.9
0-19|0.8|0.9|0.9|723|Incidence|83197604|All Races|Male and Female|Bones and Joints|2008|0.8|0.9|0.9
0-19|2.8|3.0|2.9|2116|Incidence|72548146|All Races|Male and Female|Brain and Other Nervous System|1999|2.8|3.0|2.9
0-19|2.9|3.2|3.1|2240|Incidence|73017204|All Races|Male and Female|Brain and Other Nervous System|2000|2.9|3.2|3.1
0-19|2.9|3.1|3.0|2290|Incidence|76546373|All Races|Male and Female|Brain and Other Nervous System|2001|2.9|3.1|3.0
0-19|3.0|3.3|3.1|2457|Incidence|78657753|All Races|Male and Female|Brain and Other Nervous System|2002|3.0|3.2|3.1
0-19|2.9|3.1|3.0|2446|Incidence|81485313|All Races|Male and Female|Brain and Other Nervous System|2003|2.9|3.1|3.0
0-19|3.1|3.3|3.2|2598|Incidence|81819970|All Races|Male and Female|Brain and Other Nervous System|2004|3.1|3.3|3.2
0-19|3.0|3.1|3.1|12723|Incidence|412337089|All Races|Male and Female|Brain and Other Nervous System|2004-2008|3.0|3.1|3.1
0-19|2.9|3.1|3.0|2450|Incidence|82072745|All Races|Male and Female|Brain and Other Nervous System|2005|2.9|3.1|3.0
0-19|2.9|3.2|3.1|2529|Incidence|82389800|All Races|Male and Female|Brain and Other Nervous System|2006|3.0|3.2|3.1
0-19|3.0|3.3|3.1|2607|Incidence|82856970|All Races|Male and Female|Brain and Other Nervous System|2007|3.0|3.3|3.1
0-19|2.9|3.2|3.0|2539|Incidence|83197604|All Races|Male and Female|Brain and Other Nervous System|2008|2.9|3.2|3.1
0-19|1.1|1.3|1.2|854|Incidence|72548146|All Races|Male and Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.3|1.2|903|Incidence|73017204|All Races|Male and Female|Hodgkin Lymphoma|2000|1.2|1.3|1.2
0-19|1.2|1.3|1.3|964|Incidence|76546373|All Races|Male and Female|Hodgkin Lymphoma|2001|1.2|1.3|1.3
0-19|1.2|1.3|1.2|970|Incidence|78657753|All Races|Male and Female|Hodgkin Lymphoma|2002|1.2|1.3|1.2
0-19|1.2|1.3|1.2|1021|Incidence|81485313|All Races|Male and Female|Hodgkin Lymphoma|2003|1.2|1.3|1.3
0-19|1.1|1.3|1.2|991|Incidence|81819970|All Races|Male and Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.3|1.3|5220|Incidence|412337089|All Races|Male and Female|Hodgkin Lymphoma|2004-2008|1.2|1.3|1.3
0-19|1.2|1.4|1.3|1075|Incidence|82072745|All Races|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1053|Incidence|82389800|All Races|Male and Female|Hodgkin Lymphoma|2006|1.2|1.4|1.3
0-19|1.1|1.3|1.2|1022|Incidence|82856970|All Races|Male and Female|Hodgkin Lymphoma|2007|1.2|1.3|1.2
0-19|1.2|1.4|1.3|1079|Incidence|83197604|All Races|Male and Female|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|0.6|0.7|0.7|480|Incidence|72548146|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.7
0-19|0.6|0.8|0.7|506|Incidence|73017204|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|532|Incidence|76546373|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.7|525|Incidence|78657753|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.7|557|Incidence|81485313|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Incidence|81819970|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2859|Incidence|412337089|All Races|Male and Female|Kidney and Renal Pelvis|2004-2008|0.7|0.7|0.7
0-19|0.6|0.7|0.7|567|Incidence|82072745|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|567|Incidence|82389800|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.7|0.7
0-19|0.6|0.7|0.7|582|Incidence|82856970|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|598|Incidence|83197604|All Races|Male and Female|Kidney and Renal Pelvis|2008|0.7|0.8|0.7
0-19|4.0|4.3|4.1|2984|Incidence|72548146|All Races|Male and Female|Leukemia|1999|4.0|4.3|4.1
0-19|4.0|4.3|4.1|3006|Incidence|73017204|All Races|Male and Female|Leukemia|2000|4.0|4.3|4.1
0-19|4.2|4.5|4.4|3322|Incidence|76546373|All Races|Male and Female|Leukemia|2001|4.2|4.5|4.3
0-19|4.1|4.4|4.2|3323|Incidence|78657753|All Races|Male and Female|Leukemia|2002|4.1|4.4|4.2
0-19|3.9|4.2|4.0|3297|Incidence|81485313|All Races|Male and Female|Leukemia|2003|3.9|4.2|4.0
0-19|4.2|4.5|4.4|3585|Incidence|81819970|All Races|Male and Female|Leukemia|2004|4.2|4.5|4.4
0-19|4.3|4.4|4.3|17974|Incidence|412337089|All Races|Male and Female|Leukemia|2004-2008|4.3|4.4|4.4
0-19|4.1|4.3|4.2|3475|Incidence|82072745|All Races|Male and Female|Leukemia|2005|4.1|4.4|4.2
0-19|4.2|4.5|4.4|3609|Incidence|82389800|All Races|Male and Female|Leukemia|2006|4.2|4.5|4.4
0-19|4.2|4.5|4.4|3641|Incidence|82856970|All Races|Male and Female|Leukemia|2007|4.3|4.5|4.4
0-19|4.2|4.5|4.4|3664|Incidence|83197604|All Races|Male and Female|Leukemia|2008|4.3|4.5|4.4
0-19|1.0|1.1|1.1|767|Incidence|72548146|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.1|1.1
0-19|1.1|1.2|1.1|831|Incidence|73017204|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.2|1.1
0-19|1.0|1.2|1.1|857|Incidence|76546373|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|878|Incidence|78657753|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.2|1.1
0-19|1.0|1.2|1.1|879|Incidence|81485313|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.1|1.2|1.1|921|Incidence|81819970|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|1.1|1.2|1.1
0-19|1.1|1.2|1.1|4720|Incidence|412337089|All Races|Male and Female|Non-Hodgkin Lymphoma|2004-2008|1.1|1.2|1.1
0-19|1.1|1.2|1.2|965|Incidence|82072745|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.3|1.2
0-19|1.1|1.2|1.1|926|Incidence|82389800|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|1.1|1.2|1.1
0-19|1.1|1.2|1.2|966|Incidence|82856970|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.2|1.2
0-19|1.1|1.2|1.1|942|Incidence|83197604|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|1.1|1.2|1.1
0-19|4.0|4.3|4.2|3018|Incidence|72548146|All Races|Male and Female|Other|1999|4.0|4.3|4.2
0-19|4.0|4.3|4.1|3017|Incidence|73017204|All Races|Male and Female|Other|2000|4.0|4.3|4.1
0-19|4.4|4.7|4.6|3508|Incidence|76546373|All Races|Male and Female|Other|2001|4.4|4.7|4.6
0-19|4.4|4.7|4.6|3598|Incidence|78657753|All Races|Male and Female|Other|2002|4.4|4.7|4.6
0-19|4.5|4.8|4.6|3790|Incidence|81485313|All Races|Male and Female|Other|2003|4.5|4.8|4.7
0-19|4.6|4.9|4.7|3928|Incidence|81819970|All Races|Male and Female|Other|2004|4.7|5.0|4.8
0-19|4.6|4.7|4.7|19589|Incidence|412337089|All Races|Male and Female|Other|2004-2008|4.7|4.8|4.8
0-19|4.6|4.9|4.7|3948|Incidence|82072745|All Races|Male and Female|Other|2005|4.7|5.0|4.8
0-19|4.4|4.7|4.5|3799|Incidence|82389800|All Races|Male and Female|Other|2006|4.5|4.8|4.6
0-19|4.6|4.9|4.7|3995|Incidence|82856970|All Races|Male and Female|Other|2007|4.7|5.0|4.8
0-19|4.5|4.8|4.6|3919|Incidence|83197604|All Races|Male and Female|Other|2008|4.6|4.9|4.7
0-19|0.8|0.9|0.9|633|Incidence|72548146|All Races|Male and Female|Soft Tissue|1999|0.8|0.9|0.9
0-19|0.9|1.1|1.0|744|Incidence|73017204|All Races|Male and Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|767|Incidence|76546373|All Races|Male and Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.1|1.0|806|Incidence|78657753|All Races|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|0.9|1.1|1.0|829|Incidence|81485313|All Races|Male and Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.1|1.0|859|Incidence|81819970|All Races|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.1|1.0|4310|Incidence|412337089|All Races|Male and Female|Soft Tissue|2004-2008|1.0|1.1|1.0
0-19|1.0|1.1|1.0|859|Incidence|82072745|All Races|Male and Female|Soft Tissue|2005|1.0|1.1|1.0
0-19|0.9|1.1|1.0|821|Incidence|82389800|All Races|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.1|1.1|889|Incidence|82856970|All Races|Male and Female|Soft Tissue|2007|1.0|1.1|1.1
0-19|1.0|1.1|1.0|882|Incidence|83197604|All Races|Male and Female|Soft Tissue|2008|1.0|1.1|1.1
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|1.3|2.3|1.7|51|Incidence|2892479|American Indian/Alaska Native|Female|Acute Lymphocytic|2004-2008|1.3|2.3|1.8
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|0.3|0.9|0.6|17|Incidence|2892479|American Indian/Alaska Native|Female|Acute Myeloid|2004-2008|0.3|0.9|0.6
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Acute Myeloid|2008|~|~|~
0-19|7.0|12.7|9.6|47|Incidence|496850|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|7.0|12.6|9.5
0-19|5.9|11.1|8.2|42|Incidence|514503|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|5.9|11.0|8.2
0-19|8.9|14.7|11.5|64|Incidence|554054|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|8.9|14.8|11.6
0-19|8.0|13.5|10.5|59|Incidence|560058|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|8.0|13.6|10.5
0-19|6.2|11.2|8.4|48|Incidence|567307|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|6.2|11.2|8.5
0-19|7.1|12.3|9.4|54|Incidence|569596|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|7.1|12.4|9.5
0-19|8.6|10.9|9.7|285|Incidence|2892479|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004-2008|8.7|11.1|9.9
0-19|8.1|13.5|10.5|62|Incidence|572960|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|8.3|13.9|10.8
0-19|8.5|14.1|11.0|65|Incidence|577169|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|8.7|14.4|11.3
0-19|7.0|12.1|9.3|55|Incidence|583397|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|7.1|12.3|9.4
0-19|6.0|10.8|8.2|49|Incidence|589357|American Indian/Alaska Native|Female|All Cancer Sites Combined|2008|6.2|11.0|8.3
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|0.4|1.0|0.6|18|Incidence|2892479|American Indian/Alaska Native|Female|Bones and Joints|2004-2008|0.4|1.0|0.6
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|1.1|2.0|1.5|44|Incidence|2892479|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004-2008|1.1|2.0|1.5
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.3|0.9|0.5|16|Incidence|2892479|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004-2008|0.3|0.9|0.6
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.3|0.9|0.6|18|Incidence|2892479|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004-2008|0.4|1.0|0.6
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|2.2|5.6|3.6|20|Incidence|554054|American Indian/Alaska Native|Female|Leukemia|2001|2.2|5.6|3.6
0-19|1.6|4.7|2.9|16|Incidence|560058|American Indian/Alaska Native|Female|Leukemia|2002|1.6|4.6|2.9
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|1.6|4.6|2.8|16|Incidence|569596|American Indian/Alaska Native|Female|Leukemia|2004|1.6|4.6|2.8
0-19|2.1|3.4|2.7|79|Incidence|2892479|American Indian/Alaska Native|Female|Leukemia|2004-2008|2.2|3.4|2.7
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|2.0|5.1|3.3|19|Incidence|577169|American Indian/Alaska Native|Female|Leukemia|2006|2.0|5.1|3.3
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|1.9|4.9|3.1|19|Incidence|589357|American Indian/Alaska Native|Female|Leukemia|2008|1.9|5.0|3.2
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|2892479|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|2.2|5.8|3.7|18|Incidence|496850|American Indian/Alaska Native|Female|Other|1999|2.1|5.7|3.6
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|2.3|5.8|3.8|21|Incidence|554054|American Indian/Alaska Native|Female|Other|2001|2.3|5.8|3.8
0-19|2.0|5.3|3.4|19|Incidence|560058|American Indian/Alaska Native|Female|Other|2002|2.0|5.3|3.4
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|2.2|3.4|2.7|81|Incidence|2892479|American Indian/Alaska Native|Female|Other|2004-2008|2.2|3.5|2.8
0-19|2.5|5.9|3.9|23|Incidence|572960|American Indian/Alaska Native|Female|Other|2005|2.5|6.0|4.0
0-19|2.0|5.1|3.3|20|Incidence|577169|American Indian/Alaska Native|Female|Other|2006|2.1|5.4|3.5
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Other|2008|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|0.4|1.1|0.7|21|Incidence|2892479|American Indian/Alaska Native|Female|Soft Tissue|2004-2008|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Soft Tissue|2008|~|~|~
0-19|2.0|5.4|3.4|17|Incidence|515305|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|1.9|5.3|3.3
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|1.7|4.8|3.0|17|Incidence|573609|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|1.7|4.7|3.0
0-19|1.9|4.9|3.1|18|Incidence|578827|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|1.8|4.9|3.1
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|1.9|5.0|3.2|19|Incidence|588062|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|1.9|5.0|3.2
0-19|2.3|3.5|2.9|86|Incidence|2984092|American Indian/Alaska Native|Male|Acute Lymphocytic|2004-2008|2.3|3.6|2.9
0-19|1.6|4.5|2.8|16|Incidence|591083|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|1.5|4.4|2.7
0-19|1.5|4.4|2.7|16|Incidence|595112|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|1.5|4.4|2.7
0-19|1.8|4.7|3.0|19|Incidence|602074|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|1.9|4.9|3.2
0-19|1.5|4.2|2.6|16|Incidence|607761|American Indian/Alaska Native|Male|Acute Lymphocytic|2008|1.5|4.3|2.6
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|2984092|American Indian/Alaska Native|Male|Acute Myeloid|2004-2008|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Acute Myeloid|2008|~|~|~
0-19|6.3|11.6|8.6|44|Incidence|515305|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|6.2|11.5|8.5
0-19|7.3|12.8|9.8|52|Incidence|533133|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|7.3|12.8|9.8
0-19|7.9|13.4|10.4|60|Incidence|573609|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|8.0|13.5|10.5
0-19|9.4|15.2|12.0|70|Incidence|578827|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|9.4|15.3|12.1
0-19|7.3|12.5|9.6|57|Incidence|585517|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|7.4|12.6|9.7
0-19|8.2|13.7|10.7|63|Incidence|588062|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|8.2|13.7|10.7
0-19|9.5|11.9|10.7|320|Incidence|2984092|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004-2008|9.6|12.0|10.7
0-19|10.0|15.9|12.7|75|Incidence|591083|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|10.0|15.9|12.7
0-19|8.4|13.9|10.9|65|Incidence|595112|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|8.4|13.9|10.9
0-19|7.3|12.4|9.6|59|Incidence|602074|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|7.5|12.6|9.8
0-19|7.2|12.2|9.5|58|Incidence|607761|American Indian/Alaska Native|Male|All Cancer Sites Combined|2008|7.2|12.3|9.5
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|0.3|0.9|0.6|17|Incidence|2984092|American Indian/Alaska Native|Male|Bones and Joints|2004-2008|0.3|0.9|0.6
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|1.3|2.4|1.8|53|Incidence|2984092|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004-2008|1.3|2.3|1.8
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|2984092|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|2984092|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|2.1|5.7|3.6|18|Incidence|515305|American Indian/Alaska Native|Male|Leukemia|1999|2.1|5.5|3.5
0-19|2.0|5.4|3.4|18|Incidence|533133|American Indian/Alaska Native|Male|Leukemia|2000|2.0|5.3|3.4
0-19|2.4|5.8|3.9|22|Incidence|573609|American Indian/Alaska Native|Male|Leukemia|2001|2.4|5.8|3.8
0-19|2.8|6.4|4.3|25|Incidence|578827|American Indian/Alaska Native|Male|Leukemia|2002|2.8|6.4|4.3
0-19|1.8|4.9|3.1|18|Incidence|585517|American Indian/Alaska Native|Male|Leukemia|2003|1.8|4.9|3.1
0-19|2.5|5.8|3.9|23|Incidence|588062|American Indian/Alaska Native|Male|Leukemia|2004|2.5|5.9|3.9
0-19|3.0|4.4|3.6|109|Incidence|2984092|American Indian/Alaska Native|Male|Leukemia|2004-2008|3.0|4.4|3.7
0-19|2.6|6.1|4.1|24|Incidence|591083|American Indian/Alaska Native|Male|Leukemia|2005|2.6|6.0|4.1
0-19|2.2|5.4|3.5|21|Incidence|595112|American Indian/Alaska Native|Male|Leukemia|2006|2.2|5.4|3.5
0-19|1.9|4.9|3.2|20|Incidence|602074|American Indian/Alaska Native|Male|Leukemia|2007|2.0|5.1|3.3
0-19|2.1|5.3|3.5|21|Incidence|607761|American Indian/Alaska Native|Male|Leukemia|2008|2.1|5.3|3.5
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.5|1.2|0.8|24|Incidence|2984092|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004-2008|0.5|1.2|0.8
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|1.6|4.5|2.8|16|Incidence|573609|American Indian/Alaska Native|Male|Other|2001|1.6|4.5|2.8
0-19|2.2|5.5|3.6|21|Incidence|578827|American Indian/Alaska Native|Male|Other|2002|2.2|5.5|3.6
0-19|1.7|4.6|2.8|17|Incidence|585517|American Indian/Alaska Native|Male|Other|2003|1.7|4.6|2.9
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|1.8|3.0|2.4|72|Incidence|2984092|American Indian/Alaska Native|Male|Other|2004-2008|1.9|3.0|2.4
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|1.6|4.5|2.8|17|Incidence|595112|American Indian/Alaska Native|Male|Other|2006|1.7|4.6|2.9
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Other|2008|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|0.4|1.1|0.7|21|Incidence|2984092|American Indian/Alaska Native|Male|Soft Tissue|2004-2008|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Soft Tissue|2008|~|~|~
0-19|1.9|4.1|2.8|28|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|1.8|4.0|2.8
0-19|1.5|3.4|2.3|24|Incidence|1047636|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|1.5|3.4|2.3
0-19|1.9|4.0|2.8|32|Incidence|1127663|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|1.9|4.0|2.8
0-19|1.6|3.6|2.5|28|Incidence|1138885|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|1.6|3.6|2.5
0-19|1.0|2.6|1.7|19|Incidence|1152824|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|1.0|2.6|1.6
0-19|1.8|3.8|2.7|31|Incidence|1157658|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|1.8|3.8|2.7
0-19|1.9|2.7|2.3|137|Incidence|5876571|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004-2008|2.0|2.8|2.3
0-19|1.5|3.3|2.2|26|Incidence|1164043|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|1.5|3.3|2.2
0-19|1.4|3.2|2.1|25|Incidence|1172281|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|1.4|3.1|2.1
0-19|1.4|3.2|2.2|27|Incidence|1185471|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|1.5|3.3|2.3
0-19|1.5|3.3|2.3|28|Incidence|1197118|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2008|1.6|3.4|2.3
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|0.3|0.7|0.5|29|Incidence|5876571|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004-2008|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Acute Myeloid|2008|~|~|~
0-19|7.3|11.1|9.1|91|Incidence|1012155|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|7.2|11.0|9.0
0-19|7.3|11.0|9.0|94|Incidence|1047636|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|7.3|11.0|9.0
0-19|9.1|13.1|11.0|124|Incidence|1127663|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|9.1|13.1|11.0
0-19|9.4|13.4|11.3|129|Incidence|1138885|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|9.5|13.5|11.3
0-19|7.4|10.9|9.0|105|Incidence|1152824|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|7.4|11.0|9.1
0-19|8.3|12.0|10.0|117|Incidence|1157658|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|8.4|12.1|10.1
0-19|9.4|11.0|10.2|605|Incidence|5876571|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004-2008|9.5|11.1|10.3
0-19|9.8|13.8|11.6|137|Incidence|1164043|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|9.9|13.9|11.8
0-19|9.2|13.0|11.0|130|Incidence|1172281|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|9.3|13.2|11.1
0-19|7.8|11.4|9.5|114|Incidence|1185471|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|7.9|11.6|9.6
0-19|7.2|10.7|8.8|107|Incidence|1197118|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2008|7.3|10.8|8.9
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|0.4|0.8|0.6|35|Incidence|5876571|American Indian/Alaska Native|Male and Female|Bones and Joints|2004-2008|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Bones and Joints|2008|~|~|~
0-19|0.9|2.6|1.6|16|Incidence|1012155|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|0.9|2.6|1.6
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|1.0|2.6|1.7|19|Incidence|1127663|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|1.0|2.6|1.7
0-19|1.1|2.8|1.8|21|Incidence|1138885|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|1.1|2.8|1.8
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|1.2|2.9|1.9|22|Incidence|1157658|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|1.2|2.9|1.9
0-19|1.3|2.0|1.7|97|Incidence|5876571|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004-2008|1.3|2.0|1.7
0-19|1.6|3.5|2.4|28|Incidence|1164043|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|1.6|3.5|2.4
0-19|0.9|2.4|1.5|18|Incidence|1172281|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|0.9|2.4|1.5
0-19|0.9|2.4|1.5|17|Incidence|1185471|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|0.8|2.3|1.4
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.3|0.7|0.5|28|Incidence|5876571|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004-2008|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.3|0.7|0.5|30|Incidence|5876571|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004-2008|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|2.3|4.7|3.3|33|Incidence|1012155|American Indian/Alaska Native|Male and Female|Leukemia|1999|2.2|4.6|3.3
0-19|2.0|4.2|3.0|31|Incidence|1047636|American Indian/Alaska Native|Male and Female|Leukemia|2000|2.0|4.2|3.0
0-19|2.7|5.0|3.7|42|Incidence|1127663|American Indian/Alaska Native|Male and Female|Leukemia|2001|2.7|5.0|3.7
0-19|2.6|4.9|3.6|41|Incidence|1138885|American Indian/Alaska Native|Male and Female|Leukemia|2002|2.6|4.9|3.6
0-19|1.9|3.9|2.8|32|Incidence|1152824|American Indian/Alaska Native|Male and Female|Leukemia|2003|1.9|3.9|2.8
0-19|2.4|4.6|3.4|39|Incidence|1157658|American Indian/Alaska Native|Male and Female|Leukemia|2004|2.4|4.6|3.4
0-19|2.7|3.7|3.2|188|Incidence|5876571|American Indian/Alaska Native|Male and Female|Leukemia|2004-2008|2.8|3.7|3.2
0-19|2.3|4.5|3.2|38|Incidence|1164043|American Indian/Alaska Native|Male and Female|Leukemia|2005|2.3|4.5|3.3
0-19|2.4|4.7|3.4|40|Incidence|1172281|American Indian/Alaska Native|Male and Female|Leukemia|2006|2.4|4.6|3.4
0-19|1.7|3.6|2.5|31|Incidence|1185471|American Indian/Alaska Native|Male and Female|Leukemia|2007|1.8|3.7|2.6
0-19|2.4|4.5|3.3|40|Incidence|1197118|American Indian/Alaska Native|Male and Female|Leukemia|2008|2.4|4.5|3.3
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.4|0.8|0.6|32|Incidence|5876571|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.4|0.8|0.5
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|1.6|3.7|2.5|25|Incidence|1012155|American Indian/Alaska Native|Male and Female|Other|1999|1.6|3.6|2.5
0-19|1.1|2.9|1.8|19|Incidence|1047636|American Indian/Alaska Native|Male and Female|Other|2000|1.1|2.8|1.8
0-19|2.3|4.5|3.3|37|Incidence|1127663|American Indian/Alaska Native|Male and Female|Other|2001|2.3|4.5|3.3
0-19|2.5|4.7|3.5|40|Incidence|1138885|American Indian/Alaska Native|Male and Female|Other|2002|2.5|4.8|3.5
0-19|1.9|3.9|2.7|32|Incidence|1152824|American Indian/Alaska Native|Male and Female|Other|2003|1.9|3.9|2.8
0-19|1.4|3.1|2.1|25|Incidence|1157658|American Indian/Alaska Native|Male and Female|Other|2004|1.4|3.2|2.2
0-19|2.1|3.0|2.5|153|Incidence|5876571|American Indian/Alaska Native|Male and Female|Other|2004-2008|2.2|3.1|2.6
0-19|2.3|4.4|3.2|38|Incidence|1164043|American Indian/Alaska Native|Male and Female|Other|2005|2.3|4.5|3.3
0-19|2.2|4.2|3.1|37|Incidence|1172281|American Indian/Alaska Native|Male and Female|Other|2006|2.2|4.4|3.2
0-19|1.6|3.4|2.4|29|Incidence|1185471|American Indian/Alaska Native|Male and Female|Other|2007|1.6|3.5|2.4
0-19|1.2|2.8|1.9|24|Incidence|1197118|American Indian/Alaska Native|Male and Female|Other|2008|1.3|3.0|2.0
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|0.5|0.9|0.7|42|Incidence|5876571|American Indian/Alaska Native|Male and Female|Soft Tissue|2004-2008|0.5|1.0|0.7
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Soft Tissue|2008|~|~|~
0-19|1.9|3.6|2.7|42|Incidence|1570391|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|1.9|3.6|2.7
0-19|1.3|2.7|1.9|31|Incidence|1618332|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|1.3|2.7|1.9
0-19|2.1|3.7|2.8|48|Incidence|1682415|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|2.1|3.8|2.9
0-19|2.3|3.9|3.0|55|Incidence|1762776|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|2.4|4.1|3.1
0-19|1.8|3.3|2.5|46|Incidence|1822464|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|1.8|3.4|2.5
0-19|1.8|3.3|2.5|49|Incidence|1866675|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|1.9|3.5|2.6
0-19|2.3|2.9|2.6|269|Incidence|9821710|Asian/Pacific Islander|Female|Acute Lymphocytic|2004-2008|2.4|3.1|2.7
0-19|2.0|3.5|2.7|55|Incidence|1914016|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|2.2|3.7|2.9
0-19|1.8|3.3|2.5|50|Incidence|1962226|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|1.9|3.4|2.5
0-19|2.1|3.6|2.8|59|Incidence|2013981|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|2.2|3.8|2.9
0-19|1.9|3.3|2.6|56|Incidence|2064812|Asian/Pacific Islander|Female|Acute Lymphocytic|2008|2.0|3.5|2.7
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|0.7|1.0|0.8|83|Incidence|9821710|Asian/Pacific Islander|Female|Acute Myeloid|2004-2008|0.7|1.0|0.8
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|0.7|1.6|1.1|21|Incidence|1962226|Asian/Pacific Islander|Female|Acute Myeloid|2006|0.7|1.6|1.1
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|0.7|1.6|1.0|22|Incidence|2064812|Asian/Pacific Islander|Female|Acute Myeloid|2008|0.7|1.6|1.1
0-19|10.7|14.2|12.3|195|Incidence|1570391|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|10.7|14.3|12.4
0-19|8.7|11.9|10.2|167|Incidence|1618332|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|8.8|12.0|10.3
0-19|11.3|14.8|13.0|220|Incidence|1682415|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|11.4|14.9|13.1
0-19|11.0|14.4|12.6|223|Incidence|1762776|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|11.0|14.4|12.7
0-19|9.4|12.5|10.9|201|Incidence|1822464|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|9.6|12.7|11.0
0-19|10.4|13.5|11.9|226|Incidence|1866675|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|10.6|13.8|12.1
0-19|12.2|13.6|12.9|1277|Incidence|9821710|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004-2008|12.3|13.7|13.0
0-19|12.0|15.4|13.6|263|Incidence|1914016|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|12.1|15.5|13.7
0-19|11.4|14.6|12.9|255|Incidence|1962226|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|11.4|14.7|13.0
0-19|11.4|14.5|12.9|263|Incidence|2013981|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|11.5|14.7|13.1
0-19|11.4|14.6|12.9|270|Incidence|2064812|Asian/Pacific Islander|Female|All Cancer Sites Combined|2008|11.6|14.7|13.1
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|0.5|0.8|0.7|61|Incidence|9821710|Asian/Pacific Islander|Female|Bones and Joints|2004-2008|0.5|0.8|0.6
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|0.6|1.5|0.9|18|Incidence|2013981|Asian/Pacific Islander|Female|Bones and Joints|2007|0.5|1.4|0.9
0-19|0.5|1.4|0.9|17|Incidence|2064812|Asian/Pacific Islander|Female|Bones and Joints|2008|0.5|1.3|0.8
0-19|1.2|2.6|1.8|28|Incidence|1570391|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|1.2|2.6|1.8
0-19|1.4|2.8|2.0|32|Incidence|1618332|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|1.4|2.8|2.0
0-19|1.8|3.4|2.5|42|Incidence|1682415|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|1.8|3.4|2.5
0-19|1.2|2.5|1.8|31|Incidence|1762776|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|1.2|2.5|1.8
0-19|1.3|2.6|1.9|35|Incidence|1822464|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|1.3|2.7|1.9
0-19|1.6|3.0|2.2|43|Incidence|1866675|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|1.7|3.1|2.3
0-19|1.8|2.4|2.1|210|Incidence|9821710|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004-2008|1.9|2.4|2.1
0-19|1.8|3.2|2.4|47|Incidence|1914016|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|1.8|3.3|2.5
0-19|1.4|2.7|2.0|40|Incidence|1962226|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|1.5|2.8|2.0
0-19|1.4|2.7|2.0|40|Incidence|2013981|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|1.4|2.7|2.0
0-19|1.4|2.6|1.9|40|Incidence|2064812|Asian/Pacific Islander|Female|Brain and Other Nervous System|2008|1.4|2.6|1.9
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|0.5|1.5|0.9|16|Incidence|1762776|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|0.5|1.5|0.9
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.5|0.8|0.7|62|Incidence|9821710|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004-2008|0.5|0.8|0.6
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.6|1.6|1.0|19|Incidence|1962226|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.2|0.4|0.3|33|Incidence|9821710|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004-2008|0.2|0.5|0.3
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|2.7|4.7|3.6|57|Incidence|1570391|Asian/Pacific Islander|Female|Leukemia|1999|2.7|4.7|3.6
0-19|1.6|3.1|2.2|37|Incidence|1618332|Asian/Pacific Islander|Female|Leukemia|2000|1.6|3.2|2.3
0-19|2.9|4.9|3.8|65|Incidence|1682415|Asian/Pacific Islander|Female|Leukemia|2001|3.0|4.9|3.9
0-19|3.1|5.0|4.0|72|Incidence|1762776|Asian/Pacific Islander|Female|Leukemia|2002|3.2|5.1|4.1
0-19|2.5|4.2|3.3|62|Incidence|1822464|Asian/Pacific Islander|Female|Leukemia|2003|2.6|4.4|3.4
0-19|2.8|4.5|3.6|70|Incidence|1866675|Asian/Pacific Islander|Female|Leukemia|2004|2.9|4.7|3.7
0-19|3.4|4.1|3.7|380|Incidence|9821710|Asian/Pacific Islander|Female|Leukemia|2004-2008|3.5|4.3|3.9
0-19|2.9|4.7|3.7|75|Incidence|1914016|Asian/Pacific Islander|Female|Leukemia|2005|3.1|4.9|3.9
0-19|2.9|4.6|3.7|74|Incidence|1962226|Asian/Pacific Islander|Female|Leukemia|2006|3.0|4.7|3.8
0-19|3.0|4.7|3.8|78|Incidence|2013981|Asian/Pacific Islander|Female|Leukemia|2007|3.1|4.8|3.9
0-19|3.1|4.8|3.8|83|Incidence|2064812|Asian/Pacific Islander|Female|Leukemia|2008|3.2|5.0|4.0
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1762776|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.7|1.0|0.8|80|Incidence|9821710|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004-2008|0.6|1.0|0.8
0-19|0.6|1.6|1.1|20|Incidence|1914016|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|0.6|1.6|1.0
0-19|0.5|1.4|0.9|16|Incidence|1962226|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|0.5|1.3|0.8
0-19|0.5|1.3|0.8|16|Incidence|2013981|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|3.0|5.0|3.9|62|Incidence|1570391|Asian/Pacific Islander|Female|Other|1999|3.0|5.1|3.9
0-19|2.5|4.4|3.4|55|Incidence|1618332|Asian/Pacific Islander|Female|Other|2000|2.6|4.4|3.4
0-19|2.9|4.8|3.7|64|Incidence|1682415|Asian/Pacific Islander|Female|Other|2001|2.9|4.9|3.8
0-19|2.4|4.2|3.2|56|Incidence|1762776|Asian/Pacific Islander|Female|Other|2002|2.4|4.1|3.2
0-19|2.5|4.2|3.3|61|Incidence|1822464|Asian/Pacific Islander|Female|Other|2003|2.6|4.3|3.3
0-19|2.6|4.3|3.4|64|Incidence|1866675|Asian/Pacific Islander|Female|Other|2004|2.6|4.4|3.4
0-19|3.5|4.3|3.9|386|Incidence|9821710|Asian/Pacific Islander|Female|Other|2004-2008|3.5|4.3|3.9
0-19|3.2|5.1|4.1|77|Incidence|1914016|Asian/Pacific Islander|Female|Other|2005|3.2|5.0|4.0
0-19|3.3|5.1|4.1|81|Incidence|1962226|Asian/Pacific Islander|Female|Other|2006|3.3|5.1|4.1
0-19|3.1|4.9|3.9|80|Incidence|2013981|Asian/Pacific Islander|Female|Other|2007|3.1|4.9|4.0
0-19|3.3|5.1|4.1|84|Incidence|2064812|Asian/Pacific Islander|Female|Other|2008|3.2|5.0|4.1
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|0.5|0.8|0.7|65|Incidence|9821710|Asian/Pacific Islander|Female|Soft Tissue|2004-2008|0.5|0.8|0.7
0-19|0.5|1.4|0.8|16|Incidence|1914016|Asian/Pacific Islander|Female|Soft Tissue|2005|0.5|1.4|0.8
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Soft Tissue|2008|~|~|~
0-19|2.0|3.7|2.8|46|Incidence|1639643|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|2.1|3.7|2.8
0-19|1.9|3.6|2.7|45|Incidence|1686323|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|1.9|3.6|2.7
0-19|2.4|4.1|3.1|55|Incidence|1754020|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|2.4|4.1|3.1
0-19|2.6|4.3|3.3|62|Incidence|1837465|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|2.6|4.3|3.4
0-19|2.4|4.0|3.1|60|Incidence|1898564|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|2.4|4.1|3.2
0-19|2.2|3.8|2.9|58|Incidence|1943682|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|2.3|3.9|3.0
0-19|2.9|3.5|3.2|340|Incidence|10217294|Asian/Pacific Islander|Male|Acute Lymphocytic|2004-2008|3.0|3.7|3.3
0-19|2.7|4.4|3.5|73|Incidence|1991945|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|2.9|4.6|3.7
0-19|2.2|3.8|2.9|62|Incidence|2040932|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|2.3|3.9|3.0
0-19|2.4|3.9|3.1|68|Incidence|2094159|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|2.5|4.1|3.2
0-19|2.8|4.4|3.5|79|Incidence|2146576|Asian/Pacific Islander|Male|Acute Lymphocytic|2008|2.9|4.6|3.7
0-19|0.6|1.6|1.0|16|Incidence|1639643|Asian/Pacific Islander|Male|Acute Myeloid|1999|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1837465|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|0.6|1.6|1.0|20|Incidence|1943682|Asian/Pacific Islander|Male|Acute Myeloid|2004|0.6|1.6|1.0
0-19|0.7|1.0|0.8|86|Incidence|10217294|Asian/Pacific Islander|Male|Acute Myeloid|2004-2008|0.7|1.0|0.8
0-19|0.5|1.3|0.8|16|Incidence|1991945|Asian/Pacific Islander|Male|Acute Myeloid|2005|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|0.5|1.4|0.9|19|Incidence|2094159|Asian/Pacific Islander|Male|Acute Myeloid|2007|0.5|1.4|0.9
0-19|0.4|1.2|0.8|16|Incidence|2146576|Asian/Pacific Islander|Male|Acute Myeloid|2008|0.4|1.2|0.7
0-19|10.8|14.3|12.5|205|Incidence|1639643|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|10.8|14.3|12.5
0-19|11.6|15.1|13.3|225|Incidence|1686323|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|11.7|15.2|13.3
0-19|12.9|16.6|14.7|258|Incidence|1754020|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|13.0|16.6|14.7
0-19|12.3|15.8|14.0|259|Incidence|1837465|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|12.4|15.9|14.1
0-19|11.9|15.2|13.5|258|Incidence|1898564|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|12.0|15.4|13.6
0-19|12.0|15.3|13.6|267|Incidence|1943682|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|12.1|15.5|13.7
0-19|13.4|14.8|14.1|1462|Incidence|10217294|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004-2008|13.6|15.1|14.3
0-19|13.4|16.9|15.1|304|Incidence|1991945|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|13.6|17.1|15.3
0-19|11.3|14.4|12.8|266|Incidence|2040932|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|11.5|14.7|13.0
0-19|12.6|15.8|14.1|302|Incidence|2094159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|12.8|16.1|14.4
0-19|13.4|16.7|15.0|323|Incidence|2146576|Asian/Pacific Islander|Male|All Cancer Sites Combined|2008|13.5|16.8|15.0
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1754020|Asian/Pacific Islander|Male|Bones and Joints|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|17|Incidence|1837465|Asian/Pacific Islander|Male|Bones and Joints|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.9|16|Incidence|1898564|Asian/Pacific Islander|Male|Bones and Joints|2003|0.5|1.4|0.8
0-19|~|~|~|~|Incidence|1943682|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|0.5|0.9|0.7|67|Incidence|10217294|Asian/Pacific Islander|Male|Bones and Joints|2004-2008|0.5|0.8|0.7
0-19|0.6|1.6|1.0|19|Incidence|1991945|Asian/Pacific Islander|Male|Bones and Joints|2005|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|2146576|Asian/Pacific Islander|Male|Bones and Joints|2008|~|~|~
0-19|1.3|2.7|1.9|31|Incidence|1639643|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|1.3|2.7|1.9
0-19|1.3|2.8|2.0|33|Incidence|1686323|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|1.3|2.7|2.0
0-19|1.6|3.1|2.3|40|Incidence|1754020|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|1.6|3.1|2.3
0-19|1.4|2.7|2.0|36|Incidence|1837465|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|1.4|2.7|2.0
0-19|1.7|3.1|2.3|44|Incidence|1898564|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|1.7|3.1|2.3
0-19|1.2|2.5|1.8|35|Incidence|1943682|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|1.3|2.5|1.8
0-19|1.9|2.5|2.2|230|Incidence|10217294|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004-2008|2.0|2.6|2.3
0-19|1.6|3.0|2.2|44|Incidence|1991945|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|1.6|3.0|2.2
0-19|1.4|2.7|2.0|42|Incidence|2040932|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|1.5|2.8|2.1
0-19|1.9|3.3|2.5|53|Incidence|2094159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|1.9|3.3|2.5
0-19|2.0|3.4|2.6|56|Incidence|2146576|Asian/Pacific Islander|Male|Brain and Other Nervous System|2008|2.0|3.4|2.6
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|0.5|1.4|0.9|16|Incidence|1837465|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|0.5|1.4|0.9
0-19|0.8|1.9|1.2|23|Incidence|1898564|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|0.8|1.8|1.2
0-19|0.5|1.4|0.9|17|Incidence|1943682|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|0.5|1.4|0.9
0-19|0.7|1.1|0.9|87|Incidence|10217294|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004-2008|0.7|1.1|0.9
0-19|0.7|1.7|1.2|22|Incidence|1991945|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|0.5|1.4|0.9|17|Incidence|2094159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|0.5|1.3|0.8
0-19|0.4|1.3|0.8|16|Incidence|2146576|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2008|0.4|1.2|0.7
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1837465|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1943682|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.2|0.5|0.3|39|Incidence|10217294|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004-2008|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|1991945|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|2146576|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|3.4|5.5|4.3|71|Incidence|1639643|Asian/Pacific Islander|Male|Leukemia|1999|3.4|5.5|4.3
0-19|3.0|4.9|3.8|65|Incidence|1686323|Asian/Pacific Islander|Male|Leukemia|2000|3.0|4.9|3.9
0-19|3.7|5.7|4.6|81|Incidence|1754020|Asian/Pacific Islander|Male|Leukemia|2001|3.7|5.7|4.6
0-19|3.7|5.7|4.6|86|Incidence|1837465|Asian/Pacific Islander|Male|Leukemia|2002|3.7|5.8|4.7
0-19|3.5|5.4|4.3|84|Incidence|1898564|Asian/Pacific Islander|Male|Leukemia|2003|3.5|5.5|4.4
0-19|3.6|5.6|4.5|90|Incidence|1943682|Asian/Pacific Islander|Male|Leukemia|2004|3.7|5.7|4.6
0-19|4.0|4.9|4.4|469|Incidence|10217294|Asian/Pacific Islander|Male|Leukemia|2004-2008|4.2|5.0|4.6
0-19|3.8|5.7|4.7|97|Incidence|1991945|Asian/Pacific Islander|Male|Leukemia|2005|3.9|5.9|4.9
0-19|3.2|5.0|4.1|86|Incidence|2040932|Asian/Pacific Islander|Male|Leukemia|2006|3.4|5.2|4.2
0-19|3.5|5.3|4.3|93|Incidence|2094159|Asian/Pacific Islander|Male|Leukemia|2007|3.6|5.4|4.4
0-19|3.8|5.6|4.6|103|Incidence|2146576|Asian/Pacific Islander|Male|Leukemia|2008|3.9|5.8|4.8
0-19|0.6|1.7|1.0|17|Incidence|1639643|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|0.6|1.7|1.0
0-19|1.0|2.3|1.6|27|Incidence|1686323|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|1.1|2.3|1.6
0-19|0.8|1.9|1.3|22|Incidence|1754020|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|0.8|1.9|1.3
0-19|0.7|1.7|1.1|20|Incidence|1837465|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|0.7|1.7|1.1
0-19|0.9|2.0|1.4|26|Incidence|1898564|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|0.9|2.0|1.4
0-19|0.6|1.6|1.0|19|Incidence|1943682|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|0.6|1.5|1.0
0-19|1.0|1.4|1.2|117|Incidence|10217294|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004-2008|0.9|1.4|1.1
0-19|1.0|2.2|1.6|30|Incidence|1991945|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|1.0|2.2|1.5
0-19|0.7|1.7|1.1|22|Incidence|2040932|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|0.7|1.6|1.1
0-19|0.6|1.6|1.0|21|Incidence|2094159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|0.6|1.5|1.0
0-19|0.8|1.7|1.2|25|Incidence|2146576|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2008|0.8|1.7|1.2
0-19|2.2|4.0|3.0|50|Incidence|1639643|Asian/Pacific Islander|Male|Other|1999|2.3|4.0|3.0
0-19|2.5|4.3|3.3|56|Incidence|1686323|Asian/Pacific Islander|Male|Other|2000|2.5|4.3|3.3
0-19|2.7|4.5|3.5|63|Incidence|1754020|Asian/Pacific Islander|Male|Other|2001|2.8|4.6|3.6
0-19|2.4|4.0|3.1|59|Incidence|1837465|Asian/Pacific Islander|Male|Other|2002|2.4|4.1|3.2
0-19|1.8|3.2|2.4|47|Incidence|1898564|Asian/Pacific Islander|Male|Other|2003|1.8|3.3|2.5
0-19|2.6|4.3|3.4|67|Incidence|1943682|Asian/Pacific Islander|Male|Other|2004|2.7|4.4|3.4
0-19|3.2|3.9|3.5|370|Incidence|10217294|Asian/Pacific Islander|Male|Other|2004-2008|3.3|4.0|3.6
0-19|2.5|4.1|3.2|66|Incidence|1991945|Asian/Pacific Islander|Male|Other|2005|2.6|4.2|3.3
0-19|2.4|4.0|3.2|66|Incidence|2040932|Asian/Pacific Islander|Male|Other|2006|2.5|4.1|3.2
0-19|3.2|4.9|4.0|86|Incidence|2094159|Asian/Pacific Islander|Male|Other|2007|3.3|5.1|4.1
0-19|3.1|4.9|3.9|85|Incidence|2146576|Asian/Pacific Islander|Male|Other|2008|3.2|4.9|4.0
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|0.7|1.8|1.2|22|Incidence|1837465|Asian/Pacific Islander|Male|Soft Tissue|2002|0.8|1.8|1.2
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|0.5|1.4|0.9|18|Incidence|1943682|Asian/Pacific Islander|Male|Soft Tissue|2004|0.5|1.5|0.9
0-19|0.6|1.0|0.8|83|Incidence|10217294|Asian/Pacific Islander|Male|Soft Tissue|2004-2008|0.6|1.0|0.8
0-19|0.7|1.7|1.1|22|Incidence|1991945|Asian/Pacific Islander|Male|Soft Tissue|2005|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|0.6|1.5|0.9|20|Incidence|2146576|Asian/Pacific Islander|Male|Soft Tissue|2008|0.6|1.4|0.9
0-19|2.2|3.4|2.7|88|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|2.2|3.4|2.7
0-19|1.8|2.9|2.3|76|Incidence|3304655|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|1.8|2.9|2.3
0-19|2.4|3.6|3.0|103|Incidence|3436435|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|2.4|3.6|3.0
0-19|2.6|3.8|3.2|117|Incidence|3600241|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|2.7|3.9|3.2
0-19|2.3|3.4|2.8|106|Incidence|3721028|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|2.3|3.4|2.8
0-19|2.2|3.3|2.7|107|Incidence|3810357|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|2.3|3.4|2.8
0-19|2.7|3.1|2.9|609|Incidence|20039004|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004-2008|2.8|3.3|3.0
0-19|2.6|3.7|3.1|128|Incidence|3905961|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|2.7|3.9|3.3
0-19|2.2|3.3|2.7|112|Incidence|4003158|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|2.3|3.4|2.8
0-19|2.5|3.5|2.9|127|Incidence|4108140|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|2.6|3.7|3.1
0-19|2.5|3.6|3.0|135|Incidence|4211388|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2008|2.7|3.8|3.2
0-19|0.5|1.2|0.8|26|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|0.5|1.2|0.8
0-19|0.3|0.8|0.5|16|Incidence|3304655|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|0.3|0.8|0.5
0-19|0.5|1.1|0.8|26|Incidence|3436435|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|0.5|1.1|0.8
0-19|0.4|0.9|0.6|21|Incidence|3600241|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.4|1.0|0.6|25|Incidence|3721028|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|0.4|1.0|0.7
0-19|0.6|1.2|0.9|34|Incidence|3810357|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|0.6|1.2|0.9
0-19|0.7|1.0|0.8|169|Incidence|20039004|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004-2008|0.7|1.0|0.8
0-19|0.5|1.1|0.8|29|Incidence|3905961|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|0.5|1.1|0.7
0-19|0.6|1.2|0.9|36|Incidence|4003158|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|0.6|1.2|0.9
0-19|0.5|1.1|0.8|32|Incidence|4108140|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|0.5|1.1|0.8
0-19|0.6|1.2|0.9|38|Incidence|4211388|Asian/Pacific Islander|Male and Female|Acute Myeloid|2008|0.6|1.2|0.9
0-19|11.2|13.7|12.4|400|Incidence|3210034|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|11.3|13.7|12.5
0-19|10.6|13.0|11.8|392|Incidence|3304655|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|10.7|13.1|11.9
0-19|12.6|15.1|13.8|478|Incidence|3436435|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|12.7|15.2|13.9
0-19|12.1|14.5|13.3|482|Incidence|3600241|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|12.2|14.6|13.4
0-19|11.1|13.4|12.2|459|Incidence|3721028|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|11.2|13.5|12.3
0-19|11.6|13.9|12.7|493|Incidence|3810357|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|11.8|14.1|12.9
0-19|13.0|14.0|13.5|2739|Incidence|20039004|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004-2008|13.2|14.2|13.7
0-19|13.2|15.6|14.4|567|Incidence|3905961|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|13.3|15.8|14.5
0-19|11.8|14.0|12.8|521|Incidence|4003158|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|11.9|14.2|13.0
0-19|12.4|14.7|13.5|565|Incidence|4108140|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|12.6|14.9|13.8
0-19|12.9|15.1|14.0|593|Incidence|4211388|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2008|13.0|15.3|14.1
0-19|0.3|0.8|0.5|17|Incidence|3210034|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|0.3|0.8|0.5
0-19|0.4|1.0|0.7|23|Incidence|3304655|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|0.4|1.0|0.7
0-19|0.6|1.2|0.9|29|Incidence|3436435|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|0.6|1.2|0.8
0-19|0.5|1.1|0.7|26|Incidence|3600241|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|0.5|1.1|0.7
0-19|0.4|1.0|0.7|24|Incidence|3721028|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|0.4|1.0|0.6
0-19|0.4|1.0|0.7|24|Incidence|3810357|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|0.4|0.9|0.6
0-19|0.6|0.8|0.7|128|Incidence|20039004|Asian/Pacific Islander|Male and Female|Bones and Joints|2004-2008|0.5|0.8|0.6
0-19|0.5|1.1|0.7|27|Incidence|3905961|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|0.5|1.0|0.7
0-19|0.4|0.9|0.6|22|Incidence|4003158|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|0.3|0.8|0.5
0-19|0.5|1.0|0.7|27|Incidence|4108140|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|0.4|1.0|0.7
0-19|0.5|1.0|0.7|28|Incidence|4211388|Asian/Pacific Islander|Male and Female|Bones and Joints|2008|0.4|1.0|0.7
0-19|1.4|2.4|1.8|59|Incidence|3210034|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|1.4|2.4|1.8
0-19|1.5|2.5|2.0|65|Incidence|3304655|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|1.5|2.5|2.0
0-19|1.9|3.0|2.4|82|Incidence|3436435|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|1.9|3.0|2.4
0-19|1.4|2.4|1.9|67|Incidence|3600241|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|1.4|2.4|1.9
0-19|1.7|2.6|2.1|79|Incidence|3721028|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|1.7|2.6|2.1
0-19|1.6|2.5|2.0|78|Incidence|3810357|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|1.6|2.6|2.0
0-19|2.0|2.4|2.2|440|Incidence|20039004|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004-2008|2.0|2.4|2.2
0-19|1.9|2.8|2.3|91|Incidence|3905961|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|1.9|2.9|2.3
0-19|1.6|2.5|2.0|82|Incidence|4003158|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|1.6|2.5|2.0
0-19|1.8|2.7|2.2|93|Incidence|4108140|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|1.8|2.8|2.3
0-19|1.8|2.8|2.3|96|Incidence|4211388|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2008|1.8|2.8|2.3
0-19|0.3|0.8|0.5|16|Incidence|3210034|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|0.3|0.8|0.5
0-19|0.4|0.9|0.6|20|Incidence|3304655|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|0.4|0.9|0.6
0-19|0.5|1.2|0.8|27|Incidence|3436435|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|0.5|1.1|0.8
0-19|0.6|1.3|0.9|32|Incidence|3600241|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|0.6|1.3|0.9
0-19|0.5|1.1|0.8|28|Incidence|3721028|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|0.5|1.1|0.8
0-19|0.4|0.9|0.6|23|Incidence|3810357|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|0.4|0.9|0.6
0-19|0.7|0.9|0.8|149|Incidence|20039004|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004-2008|0.6|0.9|0.7
0-19|0.7|1.4|1.0|37|Incidence|3905961|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|0.7|1.3|0.9
0-19|0.6|1.2|0.9|34|Incidence|4003158|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|0.6|1.2|0.8
0-19|0.4|1.0|0.7|26|Incidence|4108140|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|0.4|0.9|0.6
0-19|0.5|1.0|0.7|29|Incidence|4211388|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2008|0.5|1.0|0.7
0-19|~|~|~|~|Incidence|3210034|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|3304655|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|3436435|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|3600241|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.8|0.5|19|Incidence|3721028|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|0.3|0.8|0.5
0-19|~|~|~|~|Incidence|3810357|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.3|0.4|0.3|72|Incidence|20039004|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004-2008|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|3905961|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|4003158|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.2|0.6|0.4|18|Incidence|4108140|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|0.3|0.7|0.4
0-19|0.2|0.6|0.4|18|Incidence|4211388|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2008|0.3|0.7|0.4
0-19|3.3|4.7|4.0|128|Incidence|3210034|Asian/Pacific Islander|Male and Female|Leukemia|1999|3.3|4.7|4.0
0-19|2.5|3.7|3.1|102|Incidence|3304655|Asian/Pacific Islander|Male and Female|Leukemia|2000|2.5|3.7|3.1
0-19|3.6|5.0|4.2|146|Incidence|3436435|Asian/Pacific Islander|Male and Female|Leukemia|2001|3.6|5.0|4.2
0-19|3.7|5.1|4.3|158|Incidence|3600241|Asian/Pacific Islander|Male and Female|Leukemia|2002|3.7|5.1|4.4
0-19|3.2|4.5|3.8|146|Incidence|3721028|Asian/Pacific Islander|Male and Female|Leukemia|2003|3.3|4.6|3.9
0-19|3.5|4.8|4.1|160|Incidence|3810357|Asian/Pacific Islander|Male and Female|Leukemia|2004|3.6|4.9|4.2
0-19|3.8|4.4|4.1|849|Incidence|20039004|Asian/Pacific Islander|Male and Female|Leukemia|2004-2008|4.0|4.5|4.2
0-19|3.6|4.9|4.2|172|Incidence|3905961|Asian/Pacific Islander|Male and Female|Leukemia|2005|3.8|5.1|4.4
0-19|3.3|4.5|3.9|160|Incidence|4003158|Asian/Pacific Islander|Male and Female|Leukemia|2006|3.4|4.7|4.0
0-19|3.4|4.7|4.0|171|Incidence|4108140|Asian/Pacific Islander|Male and Female|Leukemia|2007|3.6|4.8|4.2
0-19|3.7|4.9|4.2|186|Incidence|4211388|Asian/Pacific Islander|Male and Female|Leukemia|2008|3.8|5.1|4.4
0-19|0.6|1.3|0.9|30|Incidence|3210034|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|0.6|1.3|0.9
0-19|0.9|1.7|1.3|42|Incidence|3304655|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|0.9|1.7|1.3
0-19|0.7|1.4|1.0|35|Incidence|3436435|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|0.7|1.4|1.0
0-19|0.7|1.4|1.0|37|Incidence|3600241|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|0.7|1.4|1.0
0-19|0.7|1.4|1.0|37|Incidence|3721028|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.4|1.0
0-19|0.6|1.2|0.9|33|Incidence|3810357|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|0.6|1.2|0.9
0-19|0.9|1.2|1.0|197|Incidence|20039004|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.9|1.1|1.0
0-19|1.0|1.7|1.3|50|Incidence|3905961|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.7|1.3
0-19|0.7|1.3|1.0|38|Incidence|4003158|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|0.7|1.3|0.9
0-19|0.6|1.3|0.9|37|Incidence|4108140|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|0.6|1.2|0.9
0-19|0.7|1.3|0.9|39|Incidence|4211388|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2008|0.7|1.3|0.9
0-19|2.8|4.1|3.4|112|Incidence|3210034|Asian/Pacific Islander|Male and Female|Other|1999|2.9|4.2|3.5
0-19|2.7|4.0|3.3|111|Incidence|3304655|Asian/Pacific Islander|Male and Female|Other|2000|2.8|4.0|3.4
0-19|3.0|4.3|3.6|127|Incidence|3436435|Asian/Pacific Islander|Male and Female|Other|2001|3.1|4.4|3.7
0-19|2.6|3.8|3.2|115|Incidence|3600241|Asian/Pacific Islander|Male and Female|Other|2002|2.6|3.8|3.2
0-19|2.3|3.4|2.8|108|Incidence|3721028|Asian/Pacific Islander|Male and Female|Other|2003|2.4|3.5|2.9
0-19|2.8|4.0|3.4|131|Incidence|3810357|Asian/Pacific Islander|Male and Female|Other|2004|2.9|4.1|3.4
0-19|3.5|4.0|3.7|756|Incidence|20039004|Asian/Pacific Islander|Male and Female|Other|2004-2008|3.5|4.1|3.8
0-19|3.1|4.3|3.6|143|Incidence|3905961|Asian/Pacific Islander|Male and Female|Other|2005|3.1|4.3|3.7
0-19|3.1|4.3|3.6|147|Incidence|4003158|Asian/Pacific Islander|Male and Female|Other|2006|3.1|4.3|3.7
0-19|3.4|4.6|3.9|166|Incidence|4108140|Asian/Pacific Islander|Male and Female|Other|2007|3.4|4.7|4.0
0-19|3.4|4.7|4.0|169|Incidence|4211388|Asian/Pacific Islander|Male and Female|Other|2008|3.4|4.7|4.0
0-19|0.5|1.1|0.8|25|Incidence|3210034|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|0.5|1.1|0.8
0-19|0.3|0.8|0.5|18|Incidence|3304655|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|0.3|0.9|0.5
0-19|0.3|0.9|0.6|20|Incidence|3436435|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|0.4|0.9|0.6
0-19|0.7|1.4|1.0|37|Incidence|3600241|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|0.7|1.4|1.0
0-19|0.3|0.8|0.5|18|Incidence|3721028|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|0.3|0.8|0.5
0-19|0.5|1.1|0.8|30|Incidence|3810357|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|0.5|1.1|0.8
0-19|0.6|0.9|0.7|148|Incidence|20039004|Asian/Pacific Islander|Male and Female|Soft Tissue|2004-2008|0.6|0.9|0.7
0-19|0.7|1.3|1.0|38|Incidence|3905961|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|0.7|1.3|1.0
0-19|0.4|0.9|0.6|25|Incidence|4003158|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|0.4|0.9|0.6
0-19|0.4|0.9|0.6|27|Incidence|4108140|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|0.4|1.0|0.7
0-19|0.4|1.0|0.7|28|Incidence|4211388|Asian/Pacific Islander|Male and Female|Soft Tissue|2008|0.4|1.0|0.7
0-19|1.1|1.7|1.4|74|Incidence|5402131|Black|Female|Acute Lymphocytic|1999|1.1|1.7|1.4
0-19|1.2|1.8|1.5|80|Incidence|5446152|Black|Female|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|2.0|1.6|96|Incidence|5847078|Black|Female|Acute Lymphocytic|2001|1.3|2.0|1.6
0-19|1.0|1.6|1.3|77|Incidence|6055801|Black|Female|Acute Lymphocytic|2002|1.0|1.6|1.3
0-19|1.1|1.7|1.3|87|Incidence|6482277|Black|Female|Acute Lymphocytic|2003|1.1|1.7|1.3
0-19|1.1|1.7|1.4|91|Incidence|6505891|Black|Female|Acute Lymphocytic|2004|1.1|1.7|1.4
0-19|1.3|1.5|1.4|462|Incidence|32839888|Black|Female|Acute Lymphocytic|2004-2008|1.3|1.5|1.4
0-19|1.1|1.7|1.4|88|Incidence|6530380|Black|Female|Acute Lymphocytic|2005|1.1|1.7|1.3
0-19|1.2|1.8|1.4|94|Incidence|6560240|Black|Female|Acute Lymphocytic|2006|1.2|1.8|1.4
0-19|1.2|1.8|1.5|96|Incidence|6604633|Black|Female|Acute Lymphocytic|2007|1.2|1.8|1.5
0-19|1.1|1.7|1.4|93|Incidence|6638744|Black|Female|Acute Lymphocytic|2008|1.1|1.7|1.4
0-19|0.4|0.9|0.6|34|Incidence|5402131|Black|Female|Acute Myeloid|1999|0.4|0.9|0.6
0-19|0.3|0.8|0.5|28|Incidence|5446152|Black|Female|Acute Myeloid|2000|0.3|0.7|0.5
0-19|0.3|0.7|0.5|30|Incidence|5847078|Black|Female|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.5|0.9|0.7|41|Incidence|6055801|Black|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6482277|Black|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Incidence|6505891|Black|Female|Acute Myeloid|2004|0.4|0.8|0.6
0-19|0.6|0.8|0.7|220|Incidence|32839888|Black|Female|Acute Myeloid|2004-2008|0.6|0.8|0.7
0-19|0.4|0.8|0.5|36|Incidence|6530380|Black|Female|Acute Myeloid|2005|0.4|0.8|0.6
0-19|0.6|1.1|0.8|54|Incidence|6560240|Black|Female|Acute Myeloid|2006|0.6|1.1|0.8
0-19|0.4|0.8|0.6|38|Incidence|6604633|Black|Female|Acute Myeloid|2007|0.4|0.8|0.6
0-19|0.6|1.1|0.8|56|Incidence|6638744|Black|Female|Acute Myeloid|2008|0.6|1.1|0.8
0-19|10.5|12.3|11.4|610|Incidence|5402131|Black|Female|All Cancer Sites Combined|1999|10.4|12.2|11.3
0-19|9.8|11.6|10.7|577|Incidence|5446152|Black|Female|All Cancer Sites Combined|2000|9.7|11.5|10.6
0-19|10.6|12.3|11.4|664|Incidence|5847078|Black|Female|All Cancer Sites Combined|2001|10.5|12.3|11.4
0-19|10.5|12.2|11.3|685|Incidence|6055801|Black|Female|All Cancer Sites Combined|2002|10.5|12.2|11.3
0-19|11.8|13.6|12.7|822|Incidence|6482277|Black|Female|All Cancer Sites Combined|2003|11.8|13.6|12.7
0-19|11.8|13.6|12.7|825|Incidence|6505891|Black|Female|All Cancer Sites Combined|2004|11.8|13.6|12.7
0-19|12.1|12.9|12.5|4129|Incidence|32839888|Black|Female|All Cancer Sites Combined|2004-2008|12.2|13.0|12.6
0-19|11.6|13.4|12.5|819|Incidence|6530380|Black|Female|All Cancer Sites Combined|2005|11.7|13.4|12.5
0-19|11.3|13.0|12.1|803|Incidence|6560240|Black|Female|All Cancer Sites Combined|2006|11.4|13.1|12.2
0-19|11.8|13.5|12.6|842|Incidence|6604633|Black|Female|All Cancer Sites Combined|2007|11.9|13.6|12.7
0-19|11.7|13.4|12.5|840|Incidence|6638744|Black|Female|All Cancer Sites Combined|2008|11.8|13.5|12.7
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Bones and Joints|1999|0.5|1.0|0.7
0-19|0.3|0.7|0.5|27|Incidence|5446152|Black|Female|Bones and Joints|2000|0.3|0.7|0.5
0-19|0.5|0.9|0.7|39|Incidence|5847078|Black|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Incidence|6055801|Black|Female|Bones and Joints|2002|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Incidence|6482277|Black|Female|Bones and Joints|2003|0.5|0.9|0.7
0-19|0.7|1.2|0.9|60|Incidence|6505891|Black|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.6|0.8|0.7|228|Incidence|32839888|Black|Female|Bones and Joints|2004-2008|0.6|0.8|0.7
0-19|0.5|0.9|0.7|43|Incidence|6530380|Black|Female|Bones and Joints|2005|0.5|0.9|0.7
0-19|0.5|0.9|0.7|47|Incidence|6560240|Black|Female|Bones and Joints|2006|0.5|1.0|0.7
0-19|0.5|0.9|0.6|42|Incidence|6604633|Black|Female|Bones and Joints|2007|0.5|0.9|0.6
0-19|0.4|0.8|0.5|36|Incidence|6638744|Black|Female|Bones and Joints|2008|0.4|0.8|0.5
0-19|1.5|2.2|1.8|100|Incidence|5402131|Black|Female|Brain and Other Nervous System|1999|1.5|2.3|1.9
0-19|1.6|2.4|2.0|109|Incidence|5446152|Black|Female|Brain and Other Nervous System|2000|1.6|2.4|2.0
0-19|1.7|2.4|2.0|118|Incidence|5847078|Black|Female|Brain and Other Nervous System|2001|1.7|2.4|2.0
0-19|1.7|2.4|2.0|121|Incidence|6055801|Black|Female|Brain and Other Nervous System|2002|1.7|2.4|2.0
0-19|1.8|2.6|2.2|141|Incidence|6482277|Black|Female|Brain and Other Nervous System|2003|1.8|2.6|2.2
0-19|2.0|2.8|2.4|154|Incidence|6505891|Black|Female|Brain and Other Nervous System|2004|2.0|2.8|2.4
0-19|2.2|2.5|2.4|771|Incidence|32839888|Black|Female|Brain and Other Nervous System|2004-2008|2.2|2.5|2.3
0-19|2.0|2.7|2.3|152|Incidence|6530380|Black|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|1.9|2.7|2.3|149|Incidence|6560240|Black|Female|Brain and Other Nervous System|2006|1.9|2.7|2.3
0-19|2.0|2.7|2.3|152|Incidence|6604633|Black|Female|Brain and Other Nervous System|2007|2.0|2.7|2.3
0-19|2.1|2.9|2.5|164|Incidence|6638744|Black|Female|Brain and Other Nervous System|2008|2.1|2.9|2.5
0-19|0.4|0.9|0.6|33|Incidence|5402131|Black|Female|Hodgkin Lymphoma|1999|0.4|0.9|0.6
0-19|0.6|1.1|0.8|42|Incidence|5446152|Black|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.5|1.0|0.7|41|Incidence|5847078|Black|Female|Hodgkin Lymphoma|2001|0.5|1.0|0.7
0-19|0.7|1.2|1.0|57|Incidence|6055801|Black|Female|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.8|1.3|1.0|63|Incidence|6482277|Black|Female|Hodgkin Lymphoma|2003|0.7|1.2|1.0
0-19|0.7|1.1|0.9|57|Incidence|6505891|Black|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.0|0.9|308|Incidence|32839888|Black|Female|Hodgkin Lymphoma|2004-2008|0.8|1.0|0.9
0-19|0.8|1.3|1.0|69|Incidence|6530380|Black|Female|Hodgkin Lymphoma|2005|0.8|1.3|1.1
0-19|0.6|1.0|0.8|52|Incidence|6560240|Black|Female|Hodgkin Lymphoma|2006|0.6|1.0|0.8
0-19|0.6|1.0|0.8|54|Incidence|6604633|Black|Female|Hodgkin Lymphoma|2007|0.6|1.1|0.8
0-19|0.9|1.4|1.1|76|Incidence|6638744|Black|Female|Hodgkin Lymphoma|2008|0.9|1.4|1.1
0-19|0.7|1.2|0.9|50|Incidence|5402131|Black|Female|Kidney and Renal Pelvis|1999|0.7|1.2|0.9
0-19|0.8|1.4|1.0|57|Incidence|5446152|Black|Female|Kidney and Renal Pelvis|2000|0.8|1.4|1.0
0-19|0.5|1.0|0.7|42|Incidence|5847078|Black|Female|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.6|1.1|0.9|52|Incidence|6055801|Black|Female|Kidney and Renal Pelvis|2002|0.6|1.1|0.9
0-19|0.5|1.0|0.7|46|Incidence|6482277|Black|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.5|0.9|0.7|44|Incidence|6505891|Black|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.7|0.9|0.8|272|Incidence|32839888|Black|Female|Kidney and Renal Pelvis|2004-2008|0.7|0.9|0.8
0-19|0.7|1.2|0.9|61|Incidence|6530380|Black|Female|Kidney and Renal Pelvis|2005|0.7|1.2|0.9
0-19|0.6|1.0|0.8|50|Incidence|6560240|Black|Female|Kidney and Renal Pelvis|2006|0.6|1.0|0.8
0-19|0.7|1.1|0.9|58|Incidence|6604633|Black|Female|Kidney and Renal Pelvis|2007|0.7|1.1|0.9
0-19|0.7|1.1|0.9|59|Incidence|6638744|Black|Female|Kidney and Renal Pelvis|2008|0.7|1.1|0.9
0-19|2.0|2.9|2.4|130|Incidence|5402131|Black|Female|Leukemia|1999|2.0|2.9|2.4
0-19|1.8|2.6|2.1|116|Incidence|5446152|Black|Female|Leukemia|2000|1.8|2.6|2.1
0-19|2.0|2.8|2.4|141|Incidence|5847078|Black|Female|Leukemia|2001|2.0|2.8|2.4
0-19|1.9|2.7|2.3|139|Incidence|6055801|Black|Female|Leukemia|2002|1.9|2.7|2.3
0-19|1.9|2.6|2.2|145|Incidence|6482277|Black|Female|Leukemia|2003|1.9|2.6|2.2
0-19|2.0|2.8|2.4|153|Incidence|6505891|Black|Female|Leukemia|2004|2.0|2.8|2.4
0-19|2.2|2.6|2.4|788|Incidence|32839888|Black|Female|Leukemia|2004-2008|2.2|2.6|2.4
0-19|1.8|2.5|2.2|141|Incidence|6530380|Black|Female|Leukemia|2005|1.8|2.5|2.2
0-19|2.2|3.0|2.6|168|Incidence|6560240|Black|Female|Leukemia|2006|2.2|3.0|2.6
0-19|2.1|2.8|2.4|161|Incidence|6604633|Black|Female|Leukemia|2007|2.1|2.8|2.4
0-19|2.1|2.9|2.5|165|Incidence|6638744|Black|Female|Leukemia|2008|2.1|2.9|2.5
0-19|0.5|0.9|0.7|36|Incidence|5402131|Black|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.4|0.9|0.6|34|Incidence|5446152|Black|Female|Non-Hodgkin Lymphoma|2000|0.4|0.9|0.6
0-19|0.6|1.1|0.8|46|Incidence|5847078|Black|Female|Non-Hodgkin Lymphoma|2001|0.6|1.0|0.8
0-19|0.6|1.1|0.8|49|Incidence|6055801|Black|Female|Non-Hodgkin Lymphoma|2002|0.6|1.1|0.8
0-19|0.5|0.9|0.7|44|Incidence|6482277|Black|Female|Non-Hodgkin Lymphoma|2003|0.5|0.9|0.7
0-19|0.7|1.2|0.9|58|Incidence|6505891|Black|Female|Non-Hodgkin Lymphoma|2004|0.7|1.2|0.9
0-19|0.7|0.9|0.8|277|Incidence|32839888|Black|Female|Non-Hodgkin Lymphoma|2004-2008|0.7|0.9|0.8
0-19|0.6|1.1|0.8|55|Incidence|6530380|Black|Female|Non-Hodgkin Lymphoma|2005|0.6|1.1|0.8
0-19|0.6|1.1|0.8|54|Incidence|6560240|Black|Female|Non-Hodgkin Lymphoma|2006|0.6|1.1|0.8
0-19|0.6|1.0|0.8|50|Incidence|6604633|Black|Female|Non-Hodgkin Lymphoma|2007|0.6|1.0|0.8
0-19|0.7|1.2|0.9|60|Incidence|6638744|Black|Female|Non-Hodgkin Lymphoma|2008|0.7|1.2|0.9
0-19|3.0|4.1|3.5|185|Incidence|5402131|Black|Female|Other|1999|2.9|4.0|3.4
0-19|2.2|3.1|2.6|141|Incidence|5446152|Black|Female|Other|2000|2.2|3.1|2.6
0-19|2.9|3.8|3.3|193|Incidence|5847078|Black|Female|Other|2001|2.9|3.8|3.3
0-19|2.5|3.4|2.9|177|Incidence|6055801|Black|Female|Other|2002|2.5|3.4|2.9
0-19|3.8|4.9|4.3|280|Incidence|6482277|Black|Female|Other|2003|3.8|4.9|4.3
0-19|2.9|3.8|3.4|219|Incidence|6505891|Black|Female|Other|2004|2.9|3.8|3.4
0-19|3.3|3.7|3.5|1162|Incidence|32839888|Black|Female|Other|2004-2008|3.3|3.7|3.5
0-19|3.3|4.2|3.7|247|Incidence|6530380|Black|Female|Other|2005|3.3|4.3|3.8
0-19|2.9|3.8|3.4|226|Incidence|6560240|Black|Female|Other|2006|3.0|3.9|3.4
0-19|3.3|4.2|3.7|251|Incidence|6604633|Black|Female|Other|2007|3.3|4.3|3.8
0-19|2.8|3.7|3.2|219|Incidence|6638744|Black|Female|Other|2008|2.9|3.8|3.3
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|51|Incidence|5446152|Black|Female|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.5|1.0|0.8|44|Incidence|5847078|Black|Female|Soft Tissue|2001|0.5|1.0|0.8
0-19|0.7|1.2|0.9|54|Incidence|6055801|Black|Female|Soft Tissue|2002|0.7|1.2|0.9
0-19|0.7|1.2|0.9|59|Incidence|6482277|Black|Female|Soft Tissue|2003|0.7|1.2|0.9
0-19|1.0|1.5|1.2|80|Incidence|6505891|Black|Female|Soft Tissue|2004|1.0|1.5|1.2
0-19|0.9|1.1|1.0|323|Incidence|32839888|Black|Female|Soft Tissue|2004-2008|0.9|1.1|1.0
0-19|0.6|1.0|0.8|51|Incidence|6530380|Black|Female|Soft Tissue|2005|0.6|1.0|0.8
0-19|0.7|1.1|0.9|57|Incidence|6560240|Black|Female|Soft Tissue|2006|0.7|1.1|0.9
0-19|0.9|1.4|1.1|74|Incidence|6604633|Black|Female|Soft Tissue|2007|0.9|1.4|1.1
0-19|0.7|1.2|0.9|61|Incidence|6638744|Black|Female|Soft Tissue|2008|0.7|1.2|0.9
0-19|1.5|2.2|1.8|102|Incidence|5567502|Black|Male|Acute Lymphocytic|1999|1.5|2.2|1.8
0-19|1.2|1.8|1.5|83|Incidence|5620506|Black|Male|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|1.9|1.6|95|Incidence|6043483|Black|Male|Acute Lymphocytic|2001|1.3|1.9|1.6
0-19|1.4|2.1|1.7|109|Incidence|6261104|Black|Male|Acute Lymphocytic|2002|1.4|2.1|1.7
0-19|1.4|2.0|1.7|113|Incidence|6690871|Black|Male|Acute Lymphocytic|2003|1.4|2.0|1.7
0-19|1.7|2.4|2.0|133|Incidence|6713091|Black|Male|Acute Lymphocytic|2004|1.7|2.3|2.0
0-19|1.9|2.2|2.0|690|Incidence|33892654|Black|Male|Acute Lymphocytic|2004-2008|1.9|2.2|2.0
0-19|1.8|2.5|2.2|144|Incidence|6738111|Black|Male|Acute Lymphocytic|2005|1.8|2.5|2.1
0-19|1.8|2.5|2.1|141|Incidence|6769408|Black|Male|Acute Lymphocytic|2006|1.8|2.5|2.1
0-19|1.9|2.7|2.3|156|Incidence|6818048|Black|Male|Acute Lymphocytic|2007|1.9|2.7|2.3
0-19|1.4|2.0|1.7|116|Incidence|6853996|Black|Male|Acute Lymphocytic|2008|1.4|2.0|1.7
0-19|0.6|1.1|0.8|43|Incidence|5567502|Black|Male|Acute Myeloid|1999|0.6|1.0|0.8
0-19|0.5|0.9|0.7|37|Incidence|5620506|Black|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|31|Incidence|6043483|Black|Male|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.4|0.9|0.6|39|Incidence|6261104|Black|Male|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.6|1.1|0.8|55|Incidence|6690871|Black|Male|Acute Myeloid|2003|0.6|1.1|0.8
0-19|0.6|1.0|0.8|51|Incidence|6713091|Black|Male|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.6|0.7|0.6|219|Incidence|33892654|Black|Male|Acute Myeloid|2004-2008|0.6|0.7|0.6
0-19|0.5|0.9|0.7|44|Incidence|6738111|Black|Male|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.5|0.9|0.7|48|Incidence|6769408|Black|Male|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.3|0.6|0.5|31|Incidence|6818048|Black|Male|Acute Myeloid|2007|0.3|0.6|0.5
0-19|0.5|0.9|0.7|45|Incidence|6853996|Black|Male|Acute Myeloid|2008|0.5|0.9|0.7
0-19|11.2|13.0|12.1|666|Incidence|5567502|Black|Male|All Cancer Sites Combined|1999|11.1|12.9|12.0
0-19|11.2|13.1|12.1|677|Incidence|5620506|Black|Male|All Cancer Sites Combined|2000|11.2|13.0|12.0
0-19|11.1|12.9|12.0|719|Incidence|6043483|Black|Male|All Cancer Sites Combined|2001|11.0|12.8|11.9
0-19|11.3|13.0|12.1|754|Incidence|6261104|Black|Male|All Cancer Sites Combined|2002|11.2|12.9|12.0
0-19|12.1|13.8|12.9|864|Incidence|6690871|Black|Male|All Cancer Sites Combined|2003|12.1|13.8|12.9
0-19|12.5|14.3|13.4|900|Incidence|6713091|Black|Male|All Cancer Sites Combined|2004|12.5|14.3|13.4
0-19|13.1|13.9|13.5|4602|Incidence|33892654|Black|Male|All Cancer Sites Combined|2004-2008|13.2|14.0|13.6
0-19|12.8|14.6|13.7|923|Incidence|6738111|Black|Male|All Cancer Sites Combined|2005|12.8|14.6|13.7
0-19|12.5|14.2|13.3|907|Incidence|6769408|Black|Male|All Cancer Sites Combined|2006|12.5|14.3|13.4
0-19|12.2|13.9|13.0|899|Incidence|6818048|Black|Male|All Cancer Sites Combined|2007|12.3|14.1|13.2
0-19|13.1|14.9|14.0|973|Incidence|6853996|Black|Male|All Cancer Sites Combined|2008|13.3|15.1|14.2
0-19|0.7|1.2|0.9|49|Incidence|5567502|Black|Male|Bones and Joints|1999|0.7|1.2|0.9
0-19|0.5|1.0|0.7|40|Incidence|5620506|Black|Male|Bones and Joints|2000|0.5|1.0|0.7
0-19|0.5|0.9|0.7|39|Incidence|6043483|Black|Male|Bones and Joints|2001|0.5|0.9|0.6
0-19|0.6|1.1|0.8|51|Incidence|6261104|Black|Male|Bones and Joints|2002|0.6|1.1|0.8
0-19|0.6|1.0|0.7|50|Incidence|6690871|Black|Male|Bones and Joints|2003|0.6|1.0|0.7
0-19|0.7|1.2|0.9|63|Incidence|6713091|Black|Male|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.7|0.9|0.8|286|Incidence|33892654|Black|Male|Bones and Joints|2004-2008|0.7|0.9|0.8
0-19|0.7|1.2|0.9|64|Incidence|6738111|Black|Male|Bones and Joints|2005|0.7|1.2|0.9
0-19|0.6|1.1|0.8|57|Incidence|6769408|Black|Male|Bones and Joints|2006|0.6|1.1|0.8
0-19|0.5|0.9|0.7|47|Incidence|6818048|Black|Male|Bones and Joints|2007|0.5|0.9|0.7
0-19|0.6|1.0|0.8|55|Incidence|6853996|Black|Male|Bones and Joints|2008|0.6|1.0|0.8
0-19|1.8|2.6|2.2|124|Incidence|5567502|Black|Male|Brain and Other Nervous System|1999|1.9|2.7|2.2
0-19|2.1|2.9|2.5|140|Incidence|5620506|Black|Male|Brain and Other Nervous System|2000|2.1|2.9|2.5
0-19|1.7|2.5|2.1|125|Incidence|6043483|Black|Male|Brain and Other Nervous System|2001|1.7|2.5|2.1
0-19|2.0|2.8|2.4|148|Incidence|6261104|Black|Male|Brain and Other Nervous System|2002|2.0|2.8|2.4
0-19|1.9|2.6|2.2|148|Incidence|6690871|Black|Male|Brain and Other Nervous System|2003|1.9|2.6|2.2
0-19|2.1|2.9|2.5|165|Incidence|6713091|Black|Male|Brain and Other Nervous System|2004|2.1|2.9|2.5
0-19|2.2|2.5|2.3|785|Incidence|33892654|Black|Male|Brain and Other Nervous System|2004-2008|2.2|2.5|2.3
0-19|1.9|2.6|2.2|149|Incidence|6738111|Black|Male|Brain and Other Nervous System|2005|1.9|2.6|2.2
0-19|1.8|2.6|2.2|147|Incidence|6769408|Black|Male|Brain and Other Nervous System|2006|1.8|2.6|2.2
0-19|1.7|2.4|2.1|141|Incidence|6818048|Black|Male|Brain and Other Nervous System|2007|1.7|2.4|2.1
0-19|2.3|3.1|2.7|183|Incidence|6853996|Black|Male|Brain and Other Nervous System|2008|2.3|3.1|2.7
0-19|0.8|1.4|1.0|56|Incidence|5567502|Black|Male|Hodgkin Lymphoma|1999|0.8|1.3|1.0
0-19|0.9|1.5|1.1|62|Incidence|5620506|Black|Male|Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|0.8|1.3|1.0|59|Incidence|6043483|Black|Male|Hodgkin Lymphoma|2001|0.7|1.3|1.0
0-19|0.7|1.2|0.9|56|Incidence|6261104|Black|Male|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.7|1.2|0.9|62|Incidence|6690871|Black|Male|Hodgkin Lymphoma|2003|0.7|1.2|0.9
0-19|0.8|1.3|1.0|68|Incidence|6713091|Black|Male|Hodgkin Lymphoma|2004|0.8|1.3|1.0
0-19|1.0|1.2|1.1|379|Incidence|33892654|Black|Male|Hodgkin Lymphoma|2004-2008|1.0|1.2|1.1
0-19|1.0|1.5|1.2|85|Incidence|6738111|Black|Male|Hodgkin Lymphoma|2005|1.0|1.6|1.3
0-19|0.8|1.3|1.1|72|Incidence|6769408|Black|Male|Hodgkin Lymphoma|2006|0.8|1.3|1.1
0-19|0.8|1.3|1.1|73|Incidence|6818048|Black|Male|Hodgkin Lymphoma|2007|0.8|1.3|1.1
0-19|0.9|1.5|1.2|81|Incidence|6853996|Black|Male|Hodgkin Lymphoma|2008|0.9|1.5|1.2
0-19|0.4|0.9|0.6|36|Incidence|5567502|Black|Male|Kidney and Renal Pelvis|1999|0.5|0.9|0.6
0-19|0.6|1.1|0.9|48|Incidence|5620506|Black|Male|Kidney and Renal Pelvis|2000|0.6|1.1|0.9
0-19|0.5|1.0|0.7|45|Incidence|6043483|Black|Male|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.5|1.0|0.7|45|Incidence|6261104|Black|Male|Kidney and Renal Pelvis|2002|0.5|1.0|0.7
0-19|0.5|1.0|0.7|48|Incidence|6690871|Black|Male|Kidney and Renal Pelvis|2003|0.5|1.0|0.7
0-19|0.7|1.1|0.9|59|Incidence|6713091|Black|Male|Kidney and Renal Pelvis|2004|0.7|1.1|0.9
0-19|0.7|0.9|0.8|279|Incidence|33892654|Black|Male|Kidney and Renal Pelvis|2004-2008|0.7|0.9|0.8
0-19|0.6|1.0|0.8|53|Incidence|6738111|Black|Male|Kidney and Renal Pelvis|2005|0.6|1.0|0.8
0-19|0.7|1.2|0.9|61|Incidence|6769408|Black|Male|Kidney and Renal Pelvis|2006|0.7|1.2|0.9
0-19|0.6|1.0|0.8|54|Incidence|6818048|Black|Male|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|0.5|1.0|0.7|52|Incidence|6853996|Black|Male|Kidney and Renal Pelvis|2008|0.6|1.0|0.8
0-19|2.5|3.4|2.9|161|Incidence|5567502|Black|Male|Leukemia|1999|2.5|3.4|2.9
0-19|2.0|2.8|2.4|133|Incidence|5620506|Black|Male|Leukemia|2000|2.0|2.8|2.4
0-19|2.0|2.8|2.4|143|Incidence|6043483|Black|Male|Leukemia|2001|2.0|2.8|2.4
0-19|2.3|3.1|2.7|168|Incidence|6261104|Black|Male|Leukemia|2002|2.3|3.1|2.7
0-19|2.6|3.5|3.0|202|Incidence|6690871|Black|Male|Leukemia|2003|2.6|3.5|3.0
0-19|2.7|3.6|3.1|209|Incidence|6713091|Black|Male|Leukemia|2004|2.7|3.6|3.1
0-19|2.8|3.2|3.0|1018|Incidence|33892654|Black|Male|Leukemia|2004-2008|2.8|3.2|3.0
0-19|2.7|3.6|3.1|209|Incidence|6738111|Black|Male|Leukemia|2005|2.7|3.6|3.1
0-19|2.6|3.5|3.1|207|Incidence|6769408|Black|Male|Leukemia|2006|2.7|3.5|3.1
0-19|2.7|3.5|3.1|211|Incidence|6818048|Black|Male|Leukemia|2007|2.7|3.5|3.1
0-19|2.3|3.1|2.6|182|Incidence|6853996|Black|Male|Leukemia|2008|2.3|3.1|2.7
0-19|1.0|1.6|1.3|70|Incidence|5567502|Black|Male|Non-Hodgkin Lymphoma|1999|1.0|1.6|1.3
0-19|0.8|1.4|1.1|59|Incidence|5620506|Black|Male|Non-Hodgkin Lymphoma|2000|0.8|1.4|1.0
0-19|0.9|1.5|1.2|72|Incidence|6043483|Black|Male|Non-Hodgkin Lymphoma|2001|0.9|1.5|1.2
0-19|0.9|1.4|1.1|69|Incidence|6261104|Black|Male|Non-Hodgkin Lymphoma|2002|0.9|1.4|1.1
0-19|1.0|1.6|1.3|84|Incidence|6690871|Black|Male|Non-Hodgkin Lymphoma|2003|1.0|1.6|1.3
0-19|1.2|1.9|1.5|103|Incidence|6713091|Black|Male|Non-Hodgkin Lymphoma|2004|1.3|1.9|1.5
0-19|1.4|1.6|1.5|509|Incidence|33892654|Black|Male|Non-Hodgkin Lymphoma|2004-2008|1.4|1.6|1.5
0-19|1.2|1.8|1.5|103|Incidence|6738111|Black|Male|Non-Hodgkin Lymphoma|2005|1.2|1.9|1.5
0-19|1.2|1.8|1.5|100|Incidence|6769408|Black|Male|Non-Hodgkin Lymphoma|2006|1.2|1.8|1.5
0-19|1.2|1.7|1.4|97|Incidence|6818048|Black|Male|Non-Hodgkin Lymphoma|2007|1.2|1.7|1.4
0-19|1.3|1.8|1.5|106|Incidence|6853996|Black|Male|Non-Hodgkin Lymphoma|2008|1.3|1.9|1.5
0-19|2.0|2.8|2.4|129|Incidence|5567502|Black|Male|Other|1999|1.9|2.8|2.3
0-19|2.2|3.1|2.6|145|Incidence|5620506|Black|Male|Other|2000|2.2|3.0|2.6
0-19|2.4|3.3|2.9|172|Incidence|6043483|Black|Male|Other|2001|2.4|3.3|2.8
0-19|2.4|3.3|2.8|175|Incidence|6261104|Black|Male|Other|2002|2.4|3.2|2.8
0-19|2.8|3.7|3.2|213|Incidence|6690871|Black|Male|Other|2003|2.8|3.6|3.2
0-19|2.3|3.1|2.6|177|Incidence|6713091|Black|Male|Other|2004|2.3|3.1|2.6
0-19|2.8|3.2|3.0|1034|Incidence|33892654|Black|Male|Other|2004-2008|2.9|3.2|3.1
0-19|2.5|3.4|2.9|199|Incidence|6738111|Black|Male|Other|2005|2.6|3.4|3.0
0-19|2.5|3.3|2.9|200|Incidence|6769408|Black|Male|Other|2006|2.6|3.4|3.0
0-19|2.6|3.5|3.0|212|Incidence|6818048|Black|Male|Other|2007|2.7|3.6|3.1
0-19|3.1|3.9|3.5|246|Incidence|6853996|Black|Male|Other|2008|3.2|4.1|3.6
0-19|0.5|1.0|0.8|41|Incidence|5567502|Black|Male|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|50|Incidence|5620506|Black|Male|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.8|1.4|1.1|64|Incidence|6043483|Black|Male|Soft Tissue|2001|0.8|1.4|1.1
0-19|0.5|0.9|0.7|42|Incidence|6261104|Black|Male|Soft Tissue|2002|0.5|0.9|0.7
0-19|0.6|1.1|0.8|57|Incidence|6690871|Black|Male|Soft Tissue|2003|0.6|1.1|0.9
0-19|0.6|1.1|0.8|56|Incidence|6713091|Black|Male|Soft Tissue|2004|0.6|1.1|0.8
0-19|0.8|1.0|0.9|312|Incidence|33892654|Black|Male|Soft Tissue|2004-2008|0.8|1.0|0.9
0-19|0.7|1.2|0.9|61|Incidence|6738111|Black|Male|Soft Tissue|2005|0.7|1.2|0.9
0-19|0.7|1.2|0.9|63|Incidence|6769408|Black|Male|Soft Tissue|2006|0.7|1.2|0.9
0-19|0.7|1.2|0.9|64|Incidence|6818048|Black|Male|Soft Tissue|2007|0.7|1.2|0.9
0-19|0.8|1.2|1.0|68|Incidence|6853996|Black|Male|Soft Tissue|2008|0.8|1.3|1.0
0-19|1.4|1.8|1.6|176|Incidence|10969633|Black|Male and Female|Acute Lymphocytic|1999|1.4|1.9|1.6
0-19|1.2|1.7|1.5|163|Incidence|11066658|Black|Male and Female|Acute Lymphocytic|2000|1.3|1.7|1.5
0-19|1.4|1.9|1.6|191|Incidence|11890561|Black|Male and Female|Acute Lymphocytic|2001|1.4|1.9|1.6
0-19|1.3|1.7|1.5|186|Incidence|12316905|Black|Male and Female|Acute Lymphocytic|2002|1.3|1.7|1.5
0-19|1.3|1.7|1.5|200|Incidence|13173148|Black|Male and Female|Acute Lymphocytic|2003|1.3|1.7|1.5
0-19|1.5|1.9|1.7|224|Incidence|13218982|Black|Male and Female|Acute Lymphocytic|2004|1.5|1.9|1.7
0-19|1.6|1.8|1.7|1152|Incidence|66732542|Black|Male and Female|Acute Lymphocytic|2004-2008|1.6|1.8|1.7
0-19|1.5|2.0|1.8|232|Incidence|13268491|Black|Male and Female|Acute Lymphocytic|2005|1.5|2.0|1.7
0-19|1.5|2.0|1.8|235|Incidence|13329648|Black|Male and Female|Acute Lymphocytic|2006|1.5|2.0|1.8
0-19|1.7|2.1|1.9|252|Incidence|13422681|Black|Male and Female|Acute Lymphocytic|2007|1.7|2.1|1.9
0-19|1.4|1.8|1.6|209|Incidence|13492740|Black|Male and Female|Acute Lymphocytic|2008|1.3|1.8|1.5
0-19|0.6|0.9|0.7|77|Incidence|10969633|Black|Male and Female|Acute Myeloid|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.6|65|Incidence|11066658|Black|Male and Female|Acute Myeloid|2000|0.5|0.7|0.6
0-19|0.4|0.7|0.5|61|Incidence|11890561|Black|Male and Female|Acute Myeloid|2001|0.4|0.7|0.5
0-19|0.5|0.8|0.6|80|Incidence|12316905|Black|Male and Female|Acute Myeloid|2002|0.5|0.8|0.6
0-19|0.6|0.9|0.7|98|Incidence|13173148|Black|Male and Female|Acute Myeloid|2003|0.6|0.9|0.7
0-19|0.5|0.8|0.7|87|Incidence|13218982|Black|Male and Female|Acute Myeloid|2004|0.5|0.8|0.7
0-19|0.6|0.7|0.7|439|Incidence|66732542|Black|Male and Female|Acute Myeloid|2004-2008|0.6|0.7|0.7
0-19|0.5|0.7|0.6|80|Incidence|13268491|Black|Male and Female|Acute Myeloid|2005|0.5|0.8|0.6
0-19|0.6|0.9|0.8|102|Incidence|13329648|Black|Male and Female|Acute Myeloid|2006|0.6|0.9|0.8
0-19|0.4|0.6|0.5|69|Incidence|13422681|Black|Male and Female|Acute Myeloid|2007|0.4|0.7|0.5
0-19|0.6|0.9|0.7|101|Incidence|13492740|Black|Male and Female|Acute Myeloid|2008|0.6|0.9|0.7
0-19|11.1|12.4|11.7|1276|Incidence|10969633|Black|Male and Female|All Cancer Sites Combined|1999|11.0|12.3|11.6
0-19|10.8|12.1|11.4|1254|Incidence|11066658|Black|Male and Female|All Cancer Sites Combined|2000|10.7|12.0|11.3
0-19|11.1|12.3|11.7|1383|Incidence|11890561|Black|Male and Female|All Cancer Sites Combined|2001|11.0|12.3|11.6
0-19|11.1|12.3|11.7|1439|Incidence|12316905|Black|Male and Female|All Cancer Sites Combined|2002|11.1|12.3|11.7
0-19|12.2|13.4|12.8|1686|Incidence|13173148|Black|Male and Female|All Cancer Sites Combined|2003|12.2|13.4|12.8
0-19|12.4|13.7|13.0|1725|Incidence|13218982|Black|Male and Female|All Cancer Sites Combined|2004|12.4|13.7|13.0
0-19|12.7|13.3|13.0|8731|Incidence|66732542|Black|Male and Female|All Cancer Sites Combined|2004-2008|12.8|13.4|13.1
0-19|12.5|13.7|13.1|1742|Incidence|13268491|Black|Male and Female|All Cancer Sites Combined|2005|12.5|13.8|13.1
0-19|12.1|13.3|12.7|1710|Incidence|13329648|Black|Male and Female|All Cancer Sites Combined|2006|12.2|13.5|12.8
0-19|12.2|13.5|12.8|1741|Incidence|13422681|Black|Male and Female|All Cancer Sites Combined|2007|12.4|13.6|13.0
0-19|12.7|13.9|13.3|1813|Incidence|13492740|Black|Male and Female|All Cancer Sites Combined|2008|12.8|14.1|13.4
0-19|0.6|1.0|0.8|87|Incidence|10969633|Black|Male and Female|Bones and Joints|1999|0.6|1.0|0.8
0-19|0.5|0.8|0.6|67|Incidence|11066658|Black|Male and Female|Bones and Joints|2000|0.5|0.8|0.6
0-19|0.5|0.8|0.7|78|Incidence|11890561|Black|Male and Female|Bones and Joints|2001|0.5|0.8|0.7
0-19|0.6|0.9|0.7|87|Incidence|12316905|Black|Male and Female|Bones and Joints|2002|0.6|0.9|0.7
0-19|0.6|0.9|0.7|94|Incidence|13173148|Black|Male and Female|Bones and Joints|2003|0.6|0.9|0.7
0-19|0.8|1.1|0.9|123|Incidence|13218982|Black|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.7|0.8|0.8|514|Incidence|66732542|Black|Male and Female|Bones and Joints|2004-2008|0.7|0.8|0.8
0-19|0.7|1.0|0.8|107|Incidence|13268491|Black|Male and Female|Bones and Joints|2005|0.7|1.0|0.8
0-19|0.6|0.9|0.8|104|Incidence|13329648|Black|Male and Female|Bones and Joints|2006|0.6|0.9|0.8
0-19|0.5|0.8|0.7|89|Incidence|13422681|Black|Male and Female|Bones and Joints|2007|0.5|0.8|0.7
0-19|0.5|0.8|0.7|91|Incidence|13492740|Black|Male and Female|Bones and Joints|2008|0.5|0.8|0.7
0-19|1.8|2.3|2.0|224|Incidence|10969633|Black|Male and Female|Brain and Other Nervous System|1999|1.8|2.3|2.0
0-19|2.0|2.5|2.2|249|Incidence|11066658|Black|Male and Female|Brain and Other Nervous System|2000|2.0|2.5|2.3
0-19|1.8|2.3|2.0|243|Incidence|11890561|Black|Male and Female|Brain and Other Nervous System|2001|1.8|2.3|2.0
0-19|1.9|2.5|2.2|269|Incidence|12316905|Black|Male and Female|Brain and Other Nervous System|2002|1.9|2.5|2.2
0-19|2.0|2.5|2.2|289|Incidence|13173148|Black|Male and Female|Brain and Other Nervous System|2003|1.9|2.5|2.2
0-19|2.2|2.7|2.4|319|Incidence|13218982|Black|Male and Female|Brain and Other Nervous System|2004|2.2|2.7|2.4
0-19|2.2|2.5|2.3|1556|Incidence|66732542|Black|Male and Female|Brain and Other Nervous System|2004-2008|2.2|2.5|2.3
0-19|2.0|2.6|2.3|301|Incidence|13268491|Black|Male and Female|Brain and Other Nervous System|2005|2.0|2.5|2.3
0-19|2.0|2.5|2.2|296|Incidence|13329648|Black|Male and Female|Brain and Other Nervous System|2006|2.0|2.5|2.2
0-19|2.0|2.5|2.2|293|Incidence|13422681|Black|Male and Female|Brain and Other Nervous System|2007|1.9|2.4|2.2
0-19|2.3|2.9|2.6|347|Incidence|13492740|Black|Male and Female|Brain and Other Nervous System|2008|2.3|2.9|2.6
0-19|0.7|1.0|0.8|89|Incidence|10969633|Black|Male and Female|Hodgkin Lymphoma|1999|0.7|1.0|0.8
0-19|0.8|1.2|1.0|104|Incidence|11066658|Black|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|0.7|1.0|0.9|100|Incidence|11890561|Black|Male and Female|Hodgkin Lymphoma|2001|0.7|1.0|0.8
0-19|0.8|1.1|0.9|113|Incidence|12316905|Black|Male and Female|Hodgkin Lymphoma|2002|0.8|1.1|0.9
0-19|0.8|1.1|1.0|125|Incidence|13173148|Black|Male and Female|Hodgkin Lymphoma|2003|0.8|1.1|0.9
0-19|0.8|1.1|0.9|125|Incidence|13218982|Black|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|0.9|1.1|1.0|687|Incidence|66732542|Black|Male and Female|Hodgkin Lymphoma|2004-2008|1.0|1.1|1.0
0-19|1.0|1.3|1.1|154|Incidence|13268491|Black|Male and Female|Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|0.8|1.1|0.9|124|Incidence|13329648|Black|Male and Female|Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|0.9|127|Incidence|13422681|Black|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|1.0|1.3|1.1|157|Incidence|13492740|Black|Male and Female|Hodgkin Lymphoma|2008|1.0|1.4|1.2
0-19|0.6|1.0|0.8|86|Incidence|10969633|Black|Male and Female|Kidney and Renal Pelvis|1999|0.6|1.0|0.8
0-19|0.8|1.1|0.9|105|Incidence|11066658|Black|Male and Female|Kidney and Renal Pelvis|2000|0.8|1.1|0.9
0-19|0.6|0.9|0.7|87|Incidence|11890561|Black|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.9|0.7
0-19|0.6|1.0|0.8|97|Incidence|12316905|Black|Male and Female|Kidney and Renal Pelvis|2002|0.6|1.0|0.8
0-19|0.6|0.9|0.7|94|Incidence|13173148|Black|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.9|0.7
0-19|0.6|1.0|0.8|103|Incidence|13218982|Black|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.9|0.8
0-19|0.8|0.9|0.8|551|Incidence|66732542|Black|Male and Female|Kidney and Renal Pelvis|2004-2008|0.8|0.9|0.8
0-19|0.7|1.0|0.9|114|Incidence|13268491|Black|Male and Female|Kidney and Renal Pelvis|2005|0.7|1.0|0.9
0-19|0.7|1.0|0.8|111|Incidence|13329648|Black|Male and Female|Kidney and Renal Pelvis|2006|0.7|1.0|0.8
0-19|0.7|1.0|0.8|112|Incidence|13422681|Black|Male and Female|Kidney and Renal Pelvis|2007|0.7|1.0|0.8
0-19|0.7|1.0|0.8|111|Incidence|13492740|Black|Male and Female|Kidney and Renal Pelvis|2008|0.7|1.0|0.8
0-19|2.4|3.0|2.7|291|Incidence|10969633|Black|Male and Female|Leukemia|1999|2.4|3.0|2.7
0-19|2.0|2.5|2.2|249|Incidence|11066658|Black|Male and Female|Leukemia|2000|2.0|2.5|2.3
0-19|2.1|2.7|2.4|284|Incidence|11890561|Black|Male and Female|Leukemia|2001|2.1|2.7|2.4
0-19|2.2|2.8|2.5|307|Incidence|12316905|Black|Male and Female|Leukemia|2002|2.2|2.8|2.5
0-19|2.4|2.9|2.6|347|Incidence|13173148|Black|Male and Female|Leukemia|2003|2.4|2.9|2.6
0-19|2.5|3.0|2.7|362|Incidence|13218982|Black|Male and Female|Leukemia|2004|2.5|3.0|2.7
0-19|2.6|2.8|2.7|1806|Incidence|66732542|Black|Male and Female|Leukemia|2004-2008|2.6|2.8|2.7
0-19|2.4|2.9|2.6|350|Incidence|13268491|Black|Male and Female|Leukemia|2005|2.4|2.9|2.6
0-19|2.5|3.1|2.8|375|Incidence|13329648|Black|Male and Female|Leukemia|2006|2.5|3.1|2.8
0-19|2.5|3.1|2.8|372|Incidence|13422681|Black|Male and Female|Leukemia|2007|2.5|3.1|2.8
0-19|2.3|2.9|2.6|347|Incidence|13492740|Black|Male and Female|Leukemia|2008|2.3|2.9|2.6
0-19|0.8|1.2|1.0|106|Incidence|10969633|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.2|1.0
0-19|0.7|1.0|0.8|93|Incidence|11066658|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.7|1.0|0.8
0-19|0.8|1.2|1.0|118|Incidence|11890561|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.2|1.0
0-19|0.8|1.2|1.0|118|Incidence|12316905|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.8|1.1|1.0
0-19|0.8|1.2|1.0|128|Incidence|13173148|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.8|1.2|1.0
0-19|1.0|1.4|1.2|161|Incidence|13218982|Black|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.4|1.2
0-19|1.1|1.3|1.2|786|Incidence|66732542|Black|Male and Female|Non-Hodgkin Lymphoma|2004-2008|1.1|1.3|1.2
0-19|1.0|1.4|1.2|158|Incidence|13268491|Black|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|1.0|1.3|1.1|154|Incidence|13329648|Black|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.4|1.2
0-19|0.9|1.3|1.1|147|Incidence|13422681|Black|Male and Female|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|1.0|1.4|1.2|166|Incidence|13492740|Black|Male and Female|Non-Hodgkin Lymphoma|2008|1.1|1.4|1.2
0-19|2.6|3.3|2.9|314|Incidence|10969633|Black|Male and Female|Other|1999|2.6|3.2|2.9
0-19|2.3|2.9|2.6|286|Incidence|11066658|Black|Male and Female|Other|2000|2.3|2.9|2.6
0-19|2.8|3.4|3.1|365|Incidence|11890561|Black|Male and Female|Other|2001|2.8|3.4|3.1
0-19|2.6|3.2|2.9|352|Incidence|12316905|Black|Male and Female|Other|2002|2.6|3.2|2.9
0-19|3.4|4.1|3.8|493|Incidence|13173148|Black|Male and Female|Other|2003|3.4|4.1|3.7
0-19|2.7|3.3|3.0|396|Incidence|13218982|Black|Male and Female|Other|2004|2.7|3.3|3.0
0-19|3.1|3.4|3.2|2196|Incidence|66732542|Black|Male and Female|Other|2004-2008|3.2|3.4|3.3
0-19|3.0|3.7|3.3|446|Incidence|13268491|Black|Male and Female|Other|2005|3.1|3.7|3.4
0-19|2.8|3.5|3.1|426|Incidence|13329648|Black|Male and Female|Other|2006|2.9|3.5|3.2
0-19|3.1|3.7|3.4|463|Incidence|13422681|Black|Male and Female|Other|2007|3.1|3.8|3.4
0-19|3.1|3.7|3.4|465|Incidence|13492740|Black|Male and Female|Other|2008|3.1|3.8|3.4
0-19|0.6|0.9|0.7|79|Incidence|10969633|Black|Male and Female|Soft Tissue|1999|0.6|0.9|0.7
0-19|0.8|1.1|0.9|101|Incidence|11066658|Black|Male and Female|Soft Tissue|2000|0.7|1.1|0.9
0-19|0.7|1.1|0.9|108|Incidence|11890561|Black|Male and Female|Soft Tissue|2001|0.7|1.1|0.9
0-19|0.6|0.9|0.8|96|Incidence|12316905|Black|Male and Female|Soft Tissue|2002|0.6|1.0|0.8
0-19|0.7|1.1|0.9|116|Incidence|13173148|Black|Male and Female|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.9|1.2|1.0|136|Incidence|13218982|Black|Male and Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.9|1.0|0.9|635|Incidence|66732542|Black|Male and Female|Soft Tissue|2004-2008|0.9|1.0|1.0
0-19|0.7|1.0|0.8|112|Incidence|13268491|Black|Male and Female|Soft Tissue|2005|0.7|1.0|0.8
0-19|0.7|1.1|0.9|120|Incidence|13329648|Black|Male and Female|Soft Tissue|2006|0.7|1.1|0.9
0-19|0.9|1.2|1.0|138|Incidence|13422681|Black|Male and Female|Soft Tissue|2007|0.9|1.2|1.0
0-19|0.8|1.1|0.9|129|Incidence|13492740|Black|Male and Female|Soft Tissue|2008|0.8|1.1|1.0
0-19|2.8|3.7|3.2|211|Incidence|6236914|Hispanic|Female|Acute Lymphocytic|1999|2.9|3.9|3.4
0-19|3.5|4.4|3.9|266|Incidence|6504956|Hispanic|Female|Acute Lymphocytic|2000|3.6|4.6|4.1
0-19|3.1|4.0|3.6|255|Incidence|6813556|Hispanic|Female|Acute Lymphocytic|2001|3.3|4.2|3.7
0-19|3.3|4.2|3.7|280|Incidence|7093421|Hispanic|Female|Acute Lymphocytic|2002|3.5|4.4|3.9
0-19|3.0|3.9|3.4|267|Incidence|7365360|Hispanic|Female|Acute Lymphocytic|2003|3.2|4.1|3.6
0-19|3.0|3.8|3.4|272|Incidence|7606752|Hispanic|Female|Acute Lymphocytic|2004|3.2|4.0|3.6
0-19|3.5|3.8|3.6|1561|Incidence|40710732|Hispanic|Female|Acute Lymphocytic|2004-2008|3.6|4.0|3.8
0-19|3.0|3.8|3.4|283|Incidence|7859967|Hispanic|Female|Acute Lymphocytic|2005|3.2|4.0|3.6
0-19|3.2|4.0|3.6|310|Incidence|8132294|Hispanic|Female|Acute Lymphocytic|2006|3.4|4.3|3.8
0-19|3.1|3.9|3.5|310|Incidence|8418953|Hispanic|Female|Acute Lymphocytic|2007|3.3|4.1|3.7
0-19|3.8|4.7|4.2|386|Incidence|8692766|Hispanic|Female|Acute Lymphocytic|2008|4.0|4.9|4.4
0-19|0.5|0.9|0.7|42|Incidence|6236914|Hispanic|Female|Acute Myeloid|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|53|Incidence|6504956|Hispanic|Female|Acute Myeloid|2000|0.6|1.1|0.8
0-19|0.5|0.9|0.7|46|Incidence|6813556|Hispanic|Female|Acute Myeloid|2001|0.5|0.9|0.7
0-19|0.5|1.0|0.7|51|Incidence|7093421|Hispanic|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|50|Incidence|7365360|Hispanic|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.6|1.0|0.8|61|Incidence|7606752|Hispanic|Female|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.7|0.9|0.8|320|Incidence|40710732|Hispanic|Female|Acute Myeloid|2004-2008|0.7|0.9|0.8
0-19|0.5|0.9|0.7|57|Incidence|7859967|Hispanic|Female|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.6|1.0|0.7|58|Incidence|8132294|Hispanic|Female|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.7|1.1|0.9|77|Incidence|8418953|Hispanic|Female|Acute Myeloid|2007|0.7|1.1|0.9
0-19|0.6|0.9|0.7|67|Incidence|8692766|Hispanic|Female|Acute Myeloid|2008|0.6|1.0|0.8
0-19|13.0|14.9|13.9|876|Incidence|6236914|Hispanic|Female|All Cancer Sites Combined|1999|13.1|15.0|14.0
0-19|14.5|16.4|15.4|1004|Incidence|6504956|Hispanic|Female|All Cancer Sites Combined|2000|14.5|16.4|15.4
0-19|14.0|15.9|14.9|1033|Incidence|6813556|Hispanic|Female|All Cancer Sites Combined|2001|14.3|16.1|15.2
0-19|14.2|16.0|15.1|1080|Incidence|7093421|Hispanic|Female|All Cancer Sites Combined|2002|14.3|16.2|15.2
0-19|14.5|16.3|15.4|1151|Incidence|7365360|Hispanic|Female|All Cancer Sites Combined|2003|14.7|16.6|15.6
0-19|15.6|17.4|16.5|1265|Incidence|7606752|Hispanic|Female|All Cancer Sites Combined|2004|15.7|17.6|16.6
0-19|15.4|16.2|15.8|6488|Incidence|40710732|Hispanic|Female|All Cancer Sites Combined|2004-2008|15.6|16.3|15.9
0-19|14.6|16.3|15.4|1217|Incidence|7859967|Hispanic|Female|All Cancer Sites Combined|2005|14.6|16.4|15.5
0-19|14.7|16.5|15.6|1267|Incidence|8132294|Hispanic|Female|All Cancer Sites Combined|2006|14.7|16.5|15.6
0-19|14.8|16.5|15.7|1329|Incidence|8418953|Hispanic|Female|All Cancer Sites Combined|2007|14.9|16.7|15.8
0-19|15.2|16.9|16.0|1410|Incidence|8692766|Hispanic|Female|All Cancer Sites Combined|2008|15.4|17.1|16.2
0-19|0.7|1.2|0.9|53|Incidence|6236914|Hispanic|Female|Bones and Joints|1999|0.6|1.1|0.8
0-19|0.7|1.2|0.9|55|Incidence|6504956|Hispanic|Female|Bones and Joints|2000|0.6|1.1|0.8
0-19|0.5|1.0|0.7|47|Incidence|6813556|Hispanic|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.6|1.0|0.8|51|Incidence|7093421|Hispanic|Female|Bones and Joints|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|60|Incidence|7365360|Hispanic|Female|Bones and Joints|2003|0.6|1.0|0.8
0-19|0.8|1.3|1.0|70|Incidence|7606752|Hispanic|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.7|0.9|0.8|310|Incidence|40710732|Hispanic|Female|Bones and Joints|2004-2008|0.7|0.9|0.8
0-19|0.7|1.1|0.8|62|Incidence|7859967|Hispanic|Female|Bones and Joints|2005|0.6|1.0|0.8
0-19|0.7|1.1|0.9|65|Incidence|8132294|Hispanic|Female|Bones and Joints|2006|0.6|1.0|0.8
0-19|0.5|0.8|0.6|49|Incidence|8418953|Hispanic|Female|Bones and Joints|2007|0.4|0.8|0.6
0-19|0.6|1.0|0.8|64|Incidence|8692766|Hispanic|Female|Bones and Joints|2008|0.6|0.9|0.7
0-19|1.9|2.6|2.2|145|Incidence|6236914|Hispanic|Female|Brain and Other Nervous System|1999|2.0|2.7|2.3
0-19|2.0|2.7|2.3|157|Incidence|6504956|Hispanic|Female|Brain and Other Nervous System|2000|2.1|2.8|2.4
0-19|2.0|2.7|2.3|165|Incidence|6813556|Hispanic|Female|Brain and Other Nervous System|2001|2.1|2.8|2.4
0-19|1.9|2.6|2.2|166|Incidence|7093421|Hispanic|Female|Brain and Other Nervous System|2002|2.0|2.7|2.3
0-19|2.2|2.9|2.5|192|Incidence|7365360|Hispanic|Female|Brain and Other Nervous System|2003|2.3|3.0|2.6
0-19|2.7|3.5|3.1|238|Incidence|7606752|Hispanic|Female|Brain and Other Nervous System|2004|2.7|3.6|3.1
0-19|2.4|2.7|2.5|1051|Incidence|40710732|Hispanic|Female|Brain and Other Nervous System|2004-2008|2.4|2.7|2.6
0-19|1.9|2.6|2.3|183|Incidence|7859967|Hispanic|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|2.0|2.7|2.3|191|Incidence|8132294|Hispanic|Female|Brain and Other Nervous System|2006|2.0|2.7|2.3
0-19|2.4|3.1|2.7|233|Incidence|8418953|Hispanic|Female|Brain and Other Nervous System|2007|2.4|3.1|2.8
0-19|2.0|2.6|2.3|206|Incidence|8692766|Hispanic|Female|Brain and Other Nervous System|2008|2.1|2.7|2.4
0-19|0.5|1.0|0.8|43|Incidence|6236914|Hispanic|Female|Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|49|Incidence|6504956|Hispanic|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.7|1.2|1.0|60|Incidence|6813556|Hispanic|Female|Hodgkin Lymphoma|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|49|Incidence|7093421|Hispanic|Female|Hodgkin Lymphoma|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|57|Incidence|7365360|Hispanic|Female|Hodgkin Lymphoma|2003|0.6|1.0|0.8
0-19|0.8|1.3|1.0|68|Incidence|7606752|Hispanic|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.9|1.1|1.0|358|Incidence|40710732|Hispanic|Female|Hodgkin Lymphoma|2004-2008|0.8|1.0|0.9
0-19|0.8|1.3|1.0|71|Incidence|7859967|Hispanic|Female|Hodgkin Lymphoma|2005|0.7|1.1|0.9
0-19|0.8|1.3|1.1|77|Incidence|8132294|Hispanic|Female|Hodgkin Lymphoma|2006|0.7|1.2|0.9
0-19|0.6|1.1|0.8|63|Incidence|8418953|Hispanic|Female|Hodgkin Lymphoma|2007|0.6|1.0|0.7
0-19|0.8|1.3|1.0|79|Incidence|8692766|Hispanic|Female|Hodgkin Lymphoma|2008|0.7|1.1|0.9
0-19|0.5|0.9|0.7|46|Incidence|6236914|Hispanic|Female|Kidney and Renal Pelvis|1999|0.5|1.0|0.7
0-19|0.3|0.6|0.4|29|Incidence|6504956|Hispanic|Female|Kidney and Renal Pelvis|2000|0.3|0.6|0.4
0-19|0.4|0.8|0.6|45|Incidence|6813556|Hispanic|Female|Kidney and Renal Pelvis|2001|0.5|0.9|0.7
0-19|0.4|0.7|0.5|43|Incidence|7093421|Hispanic|Female|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.5|0.8|0.6|52|Incidence|7365360|Hispanic|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|52|Incidence|7606752|Hispanic|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.5|0.6|0.6|264|Incidence|40710732|Hispanic|Female|Kidney and Renal Pelvis|2004-2008|0.6|0.7|0.6
0-19|0.3|0.6|0.4|37|Incidence|7859967|Hispanic|Female|Kidney and Renal Pelvis|2005|0.3|0.6|0.5
0-19|0.4|0.7|0.6|52|Incidence|8132294|Hispanic|Female|Kidney and Renal Pelvis|2006|0.5|0.8|0.6
0-19|0.5|0.9|0.7|67|Incidence|8418953|Hispanic|Female|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|0.4|0.7|0.5|56|Incidence|8692766|Hispanic|Female|Kidney and Renal Pelvis|2008|0.5|0.8|0.6
0-19|3.8|4.8|4.3|276|Incidence|6236914|Hispanic|Female|Leukemia|1999|3.9|5.0|4.4
0-19|4.7|5.8|5.2|348|Incidence|6504956|Hispanic|Female|Leukemia|2000|4.8|5.9|5.3
0-19|4.2|5.2|4.7|332|Incidence|6813556|Hispanic|Female|Leukemia|2001|4.4|5.4|4.9
0-19|4.5|5.6|5.0|373|Incidence|7093421|Hispanic|Female|Leukemia|2002|4.7|5.8|5.3
0-19|4.1|5.1|4.6|353|Incidence|7365360|Hispanic|Female|Leukemia|2003|4.3|5.3|4.8
0-19|4.1|5.0|4.5|361|Incidence|7606752|Hispanic|Female|Leukemia|2004|4.3|5.3|4.7
0-19|4.6|5.0|4.8|2043|Incidence|40710732|Hispanic|Female|Leukemia|2004-2008|4.8|5.2|5.0
0-19|4.1|5.0|4.5|376|Incidence|7859967|Hispanic|Female|Leukemia|2005|4.3|5.3|4.8
0-19|4.3|5.2|4.7|400|Incidence|8132294|Hispanic|Female|Leukemia|2006|4.4|5.4|4.9
0-19|4.4|5.4|4.9|425|Incidence|8418953|Hispanic|Female|Leukemia|2007|4.6|5.6|5.0
0-19|4.8|5.8|5.3|481|Incidence|8692766|Hispanic|Female|Leukemia|2008|5.0|6.1|5.5
0-19|0.5|1.0|0.7|44|Incidence|6236914|Hispanic|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.5|0.9|0.7|45|Incidence|6504956|Hispanic|Female|Non-Hodgkin Lymphoma|2000|0.5|0.9|0.7
0-19|0.5|0.9|0.6|42|Incidence|6813556|Hispanic|Female|Non-Hodgkin Lymphoma|2001|0.4|0.8|0.6
0-19|0.6|1.1|0.8|56|Incidence|7093421|Hispanic|Female|Non-Hodgkin Lymphoma|2002|0.6|1.0|0.8
0-19|0.4|0.8|0.6|44|Incidence|7365360|Hispanic|Female|Non-Hodgkin Lymphoma|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|50|Incidence|7606752|Hispanic|Female|Non-Hodgkin Lymphoma|2004|0.5|0.9|0.7
0-19|0.6|0.8|0.7|283|Incidence|40710732|Hispanic|Female|Non-Hodgkin Lymphoma|2004-2008|0.6|0.8|0.7
0-19|0.6|1.0|0.8|61|Incidence|7859967|Hispanic|Female|Non-Hodgkin Lymphoma|2005|0.6|1.0|0.8
0-19|0.6|1.0|0.8|57|Incidence|8132294|Hispanic|Female|Non-Hodgkin Lymphoma|2006|0.5|0.9|0.7
0-19|0.6|1.0|0.7|59|Incidence|8418953|Hispanic|Female|Non-Hodgkin Lymphoma|2007|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Incidence|8692766|Hispanic|Female|Non-Hodgkin Lymphoma|2008|0.5|0.8|0.6
0-19|3.2|4.1|3.6|222|Incidence|6236914|Hispanic|Female|Other|1999|3.1|4.1|3.6
0-19|3.7|4.7|4.2|266|Incidence|6504956|Hispanic|Female|Other|2000|3.6|4.6|4.1
0-19|3.6|4.6|4.1|280|Incidence|6813556|Hispanic|Female|Other|2001|3.6|4.6|4.1
0-19|3.5|4.5|4.0|279|Incidence|7093421|Hispanic|Female|Other|2002|3.5|4.4|3.9
0-19|3.7|4.7|4.2|303|Incidence|7365360|Hispanic|Female|Other|2003|3.7|4.6|4.1
0-19|4.2|5.2|4.7|354|Incidence|7606752|Hispanic|Female|Other|2004|4.2|5.2|4.7
0-19|4.3|4.7|4.5|1784|Incidence|40710732|Hispanic|Female|Other|2004-2008|4.2|4.6|4.4
0-19|4.0|5.0|4.5|345|Incidence|7859967|Hispanic|Female|Other|2005|3.9|4.9|4.4
0-19|3.9|4.8|4.3|343|Incidence|8132294|Hispanic|Female|Other|2006|3.8|4.7|4.2
0-19|3.9|4.8|4.3|355|Incidence|8418953|Hispanic|Female|Other|2007|3.8|4.7|4.2
0-19|4.1|5.0|4.6|387|Incidence|8692766|Hispanic|Female|Other|2008|4.0|4.9|4.5
0-19|0.5|1.0|0.7|47|Incidence|6236914|Hispanic|Female|Soft Tissue|1999|0.6|1.0|0.8
0-19|0.6|1.1|0.9|55|Incidence|6504956|Hispanic|Female|Soft Tissue|2000|0.6|1.1|0.8
0-19|0.7|1.1|0.9|62|Incidence|6813556|Hispanic|Female|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.7|1.1|0.9|63|Incidence|7093421|Hispanic|Female|Soft Tissue|2002|0.7|1.1|0.9
0-19|1.0|1.5|1.2|90|Incidence|7365360|Hispanic|Female|Soft Tissue|2003|1.0|1.5|1.2
0-19|0.7|1.2|0.9|72|Incidence|7606752|Hispanic|Female|Soft Tissue|2004|0.7|1.2|0.9
0-19|0.9|1.1|1.0|395|Incidence|40710732|Hispanic|Female|Soft Tissue|2004-2008|0.9|1.1|1.0
0-19|0.8|1.3|1.0|82|Incidence|7859967|Hispanic|Female|Soft Tissue|2005|0.8|1.3|1.0
0-19|0.8|1.2|1.0|82|Incidence|8132294|Hispanic|Female|Soft Tissue|2006|0.8|1.3|1.0
0-19|0.7|1.1|0.9|78|Incidence|8418953|Hispanic|Female|Soft Tissue|2007|0.7|1.2|0.9
0-19|0.7|1.1|0.9|81|Incidence|8692766|Hispanic|Female|Soft Tissue|2008|0.7|1.2|0.9
0-19|3.9|4.9|4.3|297|Incidence|6635632|Hispanic|Male|Acute Lymphocytic|1999|4.0|5.0|4.5
0-19|4.0|4.9|4.4|315|Incidence|6919053|Hispanic|Male|Acute Lymphocytic|2000|4.1|5.1|4.6
0-19|3.9|4.9|4.4|323|Incidence|7240643|Hispanic|Male|Acute Lymphocytic|2001|4.0|5.0|4.5
0-19|4.2|5.2|4.6|361|Incidence|7518483|Hispanic|Male|Acute Lymphocytic|2002|4.3|5.3|4.8
0-19|3.6|4.5|4.0|323|Incidence|7785714|Hispanic|Male|Acute Lymphocytic|2003|3.7|4.6|4.1
0-19|4.1|5.0|4.5|381|Incidence|8024129|Hispanic|Male|Acute Lymphocytic|2004|4.3|5.2|4.7
0-19|4.5|4.9|4.7|2110|Incidence|42881505|Hispanic|Male|Acute Lymphocytic|2004-2008|4.7|5.1|4.9
0-19|4.1|5.0|4.5|386|Incidence|8283812|Hispanic|Male|Acute Lymphocytic|2005|4.2|5.1|4.7
0-19|4.4|5.3|4.8|425|Incidence|8563877|Hispanic|Male|Acute Lymphocytic|2006|4.5|5.5|5.0
0-19|4.6|5.6|5.1|469|Incidence|8863218|Hispanic|Male|Acute Lymphocytic|2007|4.8|5.8|5.3
0-19|4.3|5.2|4.7|449|Incidence|9146469|Hispanic|Male|Acute Lymphocytic|2008|4.5|5.4|4.9
0-19|0.8|1.3|1.0|65|Incidence|6635632|Hispanic|Male|Acute Myeloid|1999|0.8|1.2|1.0
0-19|0.5|0.9|0.7|47|Incidence|6919053|Hispanic|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.7|1.1|0.8|63|Incidence|7240643|Hispanic|Male|Acute Myeloid|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|59|Incidence|7518483|Hispanic|Male|Acute Myeloid|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|56|Incidence|7785714|Hispanic|Male|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.8|1.3|1.0|81|Incidence|8024129|Hispanic|Male|Acute Myeloid|2004|0.8|1.3|1.0
0-19|0.7|0.9|0.8|359|Incidence|42881505|Hispanic|Male|Acute Myeloid|2004-2008|0.8|0.9|0.8
0-19|0.7|1.1|0.8|71|Incidence|8283812|Hispanic|Male|Acute Myeloid|2005|0.7|1.1|0.9
0-19|0.6|1.0|0.8|65|Incidence|8563877|Hispanic|Male|Acute Myeloid|2006|0.6|1.0|0.8
0-19|0.6|0.9|0.7|67|Incidence|8863218|Hispanic|Male|Acute Myeloid|2007|0.6|1.0|0.8
0-19|0.6|1.0|0.8|75|Incidence|9146469|Hispanic|Male|Acute Myeloid|2008|0.6|1.0|0.8
0-19|16.2|18.2|17.1|1153|Incidence|6635632|Hispanic|Male|All Cancer Sites Combined|1999|16.4|18.4|17.4
0-19|15.4|17.3|16.3|1138|Incidence|6919053|Hispanic|Male|All Cancer Sites Combined|2000|15.5|17.4|16.4
0-19|17.3|19.2|18.2|1330|Incidence|7240643|Hispanic|Male|All Cancer Sites Combined|2001|17.4|19.4|18.4
0-19|17.5|19.5|18.5|1398|Incidence|7518483|Hispanic|Male|All Cancer Sites Combined|2002|17.6|19.6|18.6
0-19|15.5|17.3|16.4|1288|Incidence|7785714|Hispanic|Male|All Cancer Sites Combined|2003|15.7|17.5|16.5
0-19|16.8|18.6|17.7|1440|Incidence|8024129|Hispanic|Male|All Cancer Sites Combined|2004|17.0|18.9|17.9
0-19|17.5|18.3|17.9|7744|Incidence|42881505|Hispanic|Male|All Cancer Sites Combined|2004-2008|17.7|18.5|18.1
0-19|16.6|18.5|17.5|1468|Incidence|8283812|Hispanic|Male|All Cancer Sites Combined|2005|16.8|18.7|17.7
0-19|17.6|19.4|18.5|1582|Incidence|8563877|Hispanic|Male|All Cancer Sites Combined|2006|17.6|19.4|18.5
0-19|17.3|19.0|18.1|1624|Incidence|8863218|Hispanic|Male|All Cancer Sites Combined|2007|17.4|19.2|18.3
0-19|16.8|18.6|17.7|1630|Incidence|9146469|Hispanic|Male|All Cancer Sites Combined|2008|17.0|18.7|17.8
0-19|0.5|1.0|0.7|46|Incidence|6635632|Hispanic|Male|Bones and Joints|1999|0.5|0.9|0.7
0-19|0.7|1.1|0.9|59|Incidence|6919053|Hispanic|Male|Bones and Joints|2000|0.6|1.1|0.9
0-19|0.9|1.4|1.2|79|Incidence|7240643|Hispanic|Male|Bones and Joints|2001|0.9|1.4|1.1
0-19|0.9|1.5|1.2|83|Incidence|7518483|Hispanic|Male|Bones and Joints|2002|0.9|1.4|1.1
0-19|0.7|1.2|1.0|69|Incidence|7785714|Hispanic|Male|Bones and Joints|2003|0.7|1.1|0.9
0-19|0.8|1.2|1.0|73|Incidence|8024129|Hispanic|Male|Bones and Joints|2004|0.7|1.1|0.9
0-19|1.0|1.2|1.1|425|Incidence|42881505|Hispanic|Male|Bones and Joints|2004-2008|0.9|1.1|1.0
0-19|0.8|1.2|1.0|76|Incidence|8283812|Hispanic|Male|Bones and Joints|2005|0.7|1.1|0.9
0-19|1.0|1.5|1.2|97|Incidence|8563877|Hispanic|Male|Bones and Joints|2006|0.9|1.4|1.1
0-19|0.8|1.3|1.1|86|Incidence|8863218|Hispanic|Male|Bones and Joints|2007|0.8|1.2|1.0
0-19|0.9|1.4|1.1|93|Incidence|9146469|Hispanic|Male|Bones and Joints|2008|0.8|1.2|1.0
0-19|2.7|3.5|3.1|206|Incidence|6635632|Hispanic|Male|Brain and Other Nervous System|1999|2.7|3.6|3.1
0-19|2.3|3.1|2.7|190|Incidence|6919053|Hispanic|Male|Brain and Other Nervous System|2000|2.4|3.2|2.7
0-19|2.6|3.4|3.0|220|Incidence|7240643|Hispanic|Male|Brain and Other Nervous System|2001|2.7|3.5|3.0
0-19|2.5|3.3|2.9|221|Incidence|7518483|Hispanic|Male|Brain and Other Nervous System|2002|2.6|3.4|2.9
0-19|2.3|3.0|2.6|208|Incidence|7785714|Hispanic|Male|Brain and Other Nervous System|2003|2.3|3.1|2.7
0-19|2.2|2.9|2.5|209|Incidence|8024129|Hispanic|Male|Brain and Other Nervous System|2004|2.3|3.0|2.6
0-19|2.5|2.8|2.7|1171|Incidence|42881505|Hispanic|Male|Brain and Other Nervous System|2004-2008|2.6|2.9|2.7
0-19|2.5|3.2|2.8|240|Incidence|8283812|Hispanic|Male|Brain and Other Nervous System|2005|2.5|3.3|2.9
0-19|2.6|3.3|3.0|256|Incidence|8563877|Hispanic|Male|Brain and Other Nervous System|2006|2.6|3.4|3.0
0-19|2.3|3.0|2.6|240|Incidence|8863218|Hispanic|Male|Brain and Other Nervous System|2007|2.4|3.1|2.7
0-19|2.1|2.7|2.4|226|Incidence|9146469|Hispanic|Male|Brain and Other Nervous System|2008|2.2|2.8|2.5
0-19|0.9|1.5|1.2|74|Incidence|6635632|Hispanic|Male|Hodgkin Lymphoma|1999|0.9|1.4|1.1
0-19|0.9|1.4|1.1|73|Incidence|6919053|Hispanic|Male|Hodgkin Lymphoma|2000|0.8|1.3|1.1
0-19|1.1|1.7|1.4|97|Incidence|7240643|Hispanic|Male|Hodgkin Lymphoma|2001|1.1|1.6|1.3
0-19|0.9|1.4|1.2|81|Incidence|7518483|Hispanic|Male|Hodgkin Lymphoma|2002|0.9|1.3|1.1
0-19|1.2|1.8|1.5|107|Incidence|7785714|Hispanic|Male|Hodgkin Lymphoma|2003|1.1|1.7|1.4
0-19|0.8|1.2|1.0|72|Incidence|8024129|Hispanic|Male|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|1.1|1.3|1.2|456|Incidence|42881505|Hispanic|Male|Hodgkin Lymphoma|2004-2008|1.0|1.2|1.1
0-19|0.9|1.4|1.2|90|Incidence|8283812|Hispanic|Male|Hodgkin Lymphoma|2005|0.9|1.3|1.1
0-19|1.0|1.5|1.3|100|Incidence|8563877|Hispanic|Male|Hodgkin Lymphoma|2006|1.0|1.4|1.2
0-19|1.0|1.5|1.2|99|Incidence|8863218|Hispanic|Male|Hodgkin Lymphoma|2007|0.9|1.4|1.1
0-19|0.9|1.4|1.1|95|Incidence|9146469|Hispanic|Male|Hodgkin Lymphoma|2008|0.8|1.3|1.0
0-19|0.4|0.7|0.5|38|Incidence|6635632|Hispanic|Male|Kidney and Renal Pelvis|1999|0.4|0.8|0.6
0-19|0.3|0.7|0.5|35|Incidence|6919053|Hispanic|Male|Kidney and Renal Pelvis|2000|0.4|0.7|0.5
0-19|0.4|0.7|0.5|42|Incidence|7240643|Hispanic|Male|Kidney and Renal Pelvis|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7518483|Hispanic|Male|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7785714|Hispanic|Male|Kidney and Renal Pelvis|2003|0.4|0.8|0.6
0-19|0.3|0.6|0.4|40|Incidence|8024129|Hispanic|Male|Kidney and Renal Pelvis|2004|0.4|0.7|0.5
0-19|0.4|0.5|0.4|213|Incidence|42881505|Hispanic|Male|Kidney and Renal Pelvis|2004-2008|0.4|0.6|0.5
0-19|0.3|0.6|0.5|44|Incidence|8283812|Hispanic|Male|Kidney and Renal Pelvis|2005|0.4|0.7|0.5
0-19|0.3|0.5|0.4|39|Incidence|8563877|Hispanic|Male|Kidney and Renal Pelvis|2006|0.3|0.6|0.5
0-19|0.4|0.7|0.5|49|Incidence|8863218|Hispanic|Male|Kidney and Renal Pelvis|2007|0.4|0.7|0.6
0-19|0.3|0.5|0.4|41|Incidence|9146469|Hispanic|Male|Kidney and Renal Pelvis|2008|0.3|0.6|0.4
0-19|5.2|6.4|5.8|395|Incidence|6635632|Hispanic|Male|Leukemia|1999|5.4|6.6|6.0
0-19|5.0|6.1|5.5|391|Incidence|6919053|Hispanic|Male|Leukemia|2000|5.1|6.2|5.7
0-19|5.3|6.4|5.8|429|Incidence|7240643|Hispanic|Male|Leukemia|2001|5.4|6.5|5.9
0-19|5.4|6.5|5.9|457|Incidence|7518483|Hispanic|Male|Leukemia|2002|5.5|6.7|6.1
0-19|4.6|5.6|5.0|405|Incidence|7785714|Hispanic|Male|Leukemia|2003|4.7|5.7|5.2
0-19|5.5|6.6|6.0|501|Incidence|8024129|Hispanic|Male|Leukemia|2004|5.7|6.8|6.2
0-19|5.8|6.3|6.0|2680|Incidence|42881505|Hispanic|Male|Leukemia|2004-2008|6.0|6.5|6.2
0-19|5.3|6.4|5.8|499|Incidence|8283812|Hispanic|Male|Leukemia|2005|5.5|6.6|6.0
0-19|5.6|6.6|6.1|532|Incidence|8563877|Hispanic|Male|Leukemia|2006|5.7|6.8|6.2
0-19|5.8|6.9|6.3|580|Incidence|8863218|Hispanic|Male|Leukemia|2007|6.0|7.1|6.5
0-19|5.5|6.5|6.0|568|Incidence|9146469|Hispanic|Male|Leukemia|2008|5.7|6.7|6.2
0-19|0.9|1.4|1.1|73|Incidence|6635632|Hispanic|Male|Non-Hodgkin Lymphoma|1999|0.9|1.4|1.1
0-19|1.0|1.6|1.3|88|Incidence|6919053|Hispanic|Male|Non-Hodgkin Lymphoma|2000|1.0|1.6|1.3
0-19|1.0|1.5|1.2|86|Incidence|7240643|Hispanic|Male|Non-Hodgkin Lymphoma|2001|1.0|1.5|1.2
0-19|1.4|2.0|1.6|119|Incidence|7518483|Hispanic|Male|Non-Hodgkin Lymphoma|2002|1.3|1.9|1.6
0-19|0.9|1.4|1.1|82|Incidence|7785714|Hispanic|Male|Non-Hodgkin Lymphoma|2003|0.8|1.3|1.1
0-19|1.2|1.8|1.5|116|Incidence|8024129|Hispanic|Male|Non-Hodgkin Lymphoma|2004|1.2|1.7|1.4
0-19|1.2|1.4|1.3|524|Incidence|42881505|Hispanic|Male|Non-Hodgkin Lymphoma|2004-2008|1.1|1.3|1.2
0-19|1.0|1.6|1.3|100|Incidence|8283812|Hispanic|Male|Non-Hodgkin Lymphoma|2005|1.0|1.5|1.2
0-19|1.0|1.5|1.2|99|Incidence|8563877|Hispanic|Male|Non-Hodgkin Lymphoma|2006|0.9|1.4|1.2
0-19|0.9|1.4|1.2|97|Incidence|8863218|Hispanic|Male|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|1.1|1.6|1.3|112|Incidence|9146469|Hispanic|Male|Non-Hodgkin Lymphoma|2008|1.0|1.5|1.2
0-19|3.4|4.3|3.8|262|Incidence|6635632|Hispanic|Male|Other|1999|3.5|4.5|3.9
0-19|2.9|3.8|3.3|231|Incidence|6919053|Hispanic|Male|Other|2000|2.9|3.8|3.3
0-19|3.8|4.7|4.2|311|Incidence|7240643|Hispanic|Male|Other|2001|3.8|4.8|4.3
0-19|3.7|4.6|4.1|312|Incidence|7518483|Hispanic|Male|Other|2002|3.7|4.6|4.1
0-19|3.5|4.4|3.9|306|Incidence|7785714|Hispanic|Male|Other|2003|3.5|4.4|3.9
0-19|3.8|4.7|4.2|345|Incidence|8024129|Hispanic|Male|Other|2004|3.9|4.8|4.3
0-19|4.1|4.5|4.3|1871|Incidence|42881505|Hispanic|Male|Other|2004-2008|4.2|4.6|4.4
0-19|3.8|4.7|4.2|349|Incidence|8283812|Hispanic|Male|Other|2005|3.8|4.7|4.2
0-19|4.0|4.9|4.4|377|Incidence|8563877|Hispanic|Male|Other|2006|4.0|4.9|4.4
0-19|3.9|4.8|4.3|391|Incidence|8863218|Hispanic|Male|Other|2007|4.0|4.9|4.4
0-19|4.0|4.9|4.5|409|Incidence|9146469|Hispanic|Male|Other|2008|4.0|4.9|4.5
0-19|0.7|1.1|0.9|59|Incidence|6635632|Hispanic|Male|Soft Tissue|1999|0.7|1.1|0.9
0-19|0.8|1.3|1.0|71|Incidence|6919053|Hispanic|Male|Soft Tissue|2000|0.8|1.3|1.0
0-19|0.7|1.2|0.9|66|Incidence|7240643|Hispanic|Male|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.8|1.3|1.1|81|Incidence|7518483|Hispanic|Male|Soft Tissue|2002|0.9|1.3|1.1
0-19|0.6|1.1|0.8|67|Incidence|7785714|Hispanic|Male|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.8|1.3|1.0|84|Incidence|8024129|Hispanic|Male|Soft Tissue|2004|0.8|1.3|1.0
0-19|0.8|1.0|0.9|404|Incidence|42881505|Hispanic|Male|Soft Tissue|2004-2008|0.9|1.0|0.9
0-19|0.6|1.0|0.8|70|Incidence|8283812|Hispanic|Male|Soft Tissue|2005|0.7|1.1|0.8
0-19|0.8|1.2|1.0|82|Incidence|8563877|Hispanic|Male|Soft Tissue|2006|0.8|1.2|1.0
0-19|0.7|1.1|0.9|82|Incidence|8863218|Hispanic|Male|Soft Tissue|2007|0.7|1.1|0.9
0-19|0.7|1.2|0.9|86|Incidence|9146469|Hispanic|Male|Soft Tissue|2008|0.8|1.2|0.9
0-19|3.5|4.1|3.8|508|Incidence|12872546|Hispanic|Male and Female|Acute Lymphocytic|1999|3.6|4.3|3.9
0-19|3.9|4.5|4.2|581|Incidence|13424009|Hispanic|Male and Female|Acute Lymphocytic|2000|4.0|4.7|4.3
0-19|3.7|4.3|4.0|578|Incidence|14054199|Hispanic|Male and Female|Acute Lymphocytic|2001|3.8|4.5|4.1
0-19|3.9|4.6|4.2|641|Incidence|14611904|Hispanic|Male and Female|Acute Lymphocytic|2002|4.1|4.7|4.4
0-19|3.4|4.0|3.7|590|Incidence|15151074|Hispanic|Male and Female|Acute Lymphocytic|2003|3.6|4.2|3.9
0-19|3.7|4.3|4.0|653|Incidence|15630881|Hispanic|Male and Female|Acute Lymphocytic|2004|3.9|4.5|4.2
0-19|4.1|4.3|4.2|3671|Incidence|83592237|Hispanic|Male and Female|Acute Lymphocytic|2004-2008|4.3|4.5|4.4
0-19|3.7|4.3|4.0|669|Incidence|16143779|Hispanic|Male and Female|Acute Lymphocytic|2005|3.8|4.5|4.1
0-19|3.9|4.6|4.2|735|Incidence|16696171|Hispanic|Male and Female|Acute Lymphocytic|2006|4.1|4.7|4.4
0-19|4.0|4.6|4.3|779|Incidence|17282171|Hispanic|Male and Female|Acute Lymphocytic|2007|4.2|4.8|4.5
0-19|4.2|4.8|4.5|835|Incidence|17839235|Hispanic|Male and Female|Acute Lymphocytic|2008|4.4|5.0|4.7
0-19|0.7|1.0|0.8|107|Incidence|12872546|Hispanic|Male and Female|Acute Myeloid|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.8|100|Incidence|13424009|Hispanic|Male and Female|Acute Myeloid|2000|0.6|0.9|0.7
0-19|0.6|0.9|0.8|109|Incidence|14054199|Hispanic|Male and Female|Acute Myeloid|2001|0.6|0.9|0.8
0-19|0.6|0.9|0.8|110|Incidence|14611904|Hispanic|Male and Female|Acute Myeloid|2002|0.6|0.9|0.8
0-19|0.6|0.8|0.7|106|Incidence|15151074|Hispanic|Male and Female|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.8|1.1|0.9|142|Incidence|15630881|Hispanic|Male and Female|Acute Myeloid|2004|0.8|1.1|0.9
0-19|0.7|0.9|0.8|679|Incidence|83592237|Hispanic|Male and Female|Acute Myeloid|2004-2008|0.8|0.9|0.8
0-19|0.6|0.9|0.8|128|Incidence|16143779|Hispanic|Male and Female|Acute Myeloid|2005|0.7|0.9|0.8
0-19|0.6|0.9|0.7|123|Incidence|16696171|Hispanic|Male and Female|Acute Myeloid|2006|0.6|0.9|0.7
0-19|0.7|1.0|0.8|144|Incidence|17282171|Hispanic|Male and Female|Acute Myeloid|2007|0.7|1.0|0.8
0-19|0.6|0.9|0.8|142|Incidence|17839235|Hispanic|Male and Female|Acute Myeloid|2008|0.7|0.9|0.8
0-19|14.9|16.3|15.6|2029|Incidence|12872546|Hispanic|Male and Female|All Cancer Sites Combined|1999|15.1|16.5|15.8
0-19|15.2|16.6|15.9|2142|Incidence|13424009|Hispanic|Male and Female|All Cancer Sites Combined|2000|15.3|16.6|16.0
0-19|16.0|17.3|16.6|2363|Incidence|14054199|Hispanic|Male and Female|All Cancer Sites Combined|2001|16.1|17.5|16.8
0-19|16.2|17.5|16.8|2478|Incidence|14611904|Hispanic|Male and Female|All Cancer Sites Combined|2002|16.3|17.6|17.0
0-19|15.3|16.6|15.9|2439|Incidence|15151074|Hispanic|Male and Female|All Cancer Sites Combined|2003|15.5|16.7|16.1
0-19|16.5|17.8|17.1|2705|Incidence|15630881|Hispanic|Male and Female|All Cancer Sites Combined|2004|16.7|18.0|17.3
0-19|16.6|17.2|16.9|14232|Incidence|83592237|Hispanic|Male and Female|All Cancer Sites Combined|2004-2008|16.7|17.3|17.0
0-19|15.9|17.2|16.5|2685|Incidence|16143779|Hispanic|Male and Female|All Cancer Sites Combined|2005|16.0|17.3|16.6
0-19|16.4|17.7|17.1|2849|Incidence|16696171|Hispanic|Male and Female|All Cancer Sites Combined|2006|16.4|17.7|17.1
0-19|16.3|17.6|16.9|2953|Incidence|17282171|Hispanic|Male and Female|All Cancer Sites Combined|2007|16.5|17.7|17.1
0-19|16.3|17.5|16.9|3040|Incidence|17839235|Hispanic|Male and Female|All Cancer Sites Combined|2008|16.4|17.7|17.0
0-19|0.7|1.0|0.8|99|Incidence|12872546|Hispanic|Male and Female|Bones and Joints|1999|0.6|0.9|0.8
0-19|0.7|1.1|0.9|114|Incidence|13424009|Hispanic|Male and Female|Bones and Joints|2000|0.7|1.0|0.8
0-19|0.8|1.1|1.0|126|Incidence|14054199|Hispanic|Male and Female|Bones and Joints|2001|0.7|1.1|0.9
0-19|0.8|1.2|1.0|134|Incidence|14611904|Hispanic|Male and Female|Bones and Joints|2002|0.8|1.1|0.9
0-19|0.8|1.1|0.9|129|Incidence|15151074|Hispanic|Male and Female|Bones and Joints|2003|0.7|1.0|0.9
0-19|0.8|1.2|1.0|143|Incidence|15630881|Hispanic|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.9|1.0|1.0|735|Incidence|83592237|Hispanic|Male and Female|Bones and Joints|2004-2008|0.8|0.9|0.9
0-19|0.8|1.1|0.9|138|Incidence|16143779|Hispanic|Male and Female|Bones and Joints|2005|0.7|1.0|0.9
0-19|0.9|1.2|1.1|162|Incidence|16696171|Hispanic|Male and Female|Bones and Joints|2006|0.8|1.1|1.0
0-19|0.7|1.0|0.9|135|Incidence|17282171|Hispanic|Male and Female|Bones and Joints|2007|0.7|0.9|0.8
0-19|0.8|1.1|1.0|157|Incidence|17839235|Hispanic|Male and Female|Bones and Joints|2008|0.7|1.0|0.9
0-19|2.4|3.0|2.7|351|Incidence|12872546|Hispanic|Male and Female|Brain and Other Nervous System|1999|2.4|3.0|2.7
0-19|2.3|2.8|2.5|347|Incidence|13424009|Hispanic|Male and Female|Brain and Other Nervous System|2000|2.3|2.9|2.6
0-19|2.4|3.0|2.7|385|Incidence|14054199|Hispanic|Male and Female|Brain and Other Nervous System|2001|2.5|3.0|2.7
0-19|2.3|2.8|2.6|387|Incidence|14611904|Hispanic|Male and Female|Brain and Other Nervous System|2002|2.4|2.9|2.6
0-19|2.3|2.8|2.6|400|Incidence|15151074|Hispanic|Male and Female|Brain and Other Nervous System|2003|2.4|2.9|2.6
0-19|2.5|3.1|2.8|447|Incidence|15630881|Hispanic|Male and Female|Brain and Other Nervous System|2004|2.6|3.1|2.9
0-19|2.5|2.7|2.6|2222|Incidence|83592237|Hispanic|Male and Female|Brain and Other Nervous System|2004-2008|2.5|2.8|2.7
0-19|2.3|2.8|2.5|423|Incidence|16143779|Hispanic|Male and Female|Brain and Other Nervous System|2005|2.4|2.9|2.6
0-19|2.4|2.9|2.6|447|Incidence|16696171|Hispanic|Male and Female|Brain and Other Nervous System|2006|2.4|2.9|2.7
0-19|2.4|2.9|2.7|473|Incidence|17282171|Hispanic|Male and Female|Brain and Other Nervous System|2007|2.5|3.0|2.7
0-19|2.1|2.6|2.3|432|Incidence|17839235|Hispanic|Male and Female|Brain and Other Nervous System|2008|2.2|2.7|2.4
0-19|0.8|1.2|1.0|117|Incidence|12872546|Hispanic|Male and Female|Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.8|1.1|1.0|122|Incidence|13424009|Hispanic|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|1.0|1.4|1.2|157|Incidence|14054199|Hispanic|Male and Female|Hodgkin Lymphoma|2001|0.9|1.3|1.1
0-19|0.8|1.2|1.0|130|Incidence|14611904|Hispanic|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|1.0|1.4|1.2|164|Incidence|15151074|Hispanic|Male and Female|Hodgkin Lymphoma|2003|0.9|1.3|1.1
0-19|0.8|1.2|1.0|140|Incidence|15630881|Hispanic|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|1.0|1.1|1.1|814|Incidence|83592237|Hispanic|Male and Female|Hodgkin Lymphoma|2004-2008|0.9|1.0|1.0
0-19|0.9|1.3|1.1|161|Incidence|16143779|Hispanic|Male and Female|Hodgkin Lymphoma|2005|0.8|1.2|1.0
0-19|1.0|1.4|1.2|177|Incidence|16696171|Hispanic|Male and Female|Hodgkin Lymphoma|2006|0.9|1.2|1.1
0-19|0.9|1.2|1.0|162|Incidence|17282171|Hispanic|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.9|1.3|1.1|174|Incidence|17839235|Hispanic|Male and Female|Hodgkin Lymphoma|2008|0.8|1.1|1.0
0-19|0.5|0.7|0.6|84|Incidence|12872546|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|0.5|0.8|0.7
0-19|0.3|0.6|0.4|64|Incidence|13424009|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|0.4|0.6|0.5
0-19|0.5|0.7|0.6|87|Incidence|14054199|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|0.5|0.8|0.6
0-19|0.4|0.7|0.5|87|Incidence|14611904|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.5|0.7|0.6|96|Incidence|15151074|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|0.5|0.8|0.6
0-19|0.4|0.6|0.5|92|Incidence|15630881|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.5|0.5|0.5|477|Incidence|83592237|Hispanic|Male and Female|Kidney and Renal Pelvis|2004-2008|0.5|0.6|0.6
0-19|0.4|0.6|0.4|81|Incidence|16143779|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|91|Incidence|16696171|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|0.4|0.7|0.5
0-19|0.5|0.7|0.6|116|Incidence|17282171|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|0.4|0.6|0.5|97|Incidence|17839235|Hispanic|Male and Female|Kidney and Renal Pelvis|2008|0.4|0.7|0.5
0-19|4.7|5.5|5.1|671|Incidence|12872546|Hispanic|Male and Female|Leukemia|1999|4.8|5.6|5.2
0-19|5.0|5.8|5.4|739|Incidence|13424009|Hispanic|Male and Female|Leukemia|2000|5.1|5.9|5.5
0-19|4.9|5.6|5.3|761|Incidence|14054199|Hispanic|Male and Female|Leukemia|2001|5.0|5.8|5.4
0-19|5.1|5.9|5.5|830|Incidence|14611904|Hispanic|Male and Female|Leukemia|2002|5.3|6.1|5.7
0-19|4.5|5.2|4.8|758|Incidence|15151074|Hispanic|Male and Female|Leukemia|2003|4.7|5.4|5.0
0-19|4.9|5.7|5.3|862|Incidence|15630881|Hispanic|Male and Female|Leukemia|2004|5.2|5.9|5.5
0-19|5.3|5.6|5.4|4723|Incidence|83592237|Hispanic|Male and Female|Leukemia|2004-2008|5.5|5.8|5.7
0-19|4.9|5.6|5.2|875|Incidence|16143779|Hispanic|Male and Female|Leukemia|2005|5.1|5.8|5.4
0-19|5.1|5.8|5.4|932|Incidence|16696171|Hispanic|Male and Female|Leukemia|2006|5.2|6.0|5.6
0-19|5.3|6.0|5.6|1005|Incidence|17282171|Hispanic|Male and Female|Leukemia|2007|5.5|6.2|5.8
0-19|5.3|6.0|5.6|1049|Incidence|17839235|Hispanic|Male and Female|Leukemia|2008|5.5|6.2|5.9
0-19|0.8|1.1|0.9|117|Incidence|12872546|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.9|1.2|1.0|133|Incidence|13424009|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|0.8|1.2|1.0
0-19|0.8|1.1|0.9|128|Incidence|14054199|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.1|0.9
0-19|1.1|1.4|1.2|175|Incidence|14611904|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.4|1.2
0-19|0.7|1.0|0.9|126|Incidence|15151074|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.0|0.8
0-19|0.9|1.3|1.1|166|Incidence|15630881|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.9|1.2|1.1
0-19|0.9|1.1|1.0|807|Incidence|83592237|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.9|1.0|1.0
0-19|0.9|1.2|1.0|161|Incidence|16143779|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|0.8|1.2|1.0
0-19|0.8|1.2|1.0|156|Incidence|16696171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|1.0|156|Incidence|17282171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.8|1.1|1.0|168|Incidence|17839235|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2008|0.8|1.1|0.9
0-19|3.4|4.1|3.7|484|Incidence|12872546|Hispanic|Male and Female|Other|1999|3.4|4.1|3.8
0-19|3.4|4.1|3.7|497|Incidence|13424009|Hispanic|Male and Female|Other|2000|3.4|4.0|3.7
0-19|3.8|4.5|4.2|591|Incidence|14054199|Hispanic|Male and Female|Other|2001|3.9|4.6|4.2
0-19|3.7|4.4|4.1|591|Incidence|14611904|Hispanic|Male and Female|Other|2002|3.7|4.4|4.0
0-19|3.7|4.4|4.0|609|Incidence|15151074|Hispanic|Male and Female|Other|2003|3.7|4.4|4.0
0-19|4.1|4.8|4.4|699|Incidence|15630881|Hispanic|Male and Female|Other|2004|4.1|4.8|4.5
0-19|4.2|4.5|4.4|3655|Incidence|83592237|Hispanic|Male and Female|Other|2004-2008|4.2|4.5|4.4
0-19|4.0|4.7|4.3|694|Incidence|16143779|Hispanic|Male and Female|Other|2005|4.0|4.6|4.3
0-19|4.0|4.7|4.4|720|Incidence|16696171|Hispanic|Male and Female|Other|2006|4.0|4.6|4.3
0-19|4.0|4.6|4.3|746|Incidence|17282171|Hispanic|Male and Female|Other|2007|4.0|4.6|4.3
0-19|4.2|4.8|4.5|796|Incidence|17839235|Hispanic|Male and Female|Other|2008|4.2|4.8|4.5
0-19|0.7|1.0|0.8|106|Incidence|12872546|Hispanic|Male and Female|Soft Tissue|1999|0.7|1.0|0.8
0-19|0.8|1.1|0.9|126|Incidence|13424009|Hispanic|Male and Female|Soft Tissue|2000|0.8|1.1|0.9
0-19|0.8|1.1|0.9|128|Incidence|14054199|Hispanic|Male and Female|Soft Tissue|2001|0.8|1.1|0.9
0-19|0.8|1.1|1.0|144|Incidence|14611904|Hispanic|Male and Female|Soft Tissue|2002|0.8|1.2|1.0
0-19|0.9|1.2|1.0|157|Incidence|15151074|Hispanic|Male and Female|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.8|1.2|1.0|156|Incidence|15630881|Hispanic|Male and Female|Soft Tissue|2004|0.8|1.2|1.0
0-19|0.9|1.0|0.9|799|Incidence|83592237|Hispanic|Male and Female|Soft Tissue|2004-2008|0.9|1.0|1.0
0-19|0.8|1.1|0.9|152|Incidence|16143779|Hispanic|Male and Female|Soft Tissue|2005|0.8|1.1|0.9
0-19|0.8|1.1|1.0|164|Incidence|16696171|Hispanic|Male and Female|Soft Tissue|2006|0.8|1.1|1.0
0-19|0.8|1.1|0.9|160|Incidence|17282171|Hispanic|Male and Female|Soft Tissue|2007|0.8|1.1|0.9
0-19|0.8|1.1|0.9|167|Incidence|17839235|Hispanic|Male and Female|Soft Tissue|2008|0.8|1.1|0.9
0-19|2.7|3.1|2.9|803|Incidence|27890317|White|Female|Acute Lymphocytic|1999|2.7|3.1|2.9
0-19|2.9|3.3|3.1|866|Incidence|28006412|White|Female|Acute Lymphocytic|2000|2.9|3.3|3.1
0-19|2.9|3.3|3.1|910|Incidence|29210954|White|Female|Acute Lymphocytic|2001|2.9|3.3|3.1
0-19|2.8|3.2|3.0|883|Incidence|29951761|White|Female|Acute Lymphocytic|2002|2.8|3.1|2.9
0-19|2.7|3.1|2.9|892|Incidence|30859652|White|Female|Acute Lymphocytic|2003|2.7|3.1|2.9
0-19|2.8|3.2|3.0|925|Incidence|30966595|White|Female|Acute Lymphocytic|2004|2.8|3.2|3.0
0-19|3.0|3.2|3.1|4812|Incidence|155643508|White|Female|Acute Lymphocytic|2004-2008|3.0|3.2|3.1
0-19|2.8|3.2|3.0|928|Incidence|31023899|White|Female|Acute Lymphocytic|2005|2.8|3.2|3.0
0-19|2.9|3.3|3.1|960|Incidence|31103287|White|Female|Acute Lymphocytic|2006|2.9|3.3|3.1
0-19|2.9|3.3|3.1|980|Incidence|31233583|White|Female|Acute Lymphocytic|2007|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1019|Incidence|31316144|White|Female|Acute Lymphocytic|2008|3.1|3.5|3.3
0-19|0.6|0.8|0.7|184|Incidence|27890317|White|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|188|Incidence|28006412|White|Female|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|203|Incidence|29210954|White|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|200|Incidence|29951761|White|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|185|Incidence|30859652|White|Female|Acute Myeloid|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|192|Incidence|30966595|White|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|1001|Incidence|155643508|White|Female|Acute Myeloid|2004-2008|0.6|0.7|0.6
0-19|0.6|0.7|0.7|204|Incidence|31023899|White|Female|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.6|200|Incidence|31103287|White|Female|Acute Myeloid|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|215|Incidence|31233583|White|Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.5|0.7|0.6|190|Incidence|31316144|White|Female|Acute Myeloid|2008|0.5|0.7|0.6
0-19|15.0|15.9|15.4|4302|Incidence|27890317|White|Female|All Cancer Sites Combined|1999|15.0|15.9|15.4
0-19|15.8|16.8|16.3|4564|Incidence|28006412|White|Female|All Cancer Sites Combined|2000|15.8|16.8|16.3
0-19|16.5|17.4|16.9|4950|Incidence|29210954|White|Female|All Cancer Sites Combined|2001|16.5|17.4|16.9
0-19|15.8|16.7|16.3|4886|Incidence|29951761|White|Female|All Cancer Sites Combined|2002|15.9|16.8|16.3
0-19|16.2|17.1|16.7|5173|Incidence|30859652|White|Female|All Cancer Sites Combined|2003|16.3|17.2|16.8
0-19|16.5|17.4|16.9|5281|Incidence|30966595|White|Female|All Cancer Sites Combined|2004|16.6|17.5|17.1
0-19|16.5|16.9|16.7|26289|Incidence|155643508|White|Female|All Cancer Sites Combined|2004-2008|16.7|17.1|16.9
0-19|16.3|17.2|16.7|5231|Incidence|31023899|White|Female|All Cancer Sites Combined|2005|16.4|17.3|16.9
0-19|15.9|16.8|16.4|5141|Incidence|31103287|White|Female|All Cancer Sites Combined|2006|16.1|17.0|16.5
0-19|16.4|17.3|16.9|5329|Incidence|31233583|White|Female|All Cancer Sites Combined|2007|16.6|17.5|17.1
0-19|16.3|17.2|16.8|5307|Incidence|31316144|White|Female|All Cancer Sites Combined|2008|16.5|17.4|16.9
0-19|0.7|0.9|0.8|222|Incidence|27890317|White|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|1.0|0.8|236|Incidence|28006412|White|Female|Bones and Joints|2000|0.7|1.0|0.8
0-19|0.7|1.0|0.9|250|Incidence|29210954|White|Female|Bones and Joints|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|245|Incidence|29951761|White|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|1.0|0.9|278|Incidence|30859652|White|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|1.0|0.9|277|Incidence|30966595|White|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1279|Incidence|155643508|White|Female|Bones and Joints|2004-2008|0.8|0.9|0.8
0-19|0.7|1.0|0.8|261|Incidence|31023899|White|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|255|Incidence|31103287|White|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|235|Incidence|31233583|White|Female|Bones and Joints|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|251|Incidence|31316144|White|Female|Bones and Joints|2008|0.7|0.9|0.8
0-19|2.7|3.1|2.9|820|Incidence|27890317|White|Female|Brain and Other Nervous System|1999|2.7|3.1|2.9
0-19|2.8|3.2|3.0|835|Incidence|28006412|White|Female|Brain and Other Nervous System|2000|2.8|3.2|3.0
0-19|2.8|3.2|3.0|864|Incidence|29210954|White|Female|Brain and Other Nervous System|2001|2.8|3.2|3.0
0-19|2.7|3.1|2.9|871|Incidence|29951761|White|Female|Brain and Other Nervous System|2002|2.7|3.1|2.9
0-19|2.9|3.3|3.1|946|Incidence|30859652|White|Female|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.0|3.4|3.2|998|Incidence|30966595|White|Female|Brain and Other Nervous System|2004|3.0|3.4|3.2
0-19|3.0|3.1|3.0|4744|Incidence|155643508|White|Female|Brain and Other Nervous System|2004-2008|3.0|3.1|3.0
0-19|2.7|3.1|2.9|909|Incidence|31023899|White|Female|Brain and Other Nervous System|2005|2.7|3.1|2.9
0-19|2.8|3.1|2.9|917|Incidence|31103287|White|Female|Brain and Other Nervous System|2006|2.8|3.1|2.9
0-19|3.0|3.4|3.2|995|Incidence|31233583|White|Female|Brain and Other Nervous System|2007|3.0|3.4|3.2
0-19|2.8|3.1|2.9|925|Incidence|31316144|White|Female|Brain and Other Nervous System|2008|2.8|3.2|3.0
0-19|1.1|1.3|1.2|329|Incidence|27890317|White|Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.5|1.3|370|Incidence|28006412|White|Female|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.2|1.5|1.3|389|Incidence|29210954|White|Female|Hodgkin Lymphoma|2001|1.2|1.5|1.3
0-19|1.2|1.4|1.3|387|Incidence|29951761|White|Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.1|1.4|1.2|386|Incidence|30859652|White|Female|Hodgkin Lymphoma|2003|1.1|1.4|1.3
0-19|1.1|1.4|1.3|395|Incidence|30966595|White|Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1993|Incidence|155643508|White|Female|Hodgkin Lymphoma|2004-2008|1.2|1.3|1.3
0-19|1.1|1.4|1.3|400|Incidence|31023899|White|Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.1|1.4|1.3|398|Incidence|31103287|White|Female|Hodgkin Lymphoma|2006|1.2|1.4|1.3
0-19|1.1|1.3|1.2|378|Incidence|31233583|White|Female|Hodgkin Lymphoma|2007|1.1|1.3|1.2
0-19|1.2|1.5|1.3|422|Incidence|31316144|White|Female|Hodgkin Lymphoma|2008|1.2|1.5|1.3
0-19|0.6|0.8|0.7|192|Incidence|27890317|White|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|194|Incidence|28006412|White|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|224|Incidence|29210954|White|Female|Kidney and Renal Pelvis|2001|0.7|0.9|0.8
0-19|0.5|0.7|0.6|183|Incidence|29951761|White|Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.7|0.9|0.8|243|Incidence|30859652|White|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|208|Incidence|30966595|White|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1133|Incidence|155643508|White|Female|Kidney and Renal Pelvis|2004-2008|0.7|0.8|0.7
0-19|0.6|0.8|0.7|223|Incidence|31023899|White|Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|219|Incidence|31103287|White|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|243|Incidence|31233583|White|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|0.7|0.8|0.7|240|Incidence|31316144|White|Female|Kidney and Renal Pelvis|2008|0.7|0.9|0.8
0-19|3.6|4.1|3.8|1063|Incidence|27890317|White|Female|Leukemia|1999|3.6|4.0|3.8
0-19|3.9|4.4|4.1|1153|Incidence|28006412|White|Female|Leukemia|2000|3.9|4.4|4.1
0-19|4.0|4.5|4.2|1231|Incidence|29210954|White|Female|Leukemia|2001|4.0|4.5|4.2
0-19|3.8|4.3|4.0|1202|Incidence|29951761|White|Female|Leukemia|2002|3.8|4.2|4.0
0-19|3.6|4.1|3.8|1186|Incidence|30859652|White|Female|Leukemia|2003|3.6|4.1|3.8
0-19|3.7|4.2|3.9|1222|Incidence|30966595|White|Female|Leukemia|2004|3.7|4.2|3.9
0-19|4.0|4.2|4.1|6369|Incidence|155643508|White|Female|Leukemia|2004-2008|4.0|4.2|4.1
0-19|3.8|4.2|4.0|1249|Incidence|31023899|White|Female|Leukemia|2005|3.8|4.3|4.0
0-19|3.9|4.3|4.1|1281|Incidence|31103287|White|Female|Leukemia|2006|3.9|4.4|4.1
0-19|3.9|4.4|4.1|1306|Incidence|31233583|White|Female|Leukemia|2007|4.0|4.4|4.2
0-19|3.9|4.4|4.1|1311|Incidence|31316144|White|Female|Leukemia|2008|4.0|4.4|4.2
0-19|0.6|0.8|0.7|195|Incidence|27890317|White|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|219|Incidence|28006412|White|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|230|Incidence|29210954|White|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|228|Incidence|29951761|White|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|231|Incidence|30859652|White|Female|Non-Hodgkin Lymphoma|2003|0.7|0.9|0.7
0-19|0.7|0.9|0.8|237|Incidence|30966595|White|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1158|Incidence|155643508|White|Female|Non-Hodgkin Lymphoma|2004-2008|0.7|0.8|0.7
0-19|0.7|0.9|0.8|236|Incidence|31023899|White|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.6|0.8|0.7|223|Incidence|31103287|White|Female|Non-Hodgkin Lymphoma|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|242|Incidence|31233583|White|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|0.6|0.8|0.7|220|Incidence|31316144|White|Female|Non-Hodgkin Lymphoma|2008|0.6|0.8|0.7
0-19|4.2|4.7|4.4|1225|Incidence|27890317|White|Female|Other|1999|4.1|4.6|4.4
0-19|4.3|4.8|4.6|1279|Incidence|28006412|White|Female|Other|2000|4.3|4.8|4.6
0-19|4.7|5.2|5.0|1453|Incidence|29210954|White|Female|Other|2001|4.7|5.2|5.0
0-19|4.6|5.1|4.9|1473|Incidence|29951761|White|Female|Other|2002|4.7|5.2|4.9
0-19|4.8|5.3|5.0|1569|Incidence|30859652|White|Female|Other|2003|4.8|5.3|5.1
0-19|4.9|5.4|5.2|1620|Incidence|30966595|White|Female|Other|2004|5.0|5.5|5.2
0-19|4.9|5.1|5.0|7974|Incidence|155643508|White|Female|Other|2004-2008|5.0|5.2|5.1
0-19|5.0|5.5|5.2|1639|Incidence|31023899|White|Female|Other|2005|5.0|5.5|5.3
0-19|4.6|5.1|4.9|1545|Incidence|31103287|White|Female|Other|2006|4.7|5.2|5.0
0-19|4.7|5.2|5.0|1584|Incidence|31233583|White|Female|Other|2007|4.8|5.3|5.1
0-19|4.7|5.2|5.0|1586|Incidence|31316144|White|Female|Other|2008|4.8|5.3|5.1
0-19|0.8|1.0|0.9|256|Incidence|27890317|White|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|278|Incidence|28006412|White|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.2|1.1|309|Incidence|29210954|White|Female|Soft Tissue|2001|0.9|1.2|1.1
0-19|0.9|1.1|1.0|297|Incidence|29951761|White|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|1.0|1.2|1.1|334|Incidence|30859652|White|Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|0.9|1.2|1.0|324|Incidence|30966595|White|Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|1.0|1.1|1.0|1639|Incidence|155643508|White|Female|Soft Tissue|2004-2008|1.0|1.1|1.1
0-19|0.9|1.1|1.0|314|Incidence|31023899|White|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|303|Incidence|31103287|White|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|346|Incidence|31233583|White|Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|352|Incidence|31316144|White|Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|3.5|3.9|3.7|1081|Incidence|29466007|White|Male|Acute Lymphocytic|1999|3.5|3.9|3.7
0-19|3.6|4.0|3.8|1119|Incidence|29591843|White|Male|Acute Lymphocytic|2000|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1196|Incidence|30880760|White|Male|Acute Lymphocytic|2001|3.7|4.1|3.9
0-19|3.5|4.0|3.8|1184|Incidence|31649961|White|Male|Acute Lymphocytic|2002|3.5|4.0|3.7
0-19|3.4|3.8|3.6|1179|Incidence|32578661|White|Male|Acute Lymphocytic|2003|3.4|3.8|3.6
0-19|3.8|4.3|4.0|1325|Incidence|32666378|White|Male|Acute Lymphocytic|2004|3.8|4.3|4.1
0-19|3.8|4.0|3.9|6392|Incidence|164045464|White|Male|Acute Lymphocytic|2004-2008|3.8|4.0|3.9
0-19|3.5|4.0|3.7|1230|Incidence|32710351|White|Male|Acute Lymphocytic|2005|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1294|Incidence|32781426|White|Male|Acute Lymphocytic|2006|3.7|4.2|3.9
0-19|3.6|4.1|3.9|1278|Incidence|32907095|White|Male|Acute Lymphocytic|2007|3.7|4.1|3.9
0-19|3.6|4.0|3.8|1265|Incidence|32980214|White|Male|Acute Lymphocytic|2008|3.6|4.1|3.8
0-19|0.7|0.9|0.8|227|Incidence|29466007|White|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|198|Incidence|29591843|White|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|240|Incidence|30880760|White|Male|Acute Myeloid|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|243|Incidence|31649961|White|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|230|Incidence|32578661|White|Male|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.8|1.0|0.9|280|Incidence|32666378|White|Male|Acute Myeloid|2004|0.8|1.0|0.9
0-19|0.7|0.8|0.7|1214|Incidence|164045464|White|Male|Acute Myeloid|2004-2008|0.7|0.8|0.7
0-19|0.6|0.7|0.6|213|Incidence|32710351|White|Male|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|230|Incidence|32781426|White|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|243|Incidence|32907095|White|Male|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.7|0.8|0.7|248|Incidence|32980214|White|Male|Acute Myeloid|2008|0.7|0.9|0.8
0-19|17.3|18.3|17.8|5238|Incidence|29466007|White|Male|All Cancer Sites Combined|1999|17.3|18.3|17.8
0-19|17.6|18.6|18.1|5356|Incidence|29591843|White|Male|All Cancer Sites Combined|2000|17.6|18.6|18.1
0-19|18.3|19.3|18.8|5804|Incidence|30880760|White|Male|All Cancer Sites Combined|2001|18.3|19.3|18.8
0-19|18.7|19.7|19.2|6081|Incidence|31649961|White|Male|All Cancer Sites Combined|2002|18.7|19.7|19.2
0-19|17.4|18.4|17.9|5859|Incidence|32578661|White|Male|All Cancer Sites Combined|2003|17.5|18.5|18.0
0-19|18.6|19.5|19.1|6265|Incidence|32666378|White|Male|All Cancer Sites Combined|2004|18.7|19.7|19.2
0-19|18.5|18.9|18.7|30998|Incidence|164045464|White|Male|All Cancer Sites Combined|2004-2008|18.7|19.1|18.9
0-19|17.9|18.9|18.4|6072|Incidence|32710351|White|Male|All Cancer Sites Combined|2005|18.1|19.0|18.6
0-19|18.4|19.4|18.9|6246|Incidence|32781426|White|Male|All Cancer Sites Combined|2006|18.6|19.5|19.1
0-19|18.5|19.4|18.9|6295|Incidence|32907095|White|Male|All Cancer Sites Combined|2007|18.7|19.6|19.1
0-19|17.9|18.8|18.4|6120|Incidence|32980214|White|Male|All Cancer Sites Combined|2008|18.1|19.0|18.6
0-19|0.9|1.2|1.1|313|Incidence|29466007|White|Male|Bones and Joints|1999|0.9|1.2|1.1
0-19|0.9|1.1|1.0|290|Incidence|29591843|White|Male|Bones and Joints|2000|0.9|1.1|1.0
0-19|1.1|1.3|1.2|368|Incidence|30880760|White|Male|Bones and Joints|2001|1.1|1.3|1.2
0-19|1.0|1.3|1.1|367|Incidence|31649961|White|Male|Bones and Joints|2002|1.0|1.3|1.2
0-19|0.9|1.1|1.0|316|Incidence|32578661|White|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|317|Incidence|32666378|White|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|1.0|1.1|1.0|1705|Incidence|164045464|White|Male|Bones and Joints|2004-2008|1.0|1.1|1.0
0-19|0.9|1.1|1.0|323|Incidence|32710351|White|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.3|1.1|375|Incidence|32781426|White|Male|Bones and Joints|2006|1.0|1.3|1.1
0-19|1.0|1.2|1.1|364|Incidence|32907095|White|Male|Bones and Joints|2007|1.0|1.2|1.1
0-19|0.9|1.1|1.0|326|Incidence|32980214|White|Male|Bones and Joints|2008|0.9|1.1|1.0
0-19|3.1|3.5|3.3|966|Incidence|29466007|White|Male|Brain and Other Nervous System|1999|3.1|3.5|3.3
0-19|3.3|3.8|3.5|1043|Incidence|29591843|White|Male|Brain and Other Nervous System|2000|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1041|Incidence|30880760|White|Male|Brain and Other Nervous System|2001|3.2|3.6|3.4
0-19|3.5|4.0|3.7|1180|Incidence|31649961|White|Male|Brain and Other Nervous System|2002|3.5|3.9|3.7
0-19|3.1|3.5|3.3|1073|Incidence|32578661|White|Male|Brain and Other Nervous System|2003|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1127|Incidence|32666378|White|Male|Brain and Other Nervous System|2004|3.3|3.7|3.5
0-19|3.3|3.5|3.4|5581|Incidence|164045464|White|Male|Brain and Other Nervous System|2004-2008|3.3|3.5|3.4
0-19|3.1|3.5|3.3|1068|Incidence|32710351|White|Male|Brain and Other Nervous System|2005|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1158|Incidence|32781426|White|Male|Brain and Other Nervous System|2006|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1130|Incidence|32907095|White|Male|Brain and Other Nervous System|2007|3.2|3.6|3.4
0-19|3.1|3.5|3.3|1098|Incidence|32980214|White|Male|Brain and Other Nervous System|2008|3.1|3.5|3.3
0-19|1.2|1.5|1.4|406|Incidence|29466007|White|Male|Hodgkin Lymphoma|1999|1.2|1.5|1.4
0-19|1.2|1.5|1.3|394|Incidence|29591843|White|Male|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.3|1.5|1.4|433|Incidence|30880760|White|Male|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|417|Incidence|31649961|White|Male|Hodgkin Lymphoma|2002|1.2|1.5|1.3
0-19|1.3|1.5|1.4|459|Incidence|32578661|White|Male|Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.2|1.4|1.3|420|Incidence|32666378|White|Male|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.3|1.4|1.4|2270|Incidence|164045464|White|Male|Hodgkin Lymphoma|2004-2008|1.3|1.4|1.4
0-19|1.3|1.5|1.4|457|Incidence|32710351|White|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.3|1.6|1.4|476|Incidence|32781426|White|Male|Hodgkin Lymphoma|2006|1.3|1.6|1.5
0-19|1.3|1.6|1.4|472|Incidence|32907095|White|Male|Hodgkin Lymphoma|2007|1.3|1.6|1.4
0-19|1.2|1.5|1.3|445|Incidence|32980214|White|Male|Hodgkin Lymphoma|2008|1.2|1.5|1.3
0-19|0.5|0.7|0.6|179|Incidence|29466007|White|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.5|0.7|0.6|183|Incidence|29591843|White|Male|Kidney and Renal Pelvis|2000|0.5|0.7|0.6
0-19|0.5|0.7|0.6|192|Incidence|30880760|White|Male|Kidney and Renal Pelvis|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|215|Incidence|31649961|White|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|187|Incidence|32578661|White|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|203|Incidence|32666378|White|Male|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.6|0.6|0.6|1000|Incidence|164045464|White|Male|Kidney and Renal Pelvis|2004-2008|0.6|0.6|0.6
0-19|0.5|0.7|0.6|207|Incidence|32710351|White|Male|Kidney and Renal Pelvis|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|203|Incidence|32781426|White|Male|Kidney and Renal Pelvis|2006|0.5|0.7|0.6
0-19|0.5|0.6|0.5|183|Incidence|32907095|White|Male|Kidney and Renal Pelvis|2007|0.5|0.6|0.6
0-19|0.5|0.7|0.6|204|Incidence|32980214|White|Male|Kidney and Renal Pelvis|2008|0.5|0.7|0.6
0-19|4.6|5.1|4.9|1426|Incidence|29466007|White|Male|Leukemia|1999|4.6|5.1|4.8
0-19|4.6|5.1|4.8|1419|Incidence|29591843|White|Male|Leukemia|2000|4.5|5.1|4.8
0-19|4.9|5.4|5.1|1568|Incidence|30880760|White|Male|Leukemia|2001|4.8|5.3|5.1
0-19|4.7|5.2|4.9|1562|Incidence|31649961|White|Male|Leukemia|2002|4.7|5.2|4.9
0-19|4.5|4.9|4.7|1529|Incidence|32578661|White|Male|Leukemia|2003|4.5|4.9|4.7
0-19|5.1|5.6|5.3|1744|Incidence|32666378|White|Male|Leukemia|2004|5.1|5.6|5.3
0-19|4.9|5.2|5.1|8356|Incidence|164045464|White|Male|Leukemia|2004-2008|5.0|5.2|5.1
0-19|4.6|5.1|4.9|1598|Incidence|32710351|White|Male|Leukemia|2005|4.6|5.1|4.9
0-19|4.9|5.3|5.1|1681|Incidence|32781426|White|Male|Leukemia|2006|4.9|5.4|5.1
0-19|4.8|5.3|5.0|1667|Incidence|32907095|White|Male|Leukemia|2007|4.8|5.3|5.1
0-19|4.8|5.2|5.0|1666|Incidence|32980214|White|Male|Leukemia|2008|4.8|5.3|5.1
0-19|1.3|1.6|1.4|420|Incidence|29466007|White|Male|Non-Hodgkin Lymphoma|1999|1.3|1.6|1.4
0-19|1.4|1.7|1.5|449|Incidence|29591843|White|Male|Non-Hodgkin Lymphoma|2000|1.4|1.7|1.5
0-19|1.3|1.6|1.5|455|Incidence|30880760|White|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.5
0-19|1.4|1.7|1.5|482|Incidence|31649961|White|Male|Non-Hodgkin Lymphoma|2002|1.4|1.7|1.5
0-19|1.3|1.6|1.4|467|Incidence|32578661|White|Male|Non-Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.3|1.6|1.4|466|Incidence|32666378|White|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.4|1.5|1.5|2436|Incidence|164045464|White|Male|Non-Hodgkin Lymphoma|2004-2008|1.4|1.5|1.5
0-19|1.4|1.6|1.5|489|Incidence|32710351|White|Male|Non-Hodgkin Lymphoma|2005|1.4|1.6|1.5
0-19|1.3|1.6|1.5|485|Incidence|32781426|White|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.7|1.6|510|Incidence|32907095|White|Male|Non-Hodgkin Lymphoma|2007|1.4|1.7|1.5
0-19|1.3|1.6|1.5|486|Incidence|32980214|White|Male|Non-Hodgkin Lymphoma|2008|1.3|1.6|1.5
0-19|4.1|4.6|4.3|1270|Incidence|29466007|White|Male|Other|1999|4.1|4.6|4.3
0-19|4.0|4.5|4.2|1250|Incidence|29591843|White|Male|Other|2000|4.0|4.5|4.2
0-19|4.4|4.9|4.6|1437|Incidence|30880760|White|Male|Other|2001|4.4|4.9|4.7
0-19|4.5|5.0|4.7|1510|Incidence|31649961|White|Male|Other|2002|4.5|5.0|4.8
0-19|4.3|4.7|4.5|1487|Incidence|32578661|White|Male|Other|2003|4.3|4.8|4.6
0-19|4.7|5.2|5.0|1646|Incidence|32666378|White|Male|Other|2004|4.8|5.3|5.0
0-19|4.6|4.8|4.7|7890|Incidence|164045464|White|Male|Other|2004-2008|4.7|4.9|4.8
0-19|4.4|4.9|4.7|1557|Incidence|32710351|White|Male|Other|2005|4.5|5.0|4.8
0-19|4.3|4.8|4.6|1525|Incidence|32781426|White|Male|Other|2006|4.4|4.9|4.7
0-19|4.6|5.0|4.8|1616|Incidence|32907095|White|Male|Other|2007|4.7|5.2|4.9
0-19|4.4|4.8|4.6|1546|Incidence|32980214|White|Male|Other|2008|4.5|4.9|4.7
0-19|0.8|1.0|0.9|258|Incidence|29466007|White|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|328|Incidence|29591843|White|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|310|Incidence|30880760|White|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|348|Incidence|31649961|White|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|0.9|1.2|1.0|341|Incidence|32578661|White|Male|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.9|1.2|1.0|342|Incidence|32666378|White|Male|Soft Tissue|2004|0.9|1.2|1.0
0-19|1.0|1.1|1.1|1760|Incidence|164045464|White|Male|Soft Tissue|2004-2008|1.0|1.1|1.1
0-19|1.0|1.2|1.1|373|Incidence|32710351|White|Male|Soft Tissue|2005|1.0|1.3|1.1
0-19|0.9|1.1|1.0|343|Incidence|32781426|White|Male|Soft Tissue|2006|0.9|1.2|1.0
0-19|1.0|1.2|1.1|353|Incidence|32907095|White|Male|Soft Tissue|2007|1.0|1.2|1.1
0-19|0.9|1.2|1.0|349|Incidence|32980214|White|Male|Soft Tissue|2008|1.0|1.2|1.1
0-19|3.1|3.4|3.3|1884|Incidence|57356324|White|Male and Female|Acute Lymphocytic|1999|3.1|3.4|3.3
0-19|3.3|3.6|3.5|1985|Incidence|57598255|White|Male and Female|Acute Lymphocytic|2000|3.3|3.6|3.4
0-19|3.4|3.7|3.5|2106|Incidence|60091714|White|Male and Female|Acute Lymphocytic|2001|3.4|3.7|3.5
0-19|3.2|3.5|3.4|2067|Incidence|61601722|White|Male and Female|Acute Lymphocytic|2002|3.2|3.5|3.4
0-19|3.1|3.4|3.3|2071|Incidence|63438313|White|Male and Female|Acute Lymphocytic|2003|3.1|3.4|3.3
0-19|3.4|3.7|3.5|2250|Incidence|63632973|White|Male and Female|Acute Lymphocytic|2004|3.4|3.7|3.5
0-19|3.4|3.5|3.5|11204|Incidence|319688972|White|Male and Female|Acute Lymphocytic|2004-2008|3.4|3.6|3.5
0-19|3.2|3.5|3.4|2158|Incidence|63734250|White|Male and Female|Acute Lymphocytic|2005|3.2|3.5|3.4
0-19|3.4|3.7|3.5|2254|Incidence|63884713|White|Male and Female|Acute Lymphocytic|2006|3.4|3.7|3.5
0-19|3.3|3.6|3.5|2258|Incidence|64140678|White|Male and Female|Acute Lymphocytic|2007|3.4|3.7|3.5
0-19|3.4|3.7|3.5|2284|Incidence|64296358|White|Male and Female|Acute Lymphocytic|2008|3.4|3.7|3.6
0-19|0.7|0.8|0.7|411|Incidence|57356324|White|Male and Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.7|386|Incidence|57598255|White|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.7|0.8|0.7|443|Incidence|60091714|White|Male and Female|Acute Myeloid|2001|0.7|0.8|0.7
0-19|0.7|0.8|0.7|443|Incidence|61601722|White|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.6|415|Incidence|63438313|White|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|472|Incidence|63632973|White|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.7|0.7|0.7|2215|Incidence|319688972|White|Male and Female|Acute Myeloid|2004-2008|0.7|0.7|0.7
0-19|0.6|0.7|0.6|417|Incidence|63734250|White|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|430|Incidence|63884713|White|Male and Female|Acute Myeloid|2006|0.6|0.7|0.7
0-19|0.6|0.8|0.7|458|Incidence|64140678|White|Male and Female|Acute Myeloid|2007|0.7|0.8|0.7
0-19|0.6|0.7|0.7|438|Incidence|64296358|White|Male and Female|Acute Myeloid|2008|0.6|0.7|0.7
0-19|16.3|17.0|16.7|9540|Incidence|57356324|White|Male and Female|All Cancer Sites Combined|1999|16.3|17.0|16.6
0-19|16.9|17.6|17.2|9920|Incidence|57598255|White|Male and Female|All Cancer Sites Combined|2000|16.9|17.6|17.2
0-19|17.5|18.2|17.9|10754|Incidence|60091714|White|Male and Female|All Cancer Sites Combined|2001|17.6|18.2|17.9
0-19|17.4|18.1|17.8|10967|Incidence|61601722|White|Male and Female|All Cancer Sites Combined|2002|17.5|18.1|17.8
0-19|17.0|17.6|17.3|11032|Incidence|63438313|White|Male and Female|All Cancer Sites Combined|2003|17.1|17.7|17.4
0-19|17.7|18.4|18.0|11546|Incidence|63632973|White|Male and Female|All Cancer Sites Combined|2004|17.8|18.5|18.1
0-19|17.6|17.9|17.7|57287|Incidence|319688972|White|Male and Female|All Cancer Sites Combined|2004-2008|17.8|18.1|17.9
0-19|17.2|17.9|17.6|11303|Incidence|63734250|White|Male and Female|All Cancer Sites Combined|2005|17.4|18.1|17.7
0-19|17.3|18.0|17.7|11387|Incidence|63884713|White|Male and Female|All Cancer Sites Combined|2006|17.5|18.2|17.8
0-19|17.6|18.3|17.9|11624|Incidence|64140678|White|Male and Female|All Cancer Sites Combined|2007|17.8|18.5|18.1
0-19|17.3|17.9|17.6|11427|Incidence|64296358|White|Male and Female|All Cancer Sites Combined|2008|17.4|18.1|17.8
0-19|0.9|1.0|0.9|535|Incidence|57356324|White|Male and Female|Bones and Joints|1999|0.9|1.0|0.9
0-19|0.8|1.0|0.9|526|Incidence|57598255|White|Male and Female|Bones and Joints|2000|0.8|1.0|0.9
0-19|0.9|1.1|1.0|618|Incidence|60091714|White|Male and Female|Bones and Joints|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|612|Incidence|61601722|White|Male and Female|Bones and Joints|2002|0.9|1.1|1.0
0-19|0.9|1.0|0.9|594|Incidence|63438313|White|Male and Female|Bones and Joints|2003|0.9|1.0|0.9
0-19|0.9|1.0|0.9|594|Incidence|63632973|White|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.9|1.0|0.9|2984|Incidence|319688972|White|Male and Female|Bones and Joints|2004-2008|0.9|1.0|0.9
0-19|0.8|1.0|0.9|584|Incidence|63734250|White|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.1|1.0|630|Incidence|63884713|White|Male and Female|Bones and Joints|2006|0.9|1.1|1.0
0-19|0.9|1.0|0.9|599|Incidence|64140678|White|Male and Female|Bones and Joints|2007|0.9|1.0|0.9
0-19|0.8|1.0|0.9|577|Incidence|64296358|White|Male and Female|Bones and Joints|2008|0.8|1.0|0.9
0-19|3.0|3.3|3.1|1786|Incidence|57356324|White|Male and Female|Brain and Other Nervous System|1999|3.0|3.3|3.1
0-19|3.1|3.4|3.3|1878|Incidence|57598255|White|Male and Female|Brain and Other Nervous System|2000|3.1|3.4|3.3
0-19|3.0|3.3|3.2|1905|Incidence|60091714|White|Male and Female|Brain and Other Nervous System|2001|3.0|3.3|3.2
0-19|3.2|3.5|3.3|2051|Incidence|61601722|White|Male and Female|Brain and Other Nervous System|2002|3.2|3.5|3.3
0-19|3.0|3.3|3.2|2019|Incidence|63438313|White|Male and Female|Brain and Other Nervous System|2003|3.0|3.3|3.2
0-19|3.2|3.5|3.3|2125|Incidence|63632973|White|Male and Female|Brain and Other Nervous System|2004|3.2|3.5|3.3
0-19|3.2|3.3|3.2|10325|Incidence|319688972|White|Male and Female|Brain and Other Nervous System|2004-2008|3.2|3.3|3.2
0-19|3.0|3.2|3.1|1977|Incidence|63734250|White|Male and Female|Brain and Other Nervous System|2005|3.0|3.2|3.1
0-19|3.1|3.4|3.2|2075|Incidence|63884713|White|Male and Female|Brain and Other Nervous System|2006|3.1|3.4|3.2
0-19|3.2|3.5|3.3|2125|Incidence|64140678|White|Male and Female|Brain and Other Nervous System|2007|3.2|3.5|3.3
0-19|3.0|3.3|3.1|2023|Incidence|64296358|White|Male and Female|Brain and Other Nervous System|2008|3.0|3.3|3.1
0-19|1.2|1.4|1.3|735|Incidence|57356324|White|Male and Female|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.2|1.4|1.3|764|Incidence|57598255|White|Male and Female|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.3|1.5|1.4|822|Incidence|60091714|White|Male and Female|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|804|Incidence|61601722|White|Male and Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.2|1.4|1.3|845|Incidence|63438313|White|Male and Female|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.2|1.4|1.3|815|Incidence|63632973|White|Male and Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.3|1.4|1.3|4263|Incidence|319688972|White|Male and Female|Hodgkin Lymphoma|2004-2008|1.3|1.4|1.3
0-19|1.2|1.4|1.3|857|Incidence|63734250|White|Male and Female|Hodgkin Lymphoma|2005|1.3|1.4|1.3
0-19|1.3|1.4|1.4|874|Incidence|63884713|White|Male and Female|Hodgkin Lymphoma|2006|1.3|1.5|1.4
0-19|1.2|1.4|1.3|850|Incidence|64140678|White|Male and Female|Hodgkin Lymphoma|2007|1.2|1.4|1.3
0-19|1.3|1.4|1.3|867|Incidence|64296358|White|Male and Female|Hodgkin Lymphoma|2008|1.3|1.4|1.3
0-19|0.6|0.7|0.7|371|Incidence|57356324|White|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.7|377|Incidence|57598255|White|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|416|Incidence|60091714|White|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.6|398|Incidence|61601722|White|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.6
0-19|0.6|0.7|0.7|430|Incidence|63438313|White|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.6|411|Incidence|63632973|White|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.6
0-19|0.6|0.7|0.7|2133|Incidence|319688972|White|Male and Female|Kidney and Renal Pelvis|2004-2008|0.6|0.7|0.7
0-19|0.6|0.7|0.7|430|Incidence|63734250|White|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|422|Incidence|63884713|White|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.7|0.7
0-19|0.6|0.7|0.7|426|Incidence|64140678|White|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.7|0.7
0-19|0.6|0.7|0.7|444|Incidence|64296358|White|Male and Female|Kidney and Renal Pelvis|2008|0.6|0.8|0.7
0-19|4.2|4.5|4.3|2489|Incidence|57356324|White|Male and Female|Leukemia|1999|4.2|4.5|4.3
0-19|4.3|4.7|4.5|2572|Incidence|57598255|White|Male and Female|Leukemia|2000|4.3|4.6|4.5
0-19|4.5|4.9|4.7|2799|Incidence|60091714|White|Male and Female|Leukemia|2001|4.5|4.8|4.7
0-19|4.3|4.7|4.5|2764|Incidence|61601722|White|Male and Female|Leukemia|2002|4.3|4.7|4.5
0-19|4.1|4.4|4.3|2715|Incidence|63438313|White|Male and Female|Leukemia|2003|4.1|4.4|4.3
0-19|4.5|4.8|4.6|2966|Incidence|63632973|White|Male and Female|Leukemia|2004|4.5|4.8|4.7
0-19|4.5|4.6|4.6|14725|Incidence|319688972|White|Male and Female|Leukemia|2004-2008|4.5|4.7|4.6
0-19|4.3|4.6|4.4|2847|Incidence|63734250|White|Male and Female|Leukemia|2005|4.3|4.6|4.5
0-19|4.4|4.8|4.6|2962|Incidence|63884713|White|Male and Female|Leukemia|2006|4.5|4.8|4.6
0-19|4.4|4.8|4.6|2973|Incidence|64140678|White|Male and Female|Leukemia|2007|4.5|4.8|4.6
0-19|4.4|4.7|4.6|2977|Incidence|64296358|White|Male and Female|Leukemia|2008|4.5|4.8|4.6
0-19|1.0|1.2|1.1|615|Incidence|57356324|White|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.2|1.2|668|Incidence|57598255|White|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.2|1.1|685|Incidence|60091714|White|Male and Female|Non-Hodgkin Lymphoma|2001|1.1|1.2|1.1
0-19|1.1|1.2|1.2|710|Incidence|61601722|White|Male and Female|Non-Hodgkin Lymphoma|2002|1.1|1.2|1.2
0-19|1.0|1.2|1.1|698|Incidence|63438313|White|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.0|1.2|1.1|703|Incidence|63632973|White|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.2|1.1
0-19|1.1|1.2|1.1|3594|Incidence|319688972|White|Male and Female|Non-Hodgkin Lymphoma|2004-2008|1.1|1.2|1.1
0-19|1.1|1.2|1.1|725|Incidence|63734250|White|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.2|1.1
0-19|1.0|1.2|1.1|708|Incidence|63884713|White|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|1.1|1.3|1.2|752|Incidence|64140678|White|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.3|1.2
0-19|1.0|1.2|1.1|706|Incidence|64296358|White|Male and Female|Non-Hodgkin Lymphoma|2008|1.0|1.2|1.1
0-19|4.2|4.5|4.4|2495|Incidence|57356324|White|Male and Female|Other|1999|4.2|4.5|4.3
0-19|4.2|4.6|4.4|2529|Incidence|57598255|White|Male and Female|Other|2000|4.2|4.6|4.4
0-19|4.6|5.0|4.8|2890|Incidence|60091714|White|Male and Female|Other|2001|4.6|5.0|4.8
0-19|4.6|5.0|4.8|2983|Incidence|61601722|White|Male and Female|Other|2002|4.7|5.0|4.8
0-19|4.6|4.9|4.8|3056|Incidence|63438313|White|Male and Female|Other|2003|4.6|5.0|4.8
0-19|4.9|5.2|5.1|3266|Incidence|63632973|White|Male and Female|Other|2004|5.0|5.3|5.1
0-19|4.8|4.9|4.9|15864|Incidence|319688972|White|Male and Female|Other|2004-2008|4.9|5.0|5.0
0-19|4.8|5.1|4.9|3196|Incidence|63734250|White|Male and Female|Other|2005|4.8|5.2|5.0
0-19|4.5|4.9|4.7|3070|Incidence|63884713|White|Male and Female|Other|2006|4.6|5.0|4.8
0-19|4.7|5.0|4.9|3200|Incidence|64140678|White|Male and Female|Other|2007|4.8|5.2|5.0
0-19|4.6|4.9|4.8|3132|Incidence|64296358|White|Male and Female|Other|2008|4.7|5.0|4.9
0-19|0.8|1.0|0.9|514|Incidence|57356324|White|Male and Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.1|1.1|606|Incidence|57598255|White|Male and Female|Soft Tissue|2000|1.0|1.1|1.1
0-19|0.9|1.1|1.0|619|Incidence|60091714|White|Male and Female|Soft Tissue|2001|1.0|1.1|1.0
0-19|1.0|1.1|1.0|645|Incidence|61601722|White|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|1.0|1.1|1.1|675|Incidence|63438313|White|Male and Female|Soft Tissue|2003|1.0|1.1|1.1
0-19|1.0|1.1|1.0|666|Incidence|63632973|White|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.1|1.1|3399|Incidence|319688972|White|Male and Female|Soft Tissue|2004-2008|1.0|1.1|1.1
0-19|1.0|1.1|1.1|687|Incidence|63734250|White|Male and Female|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|646|Incidence|63884713|White|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|699|Incidence|64140678|White|Male and Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|701|Incidence|64296358|White|Male and Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|0.2|0.3|0.3|109|Mortality|39015588|All Races|Female|Acute Lymphocytic|1999|0.2|0.3|0.3
0-19|0.3|0.4|0.3|126|Mortality|39272685|All Races|Female|Acute Lymphocytic|2000|0.3|0.4|0.3
0-19|0.3|0.4|0.3|120|Mortality|39436460|All Races|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.3|135|Mortality|39582689|All Races|Female|Acute Lymphocytic|2002|0.3|0.4|0.3
0-19|0.3|0.4|0.3|122|Mortality|39731700|All Races|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.2|0.4|0.3|118|Mortality|39908757|All Races|Female|Acute Lymphocytic|2004|0.2|0.4|0.3
0-19|0.2|0.3|0.3|542|Mortality|201197585|All Races|Female|Acute Lymphocytic|2004-2008|0.2|0.3|0.3
0-19|0.2|0.3|0.2|91|Mortality|40041255|All Races|Female|Acute Lymphocytic|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|108|Mortality|40202922|All Races|Female|Acute Lymphocytic|2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|118|Mortality|40435594|All Races|Female|Acute Lymphocytic|2007|0.2|0.3|0.3
0-19|0.2|0.3|0.3|107|Mortality|40609057|All Races|Female|Acute Lymphocytic|2008|0.2|0.3|0.3
0-19|0.2|0.3|0.3|106|Mortality|39015588|All Races|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|95|Mortality|39272685|All Races|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|113|Mortality|39436460|All Races|Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|100|Mortality|39582689|All Races|Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|94|Mortality|39731700|All Races|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|96|Mortality|39908757|All Races|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|476|Mortality|201197585|All Races|Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|101|Mortality|40041255|All Races|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|90|Mortality|40202922|All Races|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|89|Mortality|40435594|All Races|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|100|Mortality|40609057|All Races|Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.4|2.7|2.5|977|Mortality|39015588|All Races|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.6|2.5|973|Mortality|39272685|All Races|Female|All Cancer Sites Combined|2000|2.3|2.6|2.5
0-19|2.3|2.7|2.5|986|Mortality|39436460|All Races|Female|All Cancer Sites Combined|2001|2.3|2.7|2.5
0-19|2.3|2.7|2.5|989|Mortality|39582689|All Races|Female|All Cancer Sites Combined|2002|2.3|2.7|2.5
0-19|2.2|2.5|2.4|943|Mortality|39731700|All Races|Female|All Cancer Sites Combined|2003|2.2|2.5|2.4
0-19|2.3|2.6|2.4|967|Mortality|39908757|All Races|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.4|2.3|4608|Mortality|201197585|All Races|Female|All Cancer Sites Combined|2004-2008|2.2|2.4|2.3
0-19|2.2|2.5|2.3|922|Mortality|40041255|All Races|Female|All Cancer Sites Combined|2005|2.2|2.5|2.3
0-19|2.0|2.3|2.2|866|Mortality|40202922|All Races|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|2.2|2.5|2.3|944|Mortality|40435594|All Races|Female|All Cancer Sites Combined|2007|2.2|2.5|2.3
0-19|2.1|2.4|2.2|909|Mortality|40609057|All Races|Female|All Cancer Sites Combined|2008|2.1|2.4|2.2
0-19|0.2|0.3|0.2|92|Mortality|39015588|All Races|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.2|0.2|76|Mortality|39272685|All Races|Female|Bones and Joints|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|75|Mortality|39436460|All Races|Female|Bones and Joints|2001|0.1|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|39582689|All Races|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|64|Mortality|39731700|All Races|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39908757|All Races|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.2|0.2|400|Mortality|201197585|All Races|Female|Bones and Joints|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|91|Mortality|40041255|All Races|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|40202922|All Races|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.2|0.2|80|Mortality|40435594|All Races|Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|40609057|All Races|Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.7|0.7|259|Mortality|39015588|All Races|Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.5|0.7|0.6|238|Mortality|39272685|All Races|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.6|252|Mortality|39436460|All Races|Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.5|0.7|0.6|244|Mortality|39582689|All Races|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|269|Mortality|39731700|All Races|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|254|Mortality|39908757|All Races|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.6|0.7|0.6|1241|Mortality|201197585|All Races|Female|Brain and Other Nervous System|2004-2008|0.6|0.7|0.6
0-19|0.5|0.7|0.6|246|Mortality|40041255|All Races|Female|Brain and Other Nervous System|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|237|Mortality|40202922|All Races|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.7|0.7|261|Mortality|40435594|All Races|Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.5|0.7|0.6|243|Mortality|40609057|All Races|Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|0.0|0.1|0.0|17|Mortality|39015588|All Races|Female|Hodgkin Lymphoma|1999|0.0|0.1|0.0
0-19|0.0|0.1|0.0|19|Mortality|39272685|All Races|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|39436460|All Races|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|39582689|All Races|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|39731700|All Races|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|39908757|All Races|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|47|Mortality|201197585|All Races|Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|40041255|All Races|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|40202922|All Races|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|40435594|All Races|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|40609057|All Races|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.1|0.1|0.1|30|Mortality|39015588|All Races|Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|39272685|All Races|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|39|Mortality|39436460|All Races|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39582689|All Races|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|34|Mortality|39731700|All Races|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39908757|All Races|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|145|Mortality|201197585|All Races|Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|40041255|All Races|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|25|Mortality|40202922|All Races|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|40435594|All Races|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|40609057|All Races|Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.7|0.8|0.8|293|Mortality|39015588|All Races|Female|Leukemia|1999|0.7|0.8|0.8
0-19|0.7|0.9|0.8|302|Mortality|39272685|All Races|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|318|Mortality|39436460|All Races|Female|Leukemia|2001|0.7|0.9|0.8
0-19|0.7|0.8|0.7|296|Mortality|39582689|All Races|Female|Leukemia|2002|0.7|0.8|0.7
0-19|0.6|0.8|0.7|284|Mortality|39731700|All Races|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|278|Mortality|39908757|All Races|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1355|Mortality|201197585|All Races|Female|Leukemia|2004-2008|0.6|0.7|0.7
0-19|0.6|0.7|0.6|258|Mortality|40041255|All Races|Female|Leukemia|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.6|259|Mortality|40202922|All Races|Female|Leukemia|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|278|Mortality|40435594|All Races|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|282|Mortality|40609057|All Races|Female|Leukemia|2008|0.6|0.8|0.7
0-19|0.1|0.1|0.1|37|Mortality|39015588|All Races|Female|Non-Hodgkin Lymphoma|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|36|Mortality|39272685|All Races|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39436460|All Races|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|40|Mortality|39582689|All Races|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|38|Mortality|39731700|All Races|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39908757|All Races|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|126|Mortality|201197585|All Races|Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|40041255|All Races|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|19|Mortality|40202922|All Races|Female|Non-Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|28|Mortality|40435594|All Races|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|40609057|All Races|Female|Non-Hodgkin Lymphoma|2008|0.0|0.1|0.1
0-19|0.4|0.6|0.5|189|Mortality|39015588|All Races|Female|Other|1999|0.4|0.6|0.5
0-19|0.5|0.6|0.5|207|Mortality|39272685|All Races|Female|Other|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|202|Mortality|39436460|All Races|Female|Other|2001|0.4|0.6|0.5
0-19|0.5|0.6|0.5|215|Mortality|39582689|All Races|Female|Other|2002|0.5|0.6|0.5
0-19|0.4|0.5|0.5|182|Mortality|39731700|All Races|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|205|Mortality|39908757|All Races|Female|Other|2004|0.4|0.6|0.5
0-19|0.4|0.5|0.5|929|Mortality|201197585|All Races|Female|Other|2004-2008|0.4|0.5|0.5
0-19|0.4|0.5|0.4|177|Mortality|40041255|All Races|Female|Other|2005|0.4|0.5|0.4
0-19|0.4|0.5|0.5|188|Mortality|40202922|All Races|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|189|Mortality|40435594|All Races|Female|Other|2007|0.4|0.5|0.5
0-19|0.4|0.5|0.4|170|Mortality|40609057|All Races|Female|Other|2008|0.4|0.5|0.4
0-19|0.1|0.2|0.2|60|Mortality|39015588|All Races|Female|Soft Tissue|1999|0.1|0.2|0.2
0-19|0.1|0.2|0.2|69|Mortality|39272685|All Races|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|60|Mortality|39436460|All Races|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39582689|All Races|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|62|Mortality|39731700|All Races|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.2|0.3|0.2|81|Mortality|39908757|All Races|Female|Soft Tissue|2004|0.2|0.3|0.2
0-19|0.2|0.2|0.2|365|Mortality|201197585|All Races|Female|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|40041255|All Races|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|56|Mortality|40202922|All Races|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|68|Mortality|40435594|All Races|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|73|Mortality|40609057|All Races|Female|Soft Tissue|2008|0.1|0.2|0.2
0-19|0.4|0.5|0.4|176|Mortality|41024382|All Races|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.4|0.6|0.5|206|Mortality|41303405|All Races|Male|Acute Lymphocytic|2000|0.4|0.6|0.5
0-19|0.4|0.5|0.5|193|Mortality|41499718|All Races|Male|Acute Lymphocytic|2001|0.4|0.5|0.5
0-19|0.4|0.5|0.5|188|Mortality|41637877|All Races|Male|Acute Lymphocytic|2002|0.4|0.5|0.5
0-19|0.4|0.6|0.5|206|Mortality|41753613|All Races|Male|Acute Lymphocytic|2003|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|41911213|All Races|Male|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.4|0.4|0.4|833|Mortality|211139504|All Races|Male|Acute Lymphocytic|2004-2008|0.4|0.4|0.4
0-19|0.4|0.5|0.4|176|Mortality|42031490|All Races|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.4|0.4|158|Mortality|42186878|All Races|Male|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.4|0.5|0.4|176|Mortality|42421376|All Races|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.3|0.4|0.3|146|Mortality|42588547|All Races|Male|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.2|0.3|0.2|101|Mortality|41024382|All Races|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.3|0.4|0.3|127|Mortality|41303405|All Races|Male|Acute Myeloid|2000|0.3|0.4|0.3
0-19|0.2|0.3|0.3|114|Mortality|41499718|All Races|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|109|Mortality|41637877|All Races|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|113|Mortality|41753613|All Races|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|115|Mortality|41911213|All Races|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|520|Mortality|211139504|All Races|Male|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.3|111|Mortality|42031490|All Races|Male|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|105|Mortality|42186878|All Races|Male|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|106|Mortality|42421376|All Races|Male|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.2|0.2|83|Mortality|42588547|All Races|Male|Acute Myeloid|2008|0.2|0.2|0.2
0-19|2.9|3.3|3.1|1266|Mortality|41024382|All Races|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.3|3.1|1298|Mortality|41303405|All Races|Male|All Cancer Sites Combined|2000|3.0|3.3|3.1
0-19|2.8|3.2|3.0|1240|Mortality|41499718|All Races|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1282|Mortality|41637877|All Races|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|2.9|3.3|3.1|1290|Mortality|41753613|All Races|Male|All Cancer Sites Combined|2003|2.9|3.3|3.1
0-19|2.8|3.2|3.0|1256|Mortality|41911213|All Races|Male|All Cancer Sites Combined|2004|2.8|3.2|3.0
0-19|2.7|2.9|2.8|5940|Mortality|211139504|All Races|Male|All Cancer Sites Combined|2004-2008|2.7|2.9|2.8
0-19|2.8|3.2|3.0|1261|Mortality|42031490|All Races|Male|All Cancer Sites Combined|2005|2.8|3.2|3.0
0-19|2.6|2.9|2.8|1169|Mortality|42186878|All Races|Male|All Cancer Sites Combined|2006|2.6|2.9|2.8
0-19|2.5|2.8|2.6|1124|Mortality|42421376|All Races|Male|All Cancer Sites Combined|2007|2.5|2.8|2.6
0-19|2.5|2.8|2.6|1130|Mortality|42588547|All Races|Male|All Cancer Sites Combined|2008|2.5|2.8|2.7
0-19|0.2|0.3|0.3|117|Mortality|41024382|All Races|Male|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|105|Mortality|41303405|All Races|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|114|Mortality|41499718|All Races|Male|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|96|Mortality|41637877|All Races|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.3|122|Mortality|41753613|All Races|Male|Bones and Joints|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|118|Mortality|41911213|All Races|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|529|Mortality|211139504|All Races|Male|Bones and Joints|2004-2008|0.2|0.3|0.3
0-19|0.2|0.3|0.3|121|Mortality|42031490|All Races|Male|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|99|Mortality|42186878|All Races|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|92|Mortality|42421376|All Races|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|99|Mortality|42588547|All Races|Male|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.8|0.7|287|Mortality|41024382|All Races|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.8|0.7|307|Mortality|41303405|All Races|Male|Brain and Other Nervous System|2000|0.7|0.8|0.7
0-19|0.6|0.7|0.6|268|Mortality|41499718|All Races|Male|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.9|0.8|327|Mortality|41637877|All Races|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|308|Mortality|41753613|All Races|Male|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|301|Mortality|41911213|All Races|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1436|Mortality|211139504|All Races|Male|Brain and Other Nervous System|2004-2008|0.6|0.7|0.7
0-19|0.6|0.8|0.7|298|Mortality|42031490|All Races|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|287|Mortality|42186878|All Races|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|260|Mortality|42421376|All Races|Male|Brain and Other Nervous System|2007|0.5|0.7|0.6
0-19|0.6|0.8|0.7|290|Mortality|42588547|All Races|Male|Brain and Other Nervous System|2008|0.6|0.8|0.7
0-19|0.0|0.1|0.1|24|Mortality|41024382|All Races|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|41303405|All Races|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|41499718|All Races|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|20|Mortality|41637877|All Races|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|41753613|All Races|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|41911213|All Races|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|54|Mortality|211139504|All Races|Male|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|42031490|All Races|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|42186878|All Races|Male|Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|42421376|All Races|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|42588547|All Races|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|0.1|0.1|0.1|32|Mortality|41024382|All Races|Male|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|28|Mortality|41303405|All Races|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|41499718|All Races|Male|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|41637877|All Races|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41753613|All Races|Male|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|41911213|All Races|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.1|0.1|0.1|129|Mortality|211139504|All Races|Male|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|42031490|All Races|Male|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|42186878|All Races|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|20|Mortality|42421376|All Races|Male|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.0|0.1|0.1|23|Mortality|42588547|All Races|Male|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.8|1.0|0.9|379|Mortality|41024382|All Races|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|430|Mortality|41303405|All Races|Male|Leukemia|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Mortality|41499718|All Races|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.0|0.9|382|Mortality|41637877|All Races|Male|Leukemia|2002|0.8|1.0|0.9
0-19|0.9|1.1|1.0|404|Mortality|41753613|All Races|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.8|1.0|0.9|387|Mortality|41911213|All Races|Male|Leukemia|2004|0.8|1.0|0.9
0-19|0.8|0.9|0.9|1809|Mortality|211139504|All Races|Male|Leukemia|2004-2008|0.8|0.9|0.9
0-19|0.8|1.0|0.9|382|Mortality|42031490|All Races|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|0.9|0.8|359|Mortality|42186878|All Races|Male|Leukemia|2006|0.8|0.9|0.9
0-19|0.8|1.0|0.9|365|Mortality|42421376|All Races|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.7|0.8|0.7|316|Mortality|42588547|All Races|Male|Leukemia|2008|0.7|0.8|0.7
0-19|0.1|0.2|0.2|69|Mortality|41024382|All Races|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.2|0.2|79|Mortality|41303405|All Races|Male|Non-Hodgkin Lymphoma|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|74|Mortality|41499718|All Races|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41637877|All Races|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|65|Mortality|41753613|All Races|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|67|Mortality|41911213|All Races|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|345|Mortality|211139504|All Races|Male|Non-Hodgkin Lymphoma|2004-2008|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|42031490|All Races|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|70|Mortality|42186878|All Races|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|59|Mortality|42421376|All Races|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.2|71|Mortality|42588547|All Races|Male|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.2
0-19|0.6|0.7|0.6|266|Mortality|41024382|All Races|Male|Other|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.6|264|Mortality|41303405|All Races|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|242|Mortality|41499718|All Races|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.7|0.7|275|Mortality|41637877|All Races|Male|Other|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.6|265|Mortality|41753613|All Races|Male|Other|2003|0.6|0.7|0.6
0-19|0.6|0.7|0.6|263|Mortality|41911213|All Races|Male|Other|2004|0.6|0.7|0.6
0-19|0.5|0.6|0.6|1236|Mortality|211139504|All Races|Male|Other|2004-2008|0.6|0.6|0.6
0-19|0.5|0.7|0.6|261|Mortality|42031490|All Races|Male|Other|2005|0.5|0.7|0.6
0-19|0.5|0.6|0.5|225|Mortality|42186878|All Races|Male|Other|2006|0.5|0.6|0.5
0-19|0.5|0.7|0.6|250|Mortality|42421376|All Races|Male|Other|2007|0.5|0.7|0.6
0-19|0.5|0.6|0.5|237|Mortality|42588547|All Races|Male|Other|2008|0.5|0.6|0.6
0-19|0.2|0.3|0.2|92|Mortality|41024382|All Races|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|41303405|All Races|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|41499718|All Races|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.2|0.2|0.2|82|Mortality|41637877|All Races|Male|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|41753613|All Races|Male|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|83|Mortality|41911213|All Races|Male|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|402|Mortality|211139504|All Races|Male|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.1|0.2|0.2|76|Mortality|42031490|All Races|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|42186878|All Races|Male|Soft Tissue|2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|72|Mortality|42421376|All Races|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|42588547|All Races|Male|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.3|0.4|0.4|285|Mortality|80039970|All Races|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.4|332|Mortality|80576090|All Races|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.4
0-19|0.3|0.4|0.4|313|Mortality|80936178|All Races|Male and Female|Acute Lymphocytic|2001|0.3|0.4|0.4
0-19|0.4|0.4|0.4|323|Mortality|81220566|All Races|Male and Female|Acute Lymphocytic|2002|0.4|0.4|0.4
0-19|0.4|0.4|0.4|328|Mortality|81485313|All Races|Male and Female|Acute Lymphocytic|2003|0.4|0.4|0.4
0-19|0.3|0.4|0.4|295|Mortality|81819970|All Races|Male and Female|Acute Lymphocytic|2004|0.3|0.4|0.4
0-19|0.3|0.4|0.3|1375|Mortality|412337089|All Races|Male and Female|Acute Lymphocytic|2004-2008|0.3|0.4|0.3
0-19|0.3|0.4|0.3|267|Mortality|82072745|All Races|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.3
0-19|0.3|0.4|0.3|266|Mortality|82389800|All Races|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.4|294|Mortality|82856970|All Races|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.3|0.3|0.3|253|Mortality|83197604|All Races|Male and Female|Acute Lymphocytic|2008|0.3|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|80039970|All Races|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|222|Mortality|80576090|All Races|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|227|Mortality|80936178|All Races|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|209|Mortality|81220566|All Races|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|81485313|All Races|Male and Female|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|211|Mortality|81819970|All Races|Male and Female|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|996|Mortality|412337089|All Races|Male and Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.3|212|Mortality|82072745|All Races|Male and Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|195|Mortality|82389800|All Races|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|195|Mortality|82856970|All Races|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|183|Mortality|83197604|All Races|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Races|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80576090|All Races|Male and Female|All Cancer Sites Combined|2000|2.7|2.9|2.8
0-19|2.6|2.9|2.8|2226|Mortality|80936178|All Races|Male and Female|All Cancer Sites Combined|2001|2.6|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|81220566|All Races|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.6|2.9|2.7|2233|Mortality|81485313|All Races|Male and Female|All Cancer Sites Combined|2003|2.6|2.9|2.7
0-19|2.6|2.8|2.7|2223|Mortality|81819970|All Races|Male and Female|All Cancer Sites Combined|2004|2.6|2.8|2.7
0-19|2.5|2.6|2.6|10548|Mortality|412337089|All Races|Male and Female|All Cancer Sites Combined|2004-2008|2.5|2.6|2.6
0-19|2.5|2.8|2.7|2183|Mortality|82072745|All Races|Male and Female|All Cancer Sites Combined|2005|2.5|2.8|2.7
0-19|2.4|2.6|2.5|2035|Mortality|82389800|All Races|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.4|2.6|2.5|2068|Mortality|82856970|All Races|Male and Female|All Cancer Sites Combined|2007|2.4|2.6|2.5
0-19|2.3|2.6|2.4|2039|Mortality|83197604|All Races|Male and Female|All Cancer Sites Combined|2008|2.3|2.6|2.5
0-19|0.2|0.3|0.3|209|Mortality|80039970|All Races|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|181|Mortality|80576090|All Races|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|80936178|All Races|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|179|Mortality|81220566|All Races|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|186|Mortality|81485313|All Races|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|81819970|All Races|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.2|0.2|929|Mortality|412337089|All Races|Male and Female|Bones and Joints|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.3|212|Mortality|82072745|All Races|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|174|Mortality|82389800|All Races|Male and Female|Bones and Joints|2006|0.2|0.2|0.2
0-19|0.2|0.2|0.2|172|Mortality|82856970|All Races|Male and Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|182|Mortality|83197604|All Races|Male and Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.7|0.7|546|Mortality|80039970|All Races|Male and Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Mortality|80576090|All Races|Male and Female|Brain and Other Nervous System|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.6|520|Mortality|80936178|All Races|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|571|Mortality|81220566|All Races|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|577|Mortality|81485313|All Races|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.7|0.7|555|Mortality|81819970|All Races|Male and Female|Brain and Other Nervous System|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|2677|Mortality|412337089|All Races|Male and Female|Brain and Other Nervous System|2004-2008|0.6|0.7|0.6
0-19|0.6|0.7|0.7|544|Mortality|82072745|All Races|Male and Female|Brain and Other Nervous System|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|524|Mortality|82389800|All Races|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.6|0.7|0.6|521|Mortality|82856970|All Races|Male and Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.6|0.7|0.6|533|Mortality|83197604|All Races|Male and Female|Brain and Other Nervous System|2008|0.6|0.7|0.6
0-19|0.0|0.1|0.1|41|Mortality|80039970|All Races|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|29|Mortality|80576090|All Races|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|31|Mortality|80936178|All Races|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|33|Mortality|81220566|All Races|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|21|Mortality|81485313|All Races|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81819970|All Races|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|101|Mortality|412337089|All Races|Male and Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|0.0|0.0|0.0|22|Mortality|82072745|All Races|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|82389800|All Races|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|82856970|All Races|Male and Female|Hodgkin Lymphoma|2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|83197604|All Races|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.1|0.1|0.1|62|Mortality|80039970|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|54|Mortality|80576090|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.1|0.1
0-19|0.1|0.1|0.1|66|Mortality|80936178|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|49|Mortality|81220566|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|65|Mortality|81485313|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|59|Mortality|81819970|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|274|Mortality|412337089|All Races|Male and Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|62|Mortality|82072745|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|54|Mortality|82389800|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|47|Mortality|82856970|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|52|Mortality|83197604|All Races|Male and Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.8|0.9|0.8|672|Mortality|80039970|All Races|Male and Female|Leukemia|1999|0.8|0.9|0.8
0-19|0.8|1.0|0.9|732|Mortality|80576090|All Races|Male and Female|Leukemia|2000|0.8|1.0|0.9
0-19|0.8|1.0|0.9|728|Mortality|80936178|All Races|Male and Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.8|0.9|0.8|678|Mortality|81220566|All Races|Male and Female|Leukemia|2002|0.8|0.9|0.8
0-19|0.8|0.9|0.8|688|Mortality|81485313|All Races|Male and Female|Leukemia|2003|0.8|0.9|0.8
0-19|0.8|0.9|0.8|665|Mortality|81819970|All Races|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.8|0.8|3164|Mortality|412337089|All Races|Male and Female|Leukemia|2004-2008|0.7|0.8|0.8
0-19|0.7|0.8|0.8|640|Mortality|82072745|All Races|Male and Female|Leukemia|2005|0.7|0.8|0.8
0-19|0.7|0.8|0.7|618|Mortality|82389800|All Races|Male and Female|Leukemia|2006|0.7|0.8|0.8
0-19|0.7|0.8|0.8|643|Mortality|82856970|All Races|Male and Female|Leukemia|2007|0.7|0.8|0.8
0-19|0.7|0.8|0.7|598|Mortality|83197604|All Races|Male and Female|Leukemia|2008|0.7|0.8|0.7
0-19|0.1|0.2|0.1|106|Mortality|80039970|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|115|Mortality|80576090|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|101|Mortality|80936178|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|118|Mortality|81220566|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.2|0.1|103|Mortality|81485313|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.1|0.1|100|Mortality|81819970|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|471|Mortality|412337089|All Races|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|0.1|0.2|0.1|102|Mortality|82072745|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|89|Mortality|82389800|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|87|Mortality|82856970|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|93|Mortality|83197604|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.1|0.1
0-19|0.5|0.6|0.6|455|Mortality|80039970|All Races|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|471|Mortality|80576090|All Races|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|444|Mortality|80936178|All Races|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.6|0.7|0.6|490|Mortality|81220566|All Races|Male and Female|Other|2002|0.6|0.7|0.6
0-19|0.5|0.6|0.5|447|Mortality|81485313|All Races|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.6|468|Mortality|81819970|All Races|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.5|0.5|2165|Mortality|412337089|All Races|Male and Female|Other|2004-2008|0.5|0.5|0.5
0-19|0.5|0.6|0.5|438|Mortality|82072745|All Races|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.5|0.5|0.5|413|Mortality|82389800|All Races|Male and Female|Other|2006|0.5|0.6|0.5
0-19|0.5|0.6|0.5|439|Mortality|82856970|All Races|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.4|0.5|0.5|407|Mortality|83197604|All Races|Male and Female|Other|2008|0.4|0.5|0.5
0-19|0.2|0.2|0.2|152|Mortality|80039970|All Races|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|144|Mortality|80576090|All Races|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|147|Mortality|80936178|All Races|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|153|Mortality|81220566|All Races|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|146|Mortality|81485313|All Races|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|164|Mortality|81819970|All Races|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|767|Mortality|412337089|All Races|Male and Female|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.2|0.2|0.2|163|Mortality|82072745|All Races|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|82389800|All Races|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|82856970|All Races|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.2|0.2|160|Mortality|83197604|All Races|Male and Female|Soft Tissue|2008|0.2|0.2|0.2
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Acute Lymphocytic|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Acute Myeloid|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|~|~|~
0-19|0.8|1.7|1.2|35|Mortality|2892479|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004-2008|0.8|1.7|1.2
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|All Cancer Sites Combined|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Bones and Joints|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Leukemia|2004|~|~|~
0-19|0.3|0.9|0.6|16|Mortality|2892479|American Indian/Alaska Native|Female|Leukemia|2004-2008|0.3|0.9|0.6
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Other|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|2892479|American Indian/Alaska Native|Female|Soft Tissue|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Acute Lymphocytic|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Acute Myeloid|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|~|~|~
0-19|1.6|4.4|2.7|16|Mortality|582379|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|1.6|4.5|2.7
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|~|~|~
0-19|1.5|2.5|1.9|58|Mortality|2984092|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004-2008|1.5|2.5|1.9
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|All Cancer Sites Combined|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Bones and Joints|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Leukemia|2004|~|~|~
0-19|0.5|1.1|0.7|22|Mortality|2984092|American Indian/Alaska Native|Male|Leukemia|2004-2008|0.5|1.1|0.7
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Other|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|2984092|American Indian/Alaska Native|Male|Soft Tissue|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|~|~|~
0-19|0.2|0.5|0.3|20|Mortality|5876571|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004-2008|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|~|~|~
0-19|1.0|2.6|1.7|19|Mortality|1138904|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|1.0|2.6|1.7
0-19|1.2|2.9|1.9|22|Mortality|1144922|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|1.2|2.9|1.9
0-19|1.4|3.2|2.2|25|Mortality|1149550|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|1.4|3.2|2.2
0-19|1.3|3.1|2.1|24|Mortality|1152824|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|1.3|3.1|2.1
0-19|0.9|2.5|1.6|18|Mortality|1157658|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|0.9|2.5|1.6
0-19|1.3|1.9|1.6|93|Mortality|5876571|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004-2008|1.3|1.9|1.6
0-19|0.9|2.4|1.5|18|Mortality|1164043|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|0.9|2.4|1.5
0-19|1.0|2.5|1.6|19|Mortality|1172281|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|1.0|2.5|1.6
0-19|1.0|2.5|1.6|19|Mortality|1185471|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|1.0|2.5|1.6
0-19|0.9|2.4|1.6|19|Mortality|1197118|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2008|1.0|2.5|1.6
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Bones and Joints|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|~|~|~
0-19|0.2|0.5|0.4|21|Mortality|5876571|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004-2008|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Leukemia|2004|~|~|~
0-19|0.5|0.9|0.6|38|Mortality|5876571|American Indian/Alaska Native|Male and Female|Leukemia|2004-2008|0.5|0.9|0.6
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Other|2004|~|~|~
0-19|0.2|0.4|0.3|16|Mortality|5876571|American Indian/Alaska Native|Male and Female|Other|2004-2008|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|5876571|American Indian/Alaska Native|Male and Female|Soft Tissue|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Acute Lymphocytic|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.4|0.3|25|Mortality|9821710|Asian/Pacific Islander|Female|Acute Myeloid|2004-2008|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Acute Myeloid|2008|~|~|~
0-19|1.7|3.3|2.4|39|Mortality|1642417|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|1.7|3.2|2.4
0-19|1.6|3.1|2.3|39|Mortality|1696351|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|1.6|3.1|2.3
0-19|1.5|2.9|2.1|37|Mortality|1737759|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|1.5|2.9|2.1
0-19|1.5|2.9|2.1|38|Mortality|1778779|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|1.5|2.9|2.1
0-19|1.3|2.7|1.9|35|Mortality|1822464|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|1.3|2.7|1.9
0-19|1.3|2.6|1.8|34|Mortality|1866675|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|1.3|2.5|1.8
0-19|1.5|2.0|1.7|168|Mortality|9821710|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004-2008|1.5|2.0|1.7
0-19|1.2|2.4|1.7|32|Mortality|1914016|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|1.1|2.4|1.7
0-19|1.5|2.9|2.1|41|Mortality|1962226|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|1.5|2.8|2.1
0-19|1.3|2.6|1.9|38|Mortality|2013981|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|1.3|2.6|1.9
0-19|0.7|1.7|1.1|23|Mortality|2064812|Asian/Pacific Islander|Female|All Cancer Sites Combined|2008|0.7|1.7|1.1
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Bones and Joints|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|~|~|~
0-19|0.3|0.6|0.4|42|Mortality|9821710|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004-2008|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Leukemia|2001|~|~|~
0-19|0.6|1.6|1.0|18|Mortality|1778779|Asian/Pacific Islander|Female|Leukemia|2002|0.6|1.6|1.0
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Leukemia|2004|~|~|~
0-19|0.4|0.7|0.5|51|Mortality|9821710|Asian/Pacific Islander|Female|Leukemia|2004-2008|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Other|2004|~|~|~
0-19|0.3|0.6|0.4|44|Mortality|9821710|Asian/Pacific Islander|Female|Other|2004-2008|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|9821710|Asian/Pacific Islander|Female|Soft Tissue|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|~|~|~
0-19|0.3|0.5|0.4|36|Mortality|10217294|Asian/Pacific Islander|Male|Acute Lymphocytic|2004-2008|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Acute Myeloid|2004|~|~|~
0-19|0.1|0.3|0.2|20|Mortality|10217294|Asian/Pacific Islander|Male|Acute Myeloid|2004-2008|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Acute Myeloid|2008|~|~|~
0-19|2.3|4.0|3.1|53|Mortality|1714818|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|2.3|4.0|3.1
0-19|1.9|3.5|2.7|47|Mortality|1767231|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|2.0|3.5|2.7
0-19|2.1|3.7|2.8|50|Mortality|1811188|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|2.0|3.6|2.8
0-19|2.1|3.7|2.9|53|Mortality|1853321|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|2.1|3.7|2.9
0-19|1.8|3.3|2.4|46|Mortality|1898564|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|1.8|3.2|2.4
0-19|2.1|3.7|2.8|55|Mortality|1943682|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|2.1|3.7|2.8
0-19|2.2|2.8|2.5|253|Mortality|10217294|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004-2008|2.2|2.8|2.5
0-19|1.9|3.4|2.5|50|Mortality|1991945|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|1.9|3.3|2.5
0-19|1.8|3.2|2.4|48|Mortality|2040932|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|1.7|3.1|2.4
0-19|1.7|3.1|2.3|49|Mortality|2094159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|1.7|3.1|2.3
0-19|1.8|3.2|2.4|51|Mortality|2146576|Asian/Pacific Islander|Male|All Cancer Sites Combined|2008|1.8|3.1|2.4
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|0.1|0.3|0.2|16|Mortality|10217294|Asian/Pacific Islander|Male|Bones and Joints|2004-2008|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|~|~|~
0-19|0.5|0.9|0.7|67|Mortality|10217294|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004-2008|0.5|0.8|0.7
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|~|~|~
0-19|0.4|1.2|0.8|16|Mortality|2146576|Asian/Pacific Islander|Male|Brain and Other Nervous System|2008|0.4|1.2|0.7
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|10217294|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|10217294|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.5|1.5|0.9|16|Mortality|1714818|Asian/Pacific Islander|Male|Leukemia|1999|0.5|1.5|0.9
0-19|0.8|1.9|1.3|22|Mortality|1767231|Asian/Pacific Islander|Male|Leukemia|2000|0.8|1.9|1.2
0-19|0.6|1.7|1.1|19|Mortality|1811188|Asian/Pacific Islander|Male|Leukemia|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|17|Mortality|1853321|Asian/Pacific Islander|Male|Leukemia|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.8|16|Mortality|1898564|Asian/Pacific Islander|Male|Leukemia|2003|0.5|1.4|0.8
0-19|0.5|1.4|0.9|18|Mortality|1943682|Asian/Pacific Islander|Male|Leukemia|2004|0.5|1.5|0.9
0-19|0.6|0.9|0.7|76|Mortality|10217294|Asian/Pacific Islander|Male|Leukemia|2004-2008|0.6|0.9|0.7
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Leukemia|2005|~|~|~
0-19|0.5|1.3|0.8|17|Mortality|2040932|Asian/Pacific Islander|Male|Leukemia|2006|0.5|1.3|0.8
0-19|0.5|1.4|0.9|18|Mortality|2094159|Asian/Pacific Islander|Male|Leukemia|2007|0.5|1.4|0.9
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|10217294|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Other|2004|~|~|~
0-19|0.4|0.8|0.6|60|Mortality|10217294|Asian/Pacific Islander|Male|Other|2004-2008|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|10217294|Asian/Pacific Islander|Male|Soft Tissue|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|0.2|0.7|0.4|16|Mortality|3810357|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|0.2|0.7|0.4
0-19|0.2|0.3|0.3|51|Mortality|20039004|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004-2008|0.2|0.3|0.3
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.3|0.2|45|Mortality|20039004|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Acute Myeloid|2008|~|~|~
0-19|2.2|3.4|2.7|92|Mortality|3357235|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|2.2|3.4|2.7
0-19|2.0|3.1|2.5|86|Mortality|3463582|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|2.0|3.1|2.5
0-19|2.0|3.0|2.5|87|Mortality|3548947|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|2.0|3.0|2.5
0-19|2.0|3.1|2.5|91|Mortality|3632100|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|2.0|3.1|2.5
0-19|1.7|2.7|2.2|81|Mortality|3721028|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|1.7|2.7|2.2
0-19|1.9|2.9|2.3|89|Mortality|3810357|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|1.9|2.9|2.3
0-19|1.9|2.3|2.1|421|Mortality|20039004|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004-2008|1.9|2.3|2.1
0-19|1.7|2.6|2.1|82|Mortality|3905961|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|1.7|2.6|2.1
0-19|1.8|2.8|2.2|89|Mortality|4003158|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|1.8|2.7|2.2
0-19|1.7|2.6|2.1|87|Mortality|4108140|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|1.7|2.6|2.1
0-19|1.4|2.3|1.8|74|Mortality|4211388|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2008|1.4|2.2|1.8
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|~|~|~
0-19|0.1|0.2|0.1|25|Mortality|20039004|Asian/Pacific Islander|Male and Female|Bones and Joints|2004-2008|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Bones and Joints|2008|~|~|~
0-19|0.3|0.9|0.6|19|Mortality|3357235|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|0.3|0.9|0.6
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|0.4|0.9|0.6|21|Mortality|3548947|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|0.4|0.9|0.6
0-19|0.3|0.8|0.5|20|Mortality|3632100|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|0.3|0.9|0.6
0-19|0.3|0.7|0.5|17|Mortality|3721028|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|0.3|0.7|0.5
0-19|0.5|1.0|0.7|26|Mortality|3810357|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|0.4|1.0|0.7
0-19|0.5|0.7|0.6|109|Mortality|20039004|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004-2008|0.4|0.7|0.5
0-19|0.3|0.8|0.5|20|Mortality|3905961|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|0.3|0.8|0.5
0-19|0.4|0.9|0.6|22|Mortality|4003158|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|0.3|0.8|0.5
0-19|0.2|0.7|0.4|17|Mortality|4108140|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|0.2|0.7|0.4
0-19|0.4|0.9|0.6|24|Mortality|4211388|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2008|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|20039004|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|20039004|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.6|1.3|0.9|30|Mortality|3357235|Asian/Pacific Islander|Male and Female|Leukemia|1999|0.6|1.3|0.9
0-19|0.6|1.2|0.9|30|Mortality|3463582|Asian/Pacific Islander|Male and Female|Leukemia|2000|0.6|1.2|0.9
0-19|0.6|1.2|0.9|31|Mortality|3548947|Asian/Pacific Islander|Male and Female|Leukemia|2001|0.6|1.2|0.9
0-19|0.7|1.4|1.0|35|Mortality|3632100|Asian/Pacific Islander|Male and Female|Leukemia|2002|0.7|1.3|1.0
0-19|0.5|1.1|0.8|29|Mortality|3721028|Asian/Pacific Islander|Male and Female|Leukemia|2003|0.5|1.1|0.8
0-19|0.5|1.1|0.8|30|Mortality|3810357|Asian/Pacific Islander|Male and Female|Leukemia|2004|0.5|1.1|0.8
0-19|0.5|0.8|0.6|127|Mortality|20039004|Asian/Pacific Islander|Male and Female|Leukemia|2004-2008|0.5|0.8|0.6
0-19|0.4|1.0|0.6|25|Mortality|3905961|Asian/Pacific Islander|Male and Female|Leukemia|2005|0.4|0.9|0.6
0-19|0.4|0.9|0.6|25|Mortality|4003158|Asian/Pacific Islander|Male and Female|Leukemia|2006|0.4|0.9|0.6
0-19|0.5|1.1|0.8|32|Mortality|4108140|Asian/Pacific Islander|Male and Female|Leukemia|2007|0.5|1.1|0.8
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.1|0.2|0.1|19|Mortality|20039004|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.4|0.9|0.6|20|Mortality|3357235|Asian/Pacific Islander|Male and Female|Other|1999|0.4|0.9|0.6
0-19|0.4|1.0|0.7|23|Mortality|3463582|Asian/Pacific Islander|Male and Female|Other|2000|0.4|1.0|0.7
0-19|0.5|1.1|0.7|26|Mortality|3548947|Asian/Pacific Islander|Male and Female|Other|2001|0.5|1.1|0.7
0-19|0.3|0.8|0.5|20|Mortality|3632100|Asian/Pacific Islander|Male and Female|Other|2002|0.3|0.9|0.6
0-19|0.3|0.8|0.5|19|Mortality|3721028|Asian/Pacific Islander|Male and Female|Other|2003|0.3|0.8|0.5
0-19|0.3|0.8|0.5|19|Mortality|3810357|Asian/Pacific Islander|Male and Female|Other|2004|0.3|0.8|0.5
0-19|0.4|0.6|0.5|104|Mortality|20039004|Asian/Pacific Islander|Male and Female|Other|2004-2008|0.4|0.6|0.5
0-19|0.3|0.7|0.5|18|Mortality|3905961|Asian/Pacific Islander|Male and Female|Other|2005|0.3|0.7|0.5
0-19|0.4|1.0|0.7|27|Mortality|4003158|Asian/Pacific Islander|Male and Female|Other|2006|0.4|1.0|0.7
0-19|0.3|0.8|0.5|21|Mortality|4108140|Asian/Pacific Islander|Male and Female|Other|2007|0.3|0.8|0.5
0-19|0.3|0.7|0.5|19|Mortality|4211388|Asian/Pacific Islander|Male and Female|Other|2008|0.3|0.7|0.5
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|~|~|~
0-19|0.1|0.2|0.1|27|Mortality|20039004|Asian/Pacific Islander|Male and Female|Soft Tissue|2004-2008|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Acute Lymphocytic|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6446788|Black|Female|Acute Lymphocytic|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6465179|Black|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Acute Lymphocytic|2004|~|~|~
0-19|0.1|0.2|0.1|38|Mortality|32839888|Black|Female|Acute Lymphocytic|2004-2008|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|6530380|Black|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Acute Lymphocytic|2008|~|~|~
0-19|0.1|0.4|0.3|16|Mortality|6375857|Black|Female|Acute Myeloid|1999|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6424150|Black|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Acute Myeloid|2001|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|6465179|Black|Female|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6482277|Black|Female|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6505891|Black|Female|Acute Myeloid|2004|0.2|0.5|0.4
0-19|0.2|0.4|0.3|99|Mortality|32839888|Black|Female|Acute Myeloid|2004-2008|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6530380|Black|Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.4|0.3|19|Mortality|6560240|Black|Female|Acute Myeloid|2006|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6604633|Black|Female|Acute Myeloid|2007|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6638744|Black|Female|Acute Myeloid|2008|0.2|0.5|0.3
0-19|2.3|3.1|2.7|170|Mortality|6375857|Black|Female|All Cancer Sites Combined|1999|2.3|3.1|2.7
0-19|2.1|2.9|2.5|160|Mortality|6424150|Black|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|1.8|2.6|2.2|140|Mortality|6446788|Black|Female|All Cancer Sites Combined|2001|1.8|2.6|2.2
0-19|2.2|3.0|2.5|163|Mortality|6465179|Black|Female|All Cancer Sites Combined|2002|2.1|2.9|2.5
0-19|1.9|2.6|2.2|143|Mortality|6482277|Black|Female|All Cancer Sites Combined|2003|1.9|2.6|2.2
0-19|2.3|3.1|2.7|176|Mortality|6505891|Black|Female|All Cancer Sites Combined|2004|2.3|3.1|2.7
0-19|2.1|2.5|2.3|756|Mortality|32839888|Black|Female|All Cancer Sites Combined|2004-2008|2.1|2.5|2.3
0-19|1.9|2.6|2.2|145|Mortality|6530380|Black|Female|All Cancer Sites Combined|2005|1.9|2.6|2.2
0-19|1.8|2.5|2.1|139|Mortality|6560240|Black|Female|All Cancer Sites Combined|2006|1.8|2.5|2.1
0-19|1.9|2.6|2.2|146|Mortality|6604633|Black|Female|All Cancer Sites Combined|2007|1.9|2.6|2.2
0-19|1.9|2.7|2.3|150|Mortality|6638744|Black|Female|All Cancer Sites Combined|2008|1.9|2.7|2.3
0-19|~|~|~|~|Mortality|6375857|Black|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Bones and Joints|2004|~|~|~
0-19|0.1|0.2|0.2|52|Mortality|32839888|Black|Female|Bones and Joints|2004-2008|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6530380|Black|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Bones and Joints|2008|~|~|~
0-19|0.5|1.0|0.7|46|Mortality|6375857|Black|Female|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.4|0.8|0.6|37|Mortality|6424150|Black|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.7|0.5|33|Mortality|6446788|Black|Female|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6465179|Black|Female|Brain and Other Nervous System|2002|0.5|0.9|0.6
0-19|0.4|0.8|0.6|39|Mortality|6482277|Black|Female|Brain and Other Nervous System|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6505891|Black|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.5|0.7|0.6|201|Mortality|32839888|Black|Female|Brain and Other Nervous System|2004-2008|0.5|0.7|0.6
0-19|0.4|0.8|0.6|36|Mortality|6530380|Black|Female|Brain and Other Nervous System|2005|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6560240|Black|Female|Brain and Other Nervous System|2006|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6604633|Black|Female|Brain and Other Nervous System|2007|0.4|0.8|0.6
0-19|0.4|0.8|0.6|37|Mortality|6638744|Black|Female|Brain and Other Nervous System|2008|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6375857|Black|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|32839888|Black|Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.1|0.1|0.1|28|Mortality|32839888|Black|Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6530380|Black|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.4|0.8|0.6|39|Mortality|6375857|Black|Female|Leukemia|1999|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6424150|Black|Female|Leukemia|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6446788|Black|Female|Leukemia|2001|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6465179|Black|Female|Leukemia|2002|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6482277|Black|Female|Leukemia|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|43|Mortality|6505891|Black|Female|Leukemia|2004|0.5|0.9|0.7
0-19|0.5|0.7|0.6|203|Mortality|32839888|Black|Female|Leukemia|2004-2008|0.5|0.7|0.6
0-19|0.4|0.8|0.6|40|Mortality|6530380|Black|Female|Leukemia|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|35|Mortality|6560240|Black|Female|Leukemia|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6604633|Black|Female|Leukemia|2007|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6638744|Black|Female|Leukemia|2008|0.5|0.9|0.7
0-19|~|~|~|~|Mortality|6375857|Black|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.1|0.1|22|Mortality|32839888|Black|Female|Non-Hodgkin Lymphoma|2004-2008|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|6530380|Black|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.4|0.7|0.5|33|Mortality|6375857|Black|Female|Other|1999|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6424150|Black|Female|Other|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|32|Mortality|6446788|Black|Female|Other|2001|0.3|0.7|0.5
0-19|0.5|1.0|0.7|47|Mortality|6465179|Black|Female|Other|2002|0.5|1.0|0.7
0-19|0.3|0.7|0.5|32|Mortality|6482277|Black|Female|Other|2003|0.3|0.7|0.5
0-19|0.5|0.9|0.6|41|Mortality|6505891|Black|Female|Other|2004|0.5|0.9|0.6
0-19|0.5|0.6|0.5|175|Mortality|32839888|Black|Female|Other|2004-2008|0.5|0.6|0.5
0-19|0.4|0.8|0.6|40|Mortality|6530380|Black|Female|Other|2005|0.4|0.8|0.6
0-19|0.3|0.6|0.4|28|Mortality|6560240|Black|Female|Other|2006|0.3|0.6|0.4
0-19|0.4|0.8|0.5|36|Mortality|6604633|Black|Female|Other|2007|0.4|0.8|0.5
0-19|0.3|0.7|0.5|30|Mortality|6638744|Black|Female|Other|2008|0.3|0.6|0.5
0-19|~|~|~|~|Mortality|6375857|Black|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Soft Tissue|2003|~|~|~
0-19|0.2|0.5|0.3|20|Mortality|6505891|Black|Female|Soft Tissue|2004|0.2|0.5|0.3
0-19|0.2|0.3|0.2|65|Mortality|32839888|Black|Female|Soft Tissue|2004-2008|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6530380|Black|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Soft Tissue|2007|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6638744|Black|Female|Soft Tissue|2008|0.1|0.4|0.2
0-19|0.3|0.6|0.4|26|Mortality|6562662|Black|Male|Acute Lymphocytic|1999|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6621172|Black|Male|Acute Lymphocytic|2000|0.2|0.5|0.3
0-19|0.3|0.6|0.4|29|Mortality|6657073|Black|Male|Acute Lymphocytic|2001|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6678156|Black|Male|Acute Lymphocytic|2002|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6690871|Black|Male|Acute Lymphocytic|2003|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6713091|Black|Male|Acute Lymphocytic|2004|~|~|~
0-19|0.3|0.4|0.3|104|Mortality|33892654|Black|Male|Acute Lymphocytic|2004-2008|0.3|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6738111|Black|Male|Acute Lymphocytic|2005|0.2|0.5|0.3
0-19|0.2|0.4|0.3|19|Mortality|6769408|Black|Male|Acute Lymphocytic|2006|0.2|0.4|0.3
0-19|0.2|0.5|0.4|24|Mortality|6818048|Black|Male|Acute Lymphocytic|2007|0.2|0.5|0.4
0-19|0.2|0.5|0.4|25|Mortality|6853996|Black|Male|Acute Lymphocytic|2008|0.2|0.5|0.4
0-19|0.2|0.5|0.3|20|Mortality|6562662|Black|Male|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.3|0.6|0.4|25|Mortality|6621172|Black|Male|Acute Myeloid|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|20|Mortality|6657073|Black|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6678156|Black|Male|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6690871|Black|Male|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6713091|Black|Male|Acute Myeloid|2004|0.2|0.5|0.4
0-19|0.2|0.4|0.3|99|Mortality|33892654|Black|Male|Acute Myeloid|2004-2008|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6738111|Black|Male|Acute Myeloid|2005|0.2|0.5|0.3
0-19|0.1|0.4|0.2|17|Mortality|6769408|Black|Male|Acute Myeloid|2006|0.1|0.4|0.3
0-19|0.2|0.5|0.3|21|Mortality|6818048|Black|Male|Acute Myeloid|2007|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6853996|Black|Male|Acute Myeloid|2008|~|~|~
0-19|2.8|3.7|3.3|212|Mortality|6562662|Black|Male|All Cancer Sites Combined|1999|2.8|3.7|3.2
0-19|2.7|3.6|3.2|207|Mortality|6621172|Black|Male|All Cancer Sites Combined|2000|2.7|3.6|3.1
0-19|2.7|3.5|3.1|203|Mortality|6657073|Black|Male|All Cancer Sites Combined|2001|2.6|3.5|3.0
0-19|2.7|3.6|3.2|210|Mortality|6678156|Black|Male|All Cancer Sites Combined|2002|2.7|3.6|3.1
0-19|2.4|3.2|2.8|188|Mortality|6690871|Black|Male|All Cancer Sites Combined|2003|2.4|3.2|2.8
0-19|2.5|3.3|2.9|192|Mortality|6713091|Black|Male|All Cancer Sites Combined|2004|2.5|3.3|2.9
0-19|2.6|2.9|2.8|936|Mortality|33892654|Black|Male|All Cancer Sites Combined|2004-2008|2.6|2.9|2.8
0-19|2.6|3.5|3.0|204|Mortality|6738111|Black|Male|All Cancer Sites Combined|2005|2.6|3.5|3.0
0-19|2.4|3.2|2.8|187|Mortality|6769408|Black|Male|All Cancer Sites Combined|2006|2.4|3.2|2.8
0-19|2.1|2.8|2.4|167|Mortality|6818048|Black|Male|All Cancer Sites Combined|2007|2.1|2.9|2.4
0-19|2.3|3.1|2.7|186|Mortality|6853996|Black|Male|All Cancer Sites Combined|2008|2.3|3.1|2.7
0-19|0.1|0.4|0.3|16|Mortality|6562662|Black|Male|Bones and Joints|1999|0.1|0.4|0.2
0-19|0.2|0.5|0.3|21|Mortality|6621172|Black|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6657073|Black|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Bones and Joints|2003|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6713091|Black|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.3|0.2|81|Mortality|33892654|Black|Male|Bones and Joints|2004-2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|18|Mortality|6738111|Black|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6769408|Black|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Bones and Joints|2008|~|~|~
0-19|0.5|0.9|0.7|47|Mortality|6562662|Black|Male|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.6|1.0|0.8|51|Mortality|6621172|Black|Male|Brain and Other Nervous System|2000|0.6|1.0|0.8
0-19|0.4|0.7|0.5|34|Mortality|6657073|Black|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.7|1.1|0.9|58|Mortality|6678156|Black|Male|Brain and Other Nervous System|2002|0.7|1.1|0.9
0-19|0.5|0.9|0.7|45|Mortality|6690871|Black|Male|Brain and Other Nervous System|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6713091|Black|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.5|0.6|0.5|181|Mortality|33892654|Black|Male|Brain and Other Nervous System|2004-2008|0.5|0.6|0.5
0-19|0.5|0.9|0.7|44|Mortality|6738111|Black|Male|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.8|0.6|37|Mortality|6769408|Black|Male|Brain and Other Nervous System|2006|0.4|0.8|0.5
0-19|0.2|0.5|0.3|22|Mortality|6818048|Black|Male|Brain and Other Nervous System|2007|0.2|0.5|0.3
0-19|0.4|0.7|0.5|37|Mortality|6853996|Black|Male|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6562662|Black|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6657073|Black|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|33892654|Black|Male|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|6738111|Black|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6769408|Black|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6562662|Black|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6657073|Black|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.1|0.1|0.1|36|Mortality|33892654|Black|Male|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6738111|Black|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6769408|Black|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.8|1.3|1.0|65|Mortality|6562662|Black|Male|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|62|Mortality|6621172|Black|Male|Leukemia|2000|0.7|1.2|0.9
0-19|0.8|1.3|1.0|67|Mortality|6657073|Black|Male|Leukemia|2001|0.8|1.3|1.0
0-19|0.6|1.0|0.8|52|Mortality|6678156|Black|Male|Leukemia|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|6690871|Black|Male|Leukemia|2003|0.5|0.9|0.7
0-19|0.6|1.1|0.8|54|Mortality|6713091|Black|Male|Leukemia|2004|0.6|1.0|0.8
0-19|0.7|0.9|0.8|279|Mortality|33892654|Black|Male|Leukemia|2004-2008|0.7|0.9|0.8
0-19|0.7|1.1|0.9|60|Mortality|6738111|Black|Male|Leukemia|2005|0.7|1.1|0.9
0-19|0.6|1.1|0.8|55|Mortality|6769408|Black|Male|Leukemia|2006|0.6|1.1|0.8
0-19|0.6|1.0|0.8|53|Mortality|6818048|Black|Male|Leukemia|2007|0.6|1.0|0.8
0-19|0.6|1.1|0.8|57|Mortality|6853996|Black|Male|Leukemia|2008|0.6|1.1|0.8
0-19|~|~|~|~|Mortality|6562662|Black|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6657073|Black|Male|Non-Hodgkin Lymphoma|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6678156|Black|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.1|0.2|0.2|61|Mortality|33892654|Black|Male|Non-Hodgkin Lymphoma|2004-2008|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6738111|Black|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6769408|Black|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.5|0.9|0.7|46|Mortality|6562662|Black|Male|Other|1999|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6621172|Black|Male|Other|2000|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6657073|Black|Male|Other|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.7|47|Mortality|6678156|Black|Male|Other|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.8|52|Mortality|6690871|Black|Male|Other|2003|0.6|1.0|0.8
0-19|0.5|0.9|0.7|44|Mortality|6713091|Black|Male|Other|2004|0.5|0.9|0.7
0-19|0.6|0.7|0.6|219|Mortality|33892654|Black|Male|Other|2004-2008|0.6|0.7|0.6
0-19|0.5|0.9|0.6|43|Mortality|6738111|Black|Male|Other|2005|0.5|0.9|0.6
0-19|0.4|0.8|0.6|41|Mortality|6769408|Black|Male|Other|2006|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6818048|Black|Male|Other|2007|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6853996|Black|Male|Other|2008|0.5|0.9|0.7
0-19|0.2|0.4|0.3|17|Mortality|6562662|Black|Male|Soft Tissue|1999|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6621172|Black|Male|Soft Tissue|2000|~|~|~
0-19|0.2|0.4|0.3|18|Mortality|6657073|Black|Male|Soft Tissue|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|6678156|Black|Male|Soft Tissue|2002|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6690871|Black|Male|Soft Tissue|2003|~|~|~
0-19|0.1|0.4|0.3|17|Mortality|6713091|Black|Male|Soft Tissue|2004|0.1|0.4|0.3
0-19|0.2|0.3|0.2|72|Mortality|33892654|Black|Male|Soft Tissue|2004-2008|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6738111|Black|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6769408|Black|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Soft Tissue|2008|~|~|~
0-19|0.2|0.4|0.3|37|Mortality|12938519|Black|Male and Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13045322|Black|Male and Female|Acute Lymphocytic|2000|0.2|0.4|0.3
0-19|0.3|0.5|0.3|45|Mortality|13103861|Black|Male and Female|Acute Lymphocytic|2001|0.3|0.5|0.3
0-19|0.2|0.3|0.2|31|Mortality|13143335|Black|Male and Female|Acute Lymphocytic|2002|0.2|0.3|0.2
0-19|0.1|0.3|0.2|28|Mortality|13173148|Black|Male and Female|Acute Lymphocytic|2003|0.1|0.3|0.2
0-19|0.1|0.2|0.2|20|Mortality|13218982|Black|Male and Female|Acute Lymphocytic|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|142|Mortality|66732542|Black|Male and Female|Acute Lymphocytic|2004-2008|0.2|0.3|0.2
0-19|0.1|0.3|0.2|28|Mortality|13268491|Black|Male and Female|Acute Lymphocytic|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13329648|Black|Male and Female|Acute Lymphocytic|2006|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|13422681|Black|Male and Female|Acute Lymphocytic|2007|0.2|0.3|0.2
0-19|0.2|0.4|0.3|34|Mortality|13492740|Black|Male and Female|Acute Lymphocytic|2008|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|12938519|Black|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13045322|Black|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|33|Mortality|13103861|Black|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13143335|Black|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|13173148|Black|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.3|0.5|0.4|48|Mortality|13218982|Black|Male and Female|Acute Myeloid|2004|0.3|0.5|0.4
0-19|0.3|0.3|0.3|198|Mortality|66732542|Black|Male and Female|Acute Myeloid|2004-2008|0.3|0.3|0.3
0-19|0.2|0.4|0.3|37|Mortality|13268491|Black|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13329648|Black|Male and Female|Acute Myeloid|2006|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13422681|Black|Male and Female|Acute Myeloid|2007|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13492740|Black|Male and Female|Acute Myeloid|2008|0.2|0.4|0.3
0-19|2.7|3.3|3.0|382|Mortality|12938519|Black|Male and Female|All Cancer Sites Combined|1999|2.7|3.3|3.0
0-19|2.6|3.1|2.8|367|Mortality|13045322|Black|Male and Female|All Cancer Sites Combined|2000|2.5|3.1|2.8
0-19|2.4|2.9|2.6|343|Mortality|13103861|Black|Male and Female|All Cancer Sites Combined|2001|2.3|2.9|2.6
0-19|2.6|3.2|2.9|373|Mortality|13143335|Black|Male and Female|All Cancer Sites Combined|2002|2.6|3.1|2.8
0-19|2.2|2.8|2.5|331|Mortality|13173148|Black|Male and Female|All Cancer Sites Combined|2003|2.2|2.8|2.5
0-19|2.5|3.1|2.8|368|Mortality|13218982|Black|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.4|2.7|2.5|1692|Mortality|66732542|Black|Male and Female|All Cancer Sites Combined|2004-2008|2.4|2.7|2.5
0-19|2.4|2.9|2.6|349|Mortality|13268491|Black|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.6
0-19|2.2|2.7|2.4|326|Mortality|13329648|Black|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.4
0-19|2.1|2.6|2.3|313|Mortality|13422681|Black|Male and Female|All Cancer Sites Combined|2007|2.1|2.6|2.3
0-19|2.2|2.8|2.5|336|Mortality|13492740|Black|Male and Female|All Cancer Sites Combined|2008|2.2|2.8|2.5
0-19|0.2|0.3|0.2|29|Mortality|12938519|Black|Male and Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|32|Mortality|13045322|Black|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13103861|Black|Male and Female|Bones and Joints|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13143335|Black|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13173148|Black|Male and Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.4|0.3|35|Mortality|13218982|Black|Male and Female|Bones and Joints|2004|0.2|0.4|0.3
0-19|0.2|0.2|0.2|133|Mortality|66732542|Black|Male and Female|Bones and Joints|2004-2008|0.2|0.2|0.2
0-19|0.1|0.3|0.2|29|Mortality|13268491|Black|Male and Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|13329648|Black|Male and Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13422681|Black|Male and Female|Bones and Joints|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|21|Mortality|13492740|Black|Male and Female|Bones and Joints|2008|0.1|0.2|0.2
0-19|0.6|0.9|0.7|93|Mortality|12938519|Black|Male and Female|Brain and Other Nervous System|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.7|88|Mortality|13045322|Black|Male and Female|Brain and Other Nervous System|2000|0.5|0.8|0.7
0-19|0.4|0.6|0.5|67|Mortality|13103861|Black|Male and Female|Brain and Other Nervous System|2001|0.4|0.6|0.5
0-19|0.6|0.9|0.8|100|Mortality|13143335|Black|Male and Female|Brain and Other Nervous System|2002|0.6|0.9|0.8
0-19|0.5|0.8|0.6|84|Mortality|13173148|Black|Male and Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13218982|Black|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.6
0-19|0.5|0.6|0.6|382|Mortality|66732542|Black|Male and Female|Brain and Other Nervous System|2004-2008|0.5|0.6|0.6
0-19|0.5|0.8|0.6|80|Mortality|13268491|Black|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.5|0.8|0.6|82|Mortality|13329648|Black|Male and Female|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|0.4|0.6|0.5|61|Mortality|13422681|Black|Male and Female|Brain and Other Nervous System|2007|0.3|0.6|0.5
0-19|0.4|0.7|0.6|74|Mortality|13492740|Black|Male and Female|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13045322|Black|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|13103861|Black|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|13143335|Black|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|13173148|Black|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|13218982|Black|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|17|Mortality|66732542|Black|Male and Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|13268491|Black|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|13329648|Black|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|0.1|0.2|0.1|16|Mortality|13045322|Black|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.2|21|Mortality|13103861|Black|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|13143335|Black|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|13173148|Black|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|13218982|Black|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.1|0.1|0.1|64|Mortality|66732542|Black|Male and Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|13268491|Black|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|13329648|Black|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.7|1.0|0.8|104|Mortality|12938519|Black|Male and Female|Leukemia|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.8|100|Mortality|13045322|Black|Male and Female|Leukemia|2000|0.6|0.9|0.8
0-19|0.7|1.0|0.8|105|Mortality|13103861|Black|Male and Female|Leukemia|2001|0.7|1.0|0.8
0-19|0.6|0.9|0.7|91|Mortality|13143335|Black|Male and Female|Leukemia|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|85|Mortality|13173148|Black|Male and Female|Leukemia|2003|0.5|0.8|0.6
0-19|0.6|0.9|0.7|97|Mortality|13218982|Black|Male and Female|Leukemia|2004|0.6|0.9|0.7
0-19|0.7|0.8|0.7|482|Mortality|66732542|Black|Male and Female|Leukemia|2004-2008|0.7|0.8|0.7
0-19|0.6|0.9|0.7|100|Mortality|13268491|Black|Male and Female|Leukemia|2005|0.6|0.9|0.8
0-19|0.5|0.8|0.7|90|Mortality|13329648|Black|Male and Female|Leukemia|2006|0.5|0.8|0.7
0-19|0.6|0.8|0.7|93|Mortality|13422681|Black|Male and Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.9|0.7|102|Mortality|13492740|Black|Male and Female|Leukemia|2008|0.6|0.9|0.8
0-19|0.1|0.3|0.2|26|Mortality|12938519|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.3|0.2
0-19|0.1|0.2|0.1|16|Mortality|13045322|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.3|0.2|21|Mortality|13103861|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.3|0.2|23|Mortality|13143335|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13173148|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.1|17|Mortality|13218982|Black|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|83|Mortality|66732542|Black|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.2|0.1
0-19|0.1|0.2|0.1|17|Mortality|13268491|Black|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.2|0.1|19|Mortality|13329648|Black|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.5|0.8|0.6|79|Mortality|12938519|Black|Male and Female|Other|1999|0.5|0.8|0.6
0-19|0.5|0.8|0.7|88|Mortality|13045322|Black|Male and Female|Other|2000|0.5|0.8|0.7
0-19|0.4|0.7|0.6|73|Mortality|13103861|Black|Male and Female|Other|2001|0.4|0.7|0.6
0-19|0.6|0.9|0.7|94|Mortality|13143335|Black|Male and Female|Other|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|84|Mortality|13173148|Black|Male and Female|Other|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13218982|Black|Male and Female|Other|2004|0.5|0.8|0.6
0-19|0.5|0.7|0.6|394|Mortality|66732542|Black|Male and Female|Other|2004-2008|0.5|0.7|0.6
0-19|0.5|0.8|0.6|83|Mortality|13268491|Black|Male and Female|Other|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.5|69|Mortality|13329648|Black|Male and Female|Other|2006|0.4|0.7|0.5
0-19|0.5|0.7|0.6|81|Mortality|13422681|Black|Male and Female|Other|2007|0.5|0.8|0.6
0-19|0.4|0.7|0.6|76|Mortality|13492740|Black|Male and Female|Other|2008|0.4|0.7|0.6
0-19|0.2|0.4|0.3|32|Mortality|12938519|Black|Male and Female|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.3|0.2|21|Mortality|13045322|Black|Male and Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13103861|Black|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13143335|Black|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.1|0.3|0.2|24|Mortality|13173148|Black|Male and Female|Soft Tissue|2003|0.1|0.3|0.2
0-19|0.2|0.4|0.3|37|Mortality|13218982|Black|Male and Female|Soft Tissue|2004|0.2|0.4|0.3
0-19|0.2|0.2|0.2|137|Mortality|66732542|Black|Male and Female|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.1|0.3|0.2|23|Mortality|13268491|Black|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|25|Mortality|13329648|Black|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|22|Mortality|13422681|Black|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|13492740|Black|Male and Female|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.4|0.7|0.5|32|Mortality|6382096|Hispanic|Female|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.4|0.7|0.5|34|Mortality|6671580|Hispanic|Female|Acute Lymphocytic|2000|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6904307|Hispanic|Female|Acute Lymphocytic|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.6|44|Mortality|7134087|Hispanic|Female|Acute Lymphocytic|2002|0.4|0.8|0.6
0-19|0.3|0.7|0.5|35|Mortality|7365360|Hispanic|Female|Acute Lymphocytic|2003|0.3|0.7|0.5
0-19|0.4|0.8|0.6|41|Mortality|7606752|Hispanic|Female|Acute Lymphocytic|2004|0.4|0.7|0.5
0-19|0.4|0.5|0.5|183|Mortality|40710732|Hispanic|Female|Acute Lymphocytic|2004-2008|0.4|0.5|0.4
0-19|0.3|0.5|0.4|28|Mortality|7859967|Hispanic|Female|Acute Lymphocytic|2005|0.2|0.5|0.4
0-19|0.2|0.5|0.4|28|Mortality|8132294|Hispanic|Female|Acute Lymphocytic|2006|0.2|0.5|0.3
0-19|0.4|0.7|0.5|44|Mortality|8418953|Hispanic|Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.4|0.7|0.5|42|Mortality|8692766|Hispanic|Female|Acute Lymphocytic|2008|0.3|0.7|0.5
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6671580|Hispanic|Female|Acute Myeloid|2000|0.1|0.4|0.2
0-19|0.2|0.4|0.3|20|Mortality|6904307|Hispanic|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|7134087|Hispanic|Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|21|Mortality|7365360|Hispanic|Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.3|0.2|98|Mortality|40710732|Hispanic|Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.5|0.3|23|Mortality|7859967|Hispanic|Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.1|0.4|0.2|19|Mortality|8132294|Hispanic|Female|Acute Myeloid|2006|0.1|0.4|0.2
0-19|0.1|0.3|0.2|17|Mortality|8418953|Hispanic|Female|Acute Myeloid|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|24|Mortality|8692766|Hispanic|Female|Acute Myeloid|2008|0.2|0.4|0.3
0-19|2.2|3.1|2.6|166|Mortality|6382096|Hispanic|Female|All Cancer Sites Combined|1999|2.2|3.0|2.6
0-19|2.1|2.9|2.5|165|Mortality|6671580|Hispanic|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|2.3|3.1|2.7|185|Mortality|6904307|Hispanic|Female|All Cancer Sites Combined|2001|2.3|3.1|2.7
0-19|2.3|3.1|2.6|187|Mortality|7134087|Hispanic|Female|All Cancer Sites Combined|2002|2.3|3.0|2.6
0-19|2.0|2.8|2.4|174|Mortality|7365360|Hispanic|Female|All Cancer Sites Combined|2003|2.0|2.7|2.4
0-19|2.2|2.9|2.5|189|Mortality|7606752|Hispanic|Female|All Cancer Sites Combined|2004|2.1|2.9|2.5
0-19|2.3|2.6|2.5|981|Mortality|40710732|Hispanic|Female|All Cancer Sites Combined|2004-2008|2.3|2.6|2.4
0-19|2.1|2.8|2.4|186|Mortality|7859967|Hispanic|Female|All Cancer Sites Combined|2005|2.0|2.7|2.4
0-19|2.0|2.6|2.3|180|Mortality|8132294|Hispanic|Female|All Cancer Sites Combined|2006|1.9|2.6|2.2
0-19|2.2|2.9|2.5|208|Mortality|8418953|Hispanic|Female|All Cancer Sites Combined|2007|2.1|2.8|2.5
0-19|2.2|2.9|2.6|218|Mortality|8692766|Hispanic|Female|All Cancer Sites Combined|2008|2.2|2.9|2.5
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|18|Mortality|6671580|Hispanic|Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|17|Mortality|6904307|Hispanic|Female|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7134087|Hispanic|Female|Bones and Joints|2002|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Bones and Joints|2004|~|~|~
0-19|0.2|0.3|0.2|79|Mortality|40710732|Hispanic|Female|Bones and Joints|2004-2008|0.2|0.2|0.2
0-19|0.1|0.4|0.2|17|Mortality|7859967|Hispanic|Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|16|Mortality|8132294|Hispanic|Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Bones and Joints|2007|~|~|~
0-19|0.2|0.4|0.3|23|Mortality|8692766|Hispanic|Female|Bones and Joints|2008|0.2|0.4|0.3
0-19|0.5|0.9|0.6|42|Mortality|6382096|Hispanic|Female|Brain and Other Nervous System|1999|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6671580|Hispanic|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6904307|Hispanic|Female|Brain and Other Nervous System|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|38|Mortality|7134087|Hispanic|Female|Brain and Other Nervous System|2002|0.4|0.7|0.5
0-19|0.4|0.8|0.6|46|Mortality|7365360|Hispanic|Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7606752|Hispanic|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.5|0.7|0.6|242|Mortality|40710732|Hispanic|Female|Brain and Other Nervous System|2004-2008|0.5|0.7|0.6
0-19|0.5|0.9|0.7|56|Mortality|7859967|Hispanic|Female|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|41|Mortality|8132294|Hispanic|Female|Brain and Other Nervous System|2006|0.4|0.7|0.5
0-19|0.4|0.7|0.5|44|Mortality|8418953|Hispanic|Female|Brain and Other Nervous System|2007|0.4|0.7|0.5
0-19|0.4|0.7|0.5|47|Mortality|8692766|Hispanic|Female|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|40710732|Hispanic|Female|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.0|0.1|0.0|21|Mortality|40710732|Hispanic|Female|Kidney and Renal Pelvis|2004-2008|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.8|1.4|1.1|67|Mortality|6382096|Hispanic|Female|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|63|Mortality|6671580|Hispanic|Female|Leukemia|2000|0.7|1.2|0.9
0-19|0.9|1.5|1.2|81|Mortality|6904307|Hispanic|Female|Leukemia|2001|0.9|1.5|1.2
0-19|0.8|1.3|1.0|73|Mortality|7134087|Hispanic|Female|Leukemia|2002|0.8|1.3|1.0
0-19|0.7|1.1|0.9|67|Mortality|7365360|Hispanic|Female|Leukemia|2003|0.7|1.2|0.9
0-19|0.7|1.2|0.9|71|Mortality|7606752|Hispanic|Female|Leukemia|2004|0.7|1.2|0.9
0-19|0.8|1.0|0.9|361|Mortality|40710732|Hispanic|Female|Leukemia|2004-2008|0.8|1.0|0.9
0-19|0.6|1.1|0.8|62|Mortality|7859967|Hispanic|Female|Leukemia|2005|0.6|1.0|0.8
0-19|0.6|1.0|0.8|63|Mortality|8132294|Hispanic|Female|Leukemia|2006|0.6|1.0|0.8
0-19|0.8|1.2|1.0|80|Mortality|8418953|Hispanic|Female|Leukemia|2007|0.8|1.2|1.0
0-19|0.8|1.3|1.0|85|Mortality|8692766|Hispanic|Female|Leukemia|2008|0.8|1.2|1.0
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.1|0.1|0.1|31|Mortality|40710732|Hispanic|Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|6382096|Hispanic|Female|Other|1999|0.2|0.5|0.4
0-19|0.2|0.6|0.4|25|Mortality|6671580|Hispanic|Female|Other|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6904307|Hispanic|Female|Other|2001|0.2|0.5|0.3
0-19|0.3|0.7|0.5|35|Mortality|7134087|Hispanic|Female|Other|2002|0.3|0.7|0.5
0-19|0.2|0.4|0.3|22|Mortality|7365360|Hispanic|Female|Other|2003|0.2|0.5|0.3
0-19|0.3|0.6|0.4|30|Mortality|7606752|Hispanic|Female|Other|2004|0.3|0.6|0.4
0-19|0.3|0.5|0.4|165|Mortality|40710732|Hispanic|Female|Other|2004-2008|0.3|0.5|0.4
0-19|0.2|0.5|0.3|26|Mortality|7859967|Hispanic|Female|Other|2005|0.2|0.5|0.3
0-19|0.3|0.5|0.4|31|Mortality|8132294|Hispanic|Female|Other|2006|0.3|0.5|0.4
0-19|0.3|0.7|0.5|42|Mortality|8418953|Hispanic|Female|Other|2007|0.4|0.7|0.5
0-19|0.3|0.6|0.4|36|Mortality|8692766|Hispanic|Female|Other|2008|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Soft Tissue|2004|~|~|~
0-19|0.1|0.2|0.2|74|Mortality|40710732|Hispanic|Female|Soft Tissue|2004-2008|0.1|0.2|0.2
0-19|0.1|0.4|0.2|16|Mortality|7859967|Hispanic|Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.4|0.2|18|Mortality|8132294|Hispanic|Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Soft Tissue|2008|~|~|~
0-19|0.4|0.7|0.5|34|Mortality|6802550|Hispanic|Male|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.6|1.0|0.8|55|Mortality|7110264|Hispanic|Male|Acute Lymphocytic|2000|0.6|1.0|0.8
0-19|0.6|1.1|0.8|59|Mortality|7341536|Hispanic|Male|Acute Lymphocytic|2001|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|7563793|Hispanic|Male|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.7|1.1|0.8|65|Mortality|7785714|Hispanic|Male|Acute Lymphocytic|2003|0.6|1.1|0.8
0-19|0.6|1.0|0.8|58|Mortality|8024129|Hispanic|Male|Acute Lymphocytic|2004|0.5|0.9|0.7
0-19|0.5|0.7|0.6|249|Mortality|42881505|Hispanic|Male|Acute Lymphocytic|2004-2008|0.5|0.7|0.6
0-19|0.5|0.9|0.7|56|Mortality|8283812|Hispanic|Male|Acute Lymphocytic|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|44|Mortality|8563877|Hispanic|Male|Acute Lymphocytic|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|49|Mortality|8863218|Hispanic|Male|Acute Lymphocytic|2007|0.4|0.7|0.6
0-19|0.3|0.6|0.5|42|Mortality|9146469|Hispanic|Male|Acute Lymphocytic|2008|0.3|0.6|0.5
0-19|0.2|0.5|0.4|24|Mortality|6802550|Hispanic|Male|Acute Myeloid|1999|0.2|0.5|0.4
0-19|0.2|0.5|0.3|23|Mortality|7110264|Hispanic|Male|Acute Myeloid|2000|0.2|0.5|0.3
0-19|0.2|0.5|0.3|23|Mortality|7341536|Hispanic|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.5|0.3|26|Mortality|7563793|Hispanic|Male|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|7785714|Hispanic|Male|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.5|0.3|26|Mortality|8024129|Hispanic|Male|Acute Myeloid|2004|0.2|0.5|0.3
0-19|0.2|0.3|0.2|100|Mortality|42881505|Hispanic|Male|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|20|Mortality|8283812|Hispanic|Male|Acute Myeloid|2005|0.1|0.4|0.2
0-19|0.1|0.3|0.2|18|Mortality|8563877|Hispanic|Male|Acute Myeloid|2006|0.1|0.3|0.2
0-19|0.1|0.4|0.2|20|Mortality|8863218|Hispanic|Male|Acute Myeloid|2007|0.1|0.3|0.2
0-19|0.1|0.3|0.2|16|Mortality|9146469|Hispanic|Male|Acute Myeloid|2008|0.1|0.3|0.2
0-19|2.5|3.3|2.8|192|Mortality|6802550|Hispanic|Male|All Cancer Sites Combined|1999|2.4|3.3|2.8
0-19|3.1|4.0|3.5|247|Mortality|7110264|Hispanic|Male|All Cancer Sites Combined|2000|3.1|3.9|3.5
0-19|2.8|3.7|3.2|233|Mortality|7341536|Hispanic|Male|All Cancer Sites Combined|2001|2.8|3.6|3.2
0-19|2.8|3.6|3.2|234|Mortality|7563793|Hispanic|Male|All Cancer Sites Combined|2002|2.7|3.5|3.1
0-19|3.2|4.1|3.6|278|Mortality|7785714|Hispanic|Male|All Cancer Sites Combined|2003|3.2|4.0|3.6
0-19|2.8|3.7|3.2|248|Mortality|8024129|Hispanic|Male|All Cancer Sites Combined|2004|2.7|3.5|3.1
0-19|2.8|3.1|2.9|1220|Mortality|42881505|Hispanic|Male|All Cancer Sites Combined|2004-2008|2.7|3.0|2.8
0-19|2.7|3.5|3.1|246|Mortality|8283812|Hispanic|Male|All Cancer Sites Combined|2005|2.6|3.4|3.0
0-19|2.3|3.1|2.7|226|Mortality|8563877|Hispanic|Male|All Cancer Sites Combined|2006|2.3|3.0|2.6
0-19|2.5|3.3|2.9|245|Mortality|8863218|Hispanic|Male|All Cancer Sites Combined|2007|2.4|3.1|2.8
0-19|2.5|3.2|2.9|255|Mortality|9146469|Hispanic|Male|All Cancer Sites Combined|2008|2.5|3.2|2.8
0-19|0.2|0.5|0.3|21|Mortality|6802550|Hispanic|Male|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|22|Mortality|7110264|Hispanic|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|7341536|Hispanic|Male|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7563793|Hispanic|Male|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.4|0.3|19|Mortality|7785714|Hispanic|Male|Bones and Joints|2003|0.1|0.4|0.2
0-19|0.2|0.5|0.3|25|Mortality|8024129|Hispanic|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.3|0.3|107|Mortality|42881505|Hispanic|Male|Bones and Joints|2004-2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|21|Mortality|8283812|Hispanic|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|20|Mortality|8563877|Hispanic|Male|Bones and Joints|2006|0.1|0.4|0.2
0-19|0.1|0.4|0.2|19|Mortality|8863218|Hispanic|Male|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|22|Mortality|9146469|Hispanic|Male|Bones and Joints|2008|0.2|0.4|0.2
0-19|0.4|0.8|0.6|39|Mortality|6802550|Hispanic|Male|Brain and Other Nervous System|1999|0.4|0.8|0.6
0-19|0.7|1.1|0.9|61|Mortality|7110264|Hispanic|Male|Brain and Other Nervous System|2000|0.7|1.1|0.9
0-19|0.4|0.7|0.5|40|Mortality|7341536|Hispanic|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|52|Mortality|7563793|Hispanic|Male|Brain and Other Nervous System|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.7|57|Mortality|7785714|Hispanic|Male|Brain and Other Nervous System|2003|0.6|0.9|0.7
0-19|0.5|0.8|0.6|48|Mortality|8024129|Hispanic|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.5|0.7|0.6|253|Mortality|42881505|Hispanic|Male|Brain and Other Nervous System|2004-2008|0.5|0.7|0.6
0-19|0.4|0.7|0.6|45|Mortality|8283812|Hispanic|Male|Brain and Other Nervous System|2005|0.4|0.7|0.5
0-19|0.4|0.8|0.6|51|Mortality|8563877|Hispanic|Male|Brain and Other Nervous System|2006|0.4|0.8|0.6
0-19|0.4|0.7|0.6|50|Mortality|8863218|Hispanic|Male|Brain and Other Nervous System|2007|0.4|0.7|0.6
0-19|0.5|0.8|0.7|59|Mortality|9146469|Hispanic|Male|Brain and Other Nervous System|2008|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|42881505|Hispanic|Male|Hodgkin Lymphoma|2004-2008|~|~|~
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|9146469|Hispanic|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.0|0.1|0.0|19|Mortality|42881505|Hispanic|Male|Kidney and Renal Pelvis|2004-2008|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|9146469|Hispanic|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.9|1.4|1.1|74|Mortality|6802550|Hispanic|Male|Leukemia|1999|0.9|1.4|1.1
0-19|1.1|1.6|1.3|92|Mortality|7110264|Hispanic|Male|Leukemia|2000|1.0|1.6|1.3
0-19|1.2|1.8|1.5|106|Mortality|7341536|Hispanic|Male|Leukemia|2001|1.2|1.7|1.4
0-19|1.0|1.5|1.3|91|Mortality|7563793|Hispanic|Male|Leukemia|2002|1.0|1.5|1.2
0-19|1.1|1.7|1.4|105|Mortality|7785714|Hispanic|Male|Leukemia|2003|1.1|1.6|1.3
0-19|1.2|1.8|1.5|112|Mortality|8024129|Hispanic|Male|Leukemia|2004|1.1|1.7|1.4
0-19|1.0|1.2|1.1|468|Mortality|42881505|Hispanic|Male|Leukemia|2004-2008|1.0|1.2|1.1
0-19|1.1|1.6|1.3|103|Mortality|8283812|Hispanic|Male|Leukemia|2005|1.0|1.5|1.2
0-19|0.7|1.2|0.9|77|Mortality|8563877|Hispanic|Male|Leukemia|2006|0.7|1.1|0.9
0-19|0.9|1.3|1.1|92|Mortality|8863218|Hispanic|Male|Leukemia|2007|0.8|1.3|1.0
0-19|0.7|1.2|0.9|84|Mortality|9146469|Hispanic|Male|Leukemia|2008|0.7|1.1|0.9
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.1|0.2|0.2|63|Mortality|42881505|Hispanic|Male|Non-Hodgkin Lymphoma|2004-2008|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.1|0.3|0.2|16|Mortality|9146469|Hispanic|Male|Non-Hodgkin Lymphoma|2008|0.1|0.3|0.2
0-19|0.3|0.6|0.4|29|Mortality|6802550|Hispanic|Male|Other|1999|0.3|0.6|0.4
0-19|0.5|0.9|0.7|49|Mortality|7110264|Hispanic|Male|Other|2000|0.5|0.9|0.7
0-19|0.3|0.6|0.4|31|Mortality|7341536|Hispanic|Male|Other|2001|0.3|0.6|0.4
0-19|0.4|0.8|0.6|46|Mortality|7563793|Hispanic|Male|Other|2002|0.4|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7785714|Hispanic|Male|Other|2003|0.5|0.9|0.7
0-19|0.2|0.5|0.4|28|Mortality|8024129|Hispanic|Male|Other|2004|0.2|0.5|0.3
0-19|0.5|0.6|0.5|223|Mortality|42881505|Hispanic|Male|Other|2004-2008|0.5|0.6|0.5
0-19|0.4|0.8|0.6|48|Mortality|8283812|Hispanic|Male|Other|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|46|Mortality|8563877|Hispanic|Male|Other|2006|0.4|0.7|0.5
0-19|0.5|0.8|0.6|54|Mortality|8863218|Hispanic|Male|Other|2007|0.5|0.8|0.6
0-19|0.4|0.7|0.5|47|Mortality|9146469|Hispanic|Male|Other|2008|0.4|0.7|0.5
0-19|0.1|0.4|0.2|16|Mortality|6802550|Hispanic|Male|Soft Tissue|1999|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Soft Tissue|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7341536|Hispanic|Male|Soft Tissue|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Soft Tissue|2002|~|~|~
0-19|0.2|0.4|0.3|21|Mortality|7785714|Hispanic|Male|Soft Tissue|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Soft Tissue|2004|~|~|~
0-19|0.1|0.2|0.2|73|Mortality|42881505|Hispanic|Male|Soft Tissue|2004-2008|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Soft Tissue|2007|~|~|~
0-19|0.1|0.4|0.2|19|Mortality|9146469|Hispanic|Male|Soft Tissue|2008|0.1|0.3|0.2
0-19|0.4|0.7|0.5|66|Mortality|13184646|Hispanic|Male and Female|Acute Lymphocytic|1999|0.4|0.6|0.5
0-19|0.5|0.8|0.7|89|Mortality|13781844|Hispanic|Male and Female|Acute Lymphocytic|2000|0.5|0.8|0.6
0-19|0.6|0.9|0.7|99|Mortality|14245843|Hispanic|Male and Female|Acute Lymphocytic|2001|0.6|0.8|0.7
0-19|0.5|0.8|0.6|91|Mortality|14697880|Hispanic|Male and Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.5|0.8|0.7|100|Mortality|15151074|Hispanic|Male and Female|Acute Lymphocytic|2003|0.5|0.8|0.7
0-19|0.5|0.8|0.7|99|Mortality|15630881|Hispanic|Male and Female|Acute Lymphocytic|2004|0.5|0.8|0.6
0-19|0.5|0.6|0.5|432|Mortality|83592237|Hispanic|Male and Female|Acute Lymphocytic|2004-2008|0.5|0.6|0.5
0-19|0.4|0.7|0.5|84|Mortality|16143779|Hispanic|Male and Female|Acute Lymphocytic|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|72|Mortality|16696171|Hispanic|Male and Female|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.5|0.7|0.6|93|Mortality|17282171|Hispanic|Male and Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.4|0.6|0.5|84|Mortality|17839235|Hispanic|Male and Female|Acute Lymphocytic|2008|0.4|0.6|0.5
0-19|0.2|0.4|0.3|43|Mortality|13184646|Hispanic|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|39|Mortality|13781844|Hispanic|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|14245843|Hispanic|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|45|Mortality|14697880|Hispanic|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|15151074|Hispanic|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|15630881|Hispanic|Male and Female|Acute Myeloid|2004|0.2|0.4|0.3
0-19|0.2|0.3|0.2|198|Mortality|83592237|Hispanic|Male and Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|43|Mortality|16143779|Hispanic|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|37|Mortality|16696171|Hispanic|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|37|Mortality|17282171|Hispanic|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|40|Mortality|17839235|Hispanic|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.5|3.0|2.7|358|Mortality|13184646|Hispanic|Male and Female|All Cancer Sites Combined|1999|2.4|3.0|2.7
0-19|2.8|3.3|3.0|412|Mortality|13781844|Hispanic|Male and Female|All Cancer Sites Combined|2000|2.7|3.3|3.0
0-19|2.7|3.3|3.0|418|Mortality|14245843|Hispanic|Male and Female|All Cancer Sites Combined|2001|2.7|3.2|2.9
0-19|2.6|3.2|2.9|421|Mortality|14697880|Hispanic|Male and Female|All Cancer Sites Combined|2002|2.6|3.2|2.9
0-19|2.8|3.3|3.0|452|Mortality|15151074|Hispanic|Male and Female|All Cancer Sites Combined|2003|2.7|3.3|3.0
0-19|2.6|3.2|2.9|437|Mortality|15630881|Hispanic|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.6|2.8|2.7|2201|Mortality|83592237|Hispanic|Male and Female|All Cancer Sites Combined|2004-2008|2.5|2.7|2.6
0-19|2.5|3.0|2.8|432|Mortality|16143779|Hispanic|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.7
0-19|2.2|2.7|2.5|406|Mortality|16696171|Hispanic|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.4
0-19|2.5|3.0|2.7|453|Mortality|17282171|Hispanic|Male and Female|All Cancer Sites Combined|2007|2.4|2.9|2.6
0-19|2.5|3.0|2.7|473|Mortality|17839235|Hispanic|Male and Female|All Cancer Sites Combined|2008|2.4|2.9|2.7
0-19|0.2|0.4|0.3|40|Mortality|13184646|Hispanic|Male and Female|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13781844|Hispanic|Male and Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|35|Mortality|14245843|Hispanic|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|32|Mortality|14697880|Hispanic|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.2|34|Mortality|15151074|Hispanic|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|15630881|Hispanic|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|186|Mortality|83592237|Hispanic|Male and Female|Bones and Joints|2004-2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|38|Mortality|16143779|Hispanic|Male and Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|36|Mortality|16696171|Hispanic|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.1|0.3|0.2|31|Mortality|17282171|Hispanic|Male and Female|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|45|Mortality|17839235|Hispanic|Male and Female|Bones and Joints|2008|0.2|0.3|0.3
0-19|0.5|0.7|0.6|81|Mortality|13184646|Hispanic|Male and Female|Brain and Other Nervous System|1999|0.5|0.8|0.6
0-19|0.6|0.9|0.7|100|Mortality|13781844|Hispanic|Male and Female|Brain and Other Nervous System|2000|0.6|0.9|0.7
0-19|0.4|0.7|0.6|79|Mortality|14245843|Hispanic|Male and Female|Brain and Other Nervous System|2001|0.4|0.7|0.6
0-19|0.5|0.8|0.6|90|Mortality|14697880|Hispanic|Male and Female|Brain and Other Nervous System|2002|0.5|0.8|0.6
0-19|0.6|0.8|0.7|103|Mortality|15151074|Hispanic|Male and Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.5|0.8|0.7|102|Mortality|15630881|Hispanic|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.7
0-19|0.5|0.6|0.6|495|Mortality|83592237|Hispanic|Male and Female|Brain and Other Nervous System|2004-2008|0.5|0.6|0.6
0-19|0.5|0.8|0.6|101|Mortality|16143779|Hispanic|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.5|92|Mortality|16696171|Hispanic|Male and Female|Brain and Other Nervous System|2006|0.4|0.7|0.6
0-19|0.4|0.7|0.5|94|Mortality|17282171|Hispanic|Male and Female|Brain and Other Nervous System|2007|0.4|0.7|0.5
0-19|0.5|0.7|0.6|106|Mortality|17839235|Hispanic|Male and Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|14245843|Hispanic|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|15151074|Hispanic|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|15630881|Hispanic|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|22|Mortality|83592237|Hispanic|Male and Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|16696171|Hispanic|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|17282171|Hispanic|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|17839235|Hispanic|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|14245843|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|15151074|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|15630881|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|0.0|0.1|0.0|40|Mortality|83592237|Hispanic|Male and Female|Kidney and Renal Pelvis|2004-2008|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|16696171|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|17282171|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|17839235|Hispanic|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|0.9|1.3|1.1|141|Mortality|13184646|Hispanic|Male and Female|Leukemia|1999|0.9|1.3|1.1
0-19|1.0|1.3|1.1|155|Mortality|13781844|Hispanic|Male and Female|Leukemia|2000|1.0|1.3|1.1
0-19|1.1|1.5|1.3|187|Mortality|14245843|Hispanic|Male and Female|Leukemia|2001|1.1|1.5|1.3
0-19|1.0|1.3|1.2|164|Mortality|14697880|Hispanic|Male and Female|Leukemia|2002|1.0|1.3|1.1
0-19|1.0|1.3|1.1|172|Mortality|15151074|Hispanic|Male and Female|Leukemia|2003|1.0|1.3|1.1
0-19|1.0|1.4|1.2|183|Mortality|15630881|Hispanic|Male and Female|Leukemia|2004|1.0|1.4|1.2
0-19|1.0|1.1|1.0|829|Mortality|83592237|Hispanic|Male and Female|Leukemia|2004-2008|0.9|1.1|1.0
0-19|0.9|1.2|1.1|165|Mortality|16143779|Hispanic|Male and Female|Leukemia|2005|0.9|1.2|1.0
0-19|0.7|1.0|0.9|140|Mortality|16696171|Hispanic|Male and Female|Leukemia|2006|0.7|1.0|0.8
0-19|0.9|1.2|1.0|172|Mortality|17282171|Hispanic|Male and Female|Leukemia|2007|0.9|1.2|1.0
0-19|0.8|1.1|1.0|169|Mortality|17839235|Hispanic|Male and Female|Leukemia|2008|0.8|1.1|0.9
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.2|0.1|17|Mortality|14245843|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.1|20|Mortality|15151074|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|15630881|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.1|0.1|94|Mortality|83592237|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.2|0.1|19|Mortality|16696171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|17282171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.1|22|Mortality|17839235|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.1
0-19|0.3|0.5|0.4|52|Mortality|13184646|Hispanic|Male and Female|Other|1999|0.3|0.5|0.4
0-19|0.4|0.7|0.5|74|Mortality|13781844|Hispanic|Male and Female|Other|2000|0.4|0.7|0.5
0-19|0.3|0.5|0.4|52|Mortality|14245843|Hispanic|Male and Female|Other|2001|0.3|0.5|0.4
0-19|0.4|0.7|0.6|81|Mortality|14697880|Hispanic|Male and Female|Other|2002|0.4|0.7|0.6
0-19|0.4|0.6|0.5|76|Mortality|15151074|Hispanic|Male and Female|Other|2003|0.4|0.6|0.5
0-19|0.3|0.5|0.4|58|Mortality|15630881|Hispanic|Male and Female|Other|2004|0.3|0.5|0.4
0-19|0.4|0.5|0.5|388|Mortality|83592237|Hispanic|Male and Female|Other|2004-2008|0.4|0.5|0.5
0-19|0.4|0.6|0.5|74|Mortality|16143779|Hispanic|Male and Female|Other|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|77|Mortality|16696171|Hispanic|Male and Female|Other|2006|0.4|0.6|0.5
0-19|0.4|0.7|0.6|96|Mortality|17282171|Hispanic|Male and Female|Other|2007|0.4|0.7|0.6
0-19|0.4|0.6|0.5|83|Mortality|17839235|Hispanic|Male and Female|Other|2008|0.4|0.6|0.5
0-19|0.1|0.3|0.2|24|Mortality|13184646|Hispanic|Male and Female|Soft Tissue|1999|0.1|0.3|0.2
0-19|0.1|0.3|0.2|26|Mortality|13781844|Hispanic|Male and Female|Soft Tissue|2000|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|14245843|Hispanic|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|14697880|Hispanic|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.2|35|Mortality|15151074|Hispanic|Male and Female|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|25|Mortality|15630881|Hispanic|Male and Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.2|0.2|147|Mortality|83592237|Hispanic|Male and Female|Soft Tissue|2004-2008|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|16143779|Hispanic|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|30|Mortality|16696171|Hispanic|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|28|Mortality|17282171|Hispanic|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.3|0.2|34|Mortality|17839235|Hispanic|Male and Female|Soft Tissue|2008|0.1|0.3|0.2
0-19|0.2|0.4|0.3|92|Mortality|30457609|White|Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.3|0.4|0.4|108|Mortality|30592817|White|Female|Acute Lymphocytic|2000|0.3|0.4|0.4
0-19|0.3|0.4|0.3|99|Mortality|30689370|White|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.4|115|Mortality|30773483|White|Female|Acute Lymphocytic|2002|0.3|0.4|0.4
0-19|0.3|0.4|0.3|101|Mortality|30859652|White|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.3|0.4|0.3|103|Mortality|30966595|White|Female|Acute Lymphocytic|2004|0.3|0.4|0.3
0-19|0.3|0.3|0.3|481|Mortality|155643508|White|Female|Acute Lymphocytic|2004-2008|0.3|0.3|0.3
0-19|0.2|0.3|0.3|84|Mortality|31023899|White|Female|Acute Lymphocytic|2005|0.2|0.3|0.3
0-19|0.2|0.4|0.3|96|Mortality|31103287|White|Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.3|106|Mortality|31233583|White|Female|Acute Lymphocytic|2007|0.3|0.4|0.3
0-19|0.2|0.4|0.3|92|Mortality|31316144|White|Female|Acute Lymphocytic|2008|0.2|0.4|0.3
0-19|0.2|0.3|0.3|83|Mortality|30457609|White|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|76|Mortality|30592817|White|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.4|0.3|94|Mortality|30689370|White|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|76|Mortality|30773483|White|Female|Acute Myeloid|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|30859652|White|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|69|Mortality|30966595|White|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.2|0.2|347|Mortality|155643508|White|Female|Acute Myeloid|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|78|Mortality|31023899|White|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|67|Mortality|31103287|White|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|31233583|White|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|71|Mortality|31316144|White|Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.3|2.7|2.5|760|Mortality|30457609|White|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.7|2.5|767|Mortality|30592817|White|Female|All Cancer Sites Combined|2000|2.3|2.7|2.5
0-19|2.4|2.8|2.6|803|Mortality|30689370|White|Female|All Cancer Sites Combined|2001|2.4|2.8|2.6
0-19|2.3|2.7|2.5|776|Mortality|30773483|White|Female|All Cancer Sites Combined|2002|2.3|2.7|2.5
0-19|2.3|2.6|2.4|756|Mortality|30859652|White|Female|All Cancer Sites Combined|2003|2.3|2.6|2.4
0-19|2.3|2.6|2.4|753|Mortality|30966595|White|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.3|2.4|2.3|3649|Mortality|155643508|White|Female|All Cancer Sites Combined|2004-2008|2.3|2.4|2.3
0-19|2.2|2.6|2.4|741|Mortality|31023899|White|Female|All Cancer Sites Combined|2005|2.2|2.6|2.4
0-19|2.0|2.3|2.2|676|Mortality|31103287|White|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|2.2|2.6|2.4|753|Mortality|31233583|White|Female|All Cancer Sites Combined|2007|2.2|2.6|2.4
0-19|2.1|2.5|2.3|726|Mortality|31316144|White|Female|All Cancer Sites Combined|2008|2.2|2.5|2.3
0-19|0.2|0.3|0.2|74|Mortality|30457609|White|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|30592817|White|Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|64|Mortality|30689370|White|Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|72|Mortality|30773483|White|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|53|Mortality|30859652|White|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|55|Mortality|30966595|White|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.2|0.2|335|Mortality|155643508|White|Female|Bones and Joints|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|77|Mortality|31023899|White|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|58|Mortality|31103287|White|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.3|0.2|68|Mortality|31233583|White|Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|31316144|White|Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.8|0.7|201|Mortality|30457609|White|Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.5|0.7|0.6|189|Mortality|30592817|White|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.8|0.7|209|Mortality|30689370|White|Female|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.5|0.7|0.6|191|Mortality|30773483|White|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|220|Mortality|30859652|White|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|199|Mortality|30966595|White|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.6|0.7|0.6|992|Mortality|155643508|White|Female|Brain and Other Nervous System|2004-2008|0.6|0.7|0.6
0-19|0.6|0.8|0.7|204|Mortality|31023899|White|Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.5|0.7|0.6|177|Mortality|31103287|White|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.8|0.7|215|Mortality|31233583|White|Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.5|0.7|0.6|197|Mortality|31316144|White|Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|~|~|~|~|Mortality|30457609|White|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|0.0|0.1|0.1|16|Mortality|30592817|White|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|30689370|White|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|30773483|White|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|30859652|White|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|30966595|White|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|35|Mortality|155643508|White|Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|31023899|White|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|31103287|White|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|31233583|White|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|31316144|White|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.0|0.1|0.1|20|Mortality|30457609|White|Female|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|30592817|White|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30689370|White|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30773483|White|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30859652|White|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30966595|White|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|112|Mortality|155643508|White|Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|31023899|White|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31103287|White|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31233583|White|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|31316144|White|Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.7|0.9|0.8|238|Mortality|30457609|White|Female|Leukemia|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|253|Mortality|30592817|White|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.8|1.0|0.9|265|Mortality|30689370|White|Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|236|Mortality|30773483|White|Female|Leukemia|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|227|Mortality|30859652|White|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|222|Mortality|30966595|White|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.7|0.7|0.7|1085|Mortality|155643508|White|Female|Leukemia|2004-2008|0.7|0.7|0.7
0-19|0.6|0.8|0.7|206|Mortality|31023899|White|Female|Leukemia|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|216|Mortality|31103287|White|Female|Leukemia|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|220|Mortality|31233583|White|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|221|Mortality|31316144|White|Female|Leukemia|2008|0.6|0.8|0.7
0-19|0.0|0.1|0.1|22|Mortality|30457609|White|Female|Non-Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30592817|White|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30689370|White|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30773483|White|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|26|Mortality|30859652|White|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30966595|White|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|100|Mortality|155643508|White|Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|31023899|White|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|31103287|White|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.0|0.1|0.1|23|Mortality|31233583|White|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|31316144|White|Female|Non-Hodgkin Lymphoma|2008|0.0|0.1|0.1
0-19|0.4|0.6|0.5|149|Mortality|30457609|White|Female|Other|1999|0.4|0.6|0.5
0-19|0.4|0.6|0.5|151|Mortality|30592817|White|Female|Other|2000|0.4|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|30689370|White|Female|Other|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|30773483|White|Female|Other|2002|0.4|0.6|0.5
0-19|0.4|0.5|0.5|141|Mortality|30859652|White|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|157|Mortality|30966595|White|Female|Other|2004|0.4|0.6|0.5
0-19|0.4|0.5|0.4|704|Mortality|155643508|White|Female|Other|2004-2008|0.4|0.5|0.5
0-19|0.3|0.5|0.4|128|Mortality|31023899|White|Female|Other|2005|0.3|0.5|0.4
0-19|0.4|0.5|0.5|142|Mortality|31103287|White|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|143|Mortality|31233583|White|Female|Other|2007|0.4|0.5|0.5
0-19|0.4|0.5|0.4|134|Mortality|31316144|White|Female|Other|2008|0.4|0.5|0.4
0-19|0.1|0.2|0.1|43|Mortality|30457609|White|Female|Soft Tissue|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|30592817|White|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|50|Mortality|30689370|White|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|59|Mortality|30773483|White|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|51|Mortality|30859652|White|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|58|Mortality|30966595|White|Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.2|0.2|286|Mortality|155643508|White|Female|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|73|Mortality|31023899|White|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|44|Mortality|31103287|White|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|55|Mortality|31233583|White|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|56|Mortality|31316144|White|Female|Soft Tissue|2008|0.1|0.2|0.2
0-19|0.4|0.5|0.4|144|Mortality|32187349|White|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.5|0.6|0.5|176|Mortality|32335465|White|Male|Acute Lymphocytic|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|32449078|White|Male|Acute Lymphocytic|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|32522098|White|Male|Acute Lymphocytic|2002|0.4|0.6|0.5
0-19|0.5|0.6|0.6|180|Mortality|32578661|White|Male|Acute Lymphocytic|2003|0.5|0.6|0.6
0-19|0.4|0.5|0.5|151|Mortality|32666378|White|Male|Acute Lymphocytic|2004|0.4|0.5|0.5
0-19|0.4|0.4|0.4|681|Mortality|164045464|White|Male|Acute Lymphocytic|2004-2008|0.4|0.4|0.4
0-19|0.4|0.5|0.4|146|Mortality|32710351|White|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.5|0.4|129|Mortality|32781426|White|Male|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.4|0.5|0.4|142|Mortality|32907095|White|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.3|0.4|0.3|113|Mortality|32980214|White|Male|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.2|0.3|0.2|75|Mortality|32187349|White|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|95|Mortality|32335465|White|Male|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.3|0.3|89|Mortality|32449078|White|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32522098|White|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|84|Mortality|32578661|White|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32666378|White|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|397|Mortality|164045464|White|Male|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|80|Mortality|32710351|White|Male|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|84|Mortality|32781426|White|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32907095|White|Male|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|32980214|White|Male|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.9|3.3|3.1|994|Mortality|32187349|White|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1032|Mortality|32335465|White|Male|All Cancer Sites Combined|2000|3.0|3.4|3.2
0-19|2.8|3.2|3.0|971|Mortality|32449078|White|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1006|Mortality|32522098|White|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1041|Mortality|32578661|White|Male|All Cancer Sites Combined|2003|3.0|3.4|3.2
0-19|2.9|3.2|3.0|995|Mortality|32666378|White|Male|All Cancer Sites Combined|2004|2.9|3.2|3.0
0-19|2.8|2.9|2.9|4693|Mortality|164045464|White|Male|All Cancer Sites Combined|2004-2008|2.8|2.9|2.9
0-19|2.8|3.2|3.0|993|Mortality|32710351|White|Male|All Cancer Sites Combined|2005|2.8|3.2|3.0
0-19|2.6|3.0|2.8|925|Mortality|32781426|White|Male|All Cancer Sites Combined|2006|2.6|3.0|2.8
0-19|2.5|2.9|2.7|896|Mortality|32907095|White|Male|All Cancer Sites Combined|2007|2.5|2.9|2.7
0-19|2.5|2.8|2.7|884|Mortality|32980214|White|Male|All Cancer Sites Combined|2008|2.5|2.9|2.7
0-19|0.2|0.4|0.3|94|Mortality|32187349|White|Male|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.3|0.3|82|Mortality|32335465|White|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.4|0.3|95|Mortality|32449078|White|Male|Bones and Joints|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|79|Mortality|32522098|White|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.3|0.4|0.3|103|Mortality|32578661|White|Male|Bones and Joints|2003|0.3|0.4|0.3
0-19|0.2|0.3|0.3|92|Mortality|32666378|White|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|424|Mortality|164045464|White|Male|Bones and Joints|2004-2008|0.2|0.3|0.3
0-19|0.2|0.4|0.3|98|Mortality|32710351|White|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|80|Mortality|32781426|White|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|32907095|White|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|32980214|White|Male|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.8|0.7|230|Mortality|32187349|White|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|248|Mortality|32335465|White|Male|Brain and Other Nervous System|2000|0.7|0.9|0.8
0-19|0.6|0.8|0.7|219|Mortality|32449078|White|Male|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.7|0.9|0.8|249|Mortality|32522098|White|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.9|0.8|250|Mortality|32578661|White|Male|Brain and Other Nervous System|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|241|Mortality|32666378|White|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1173|Mortality|164045464|White|Male|Brain and Other Nervous System|2004-2008|0.7|0.8|0.7
0-19|0.6|0.8|0.7|234|Mortality|32710351|White|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|238|Mortality|32781426|White|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|224|Mortality|32907095|White|Male|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|236|Mortality|32980214|White|Male|Brain and Other Nervous System|2008|0.6|0.8|0.7
0-19|0.0|0.1|0.1|21|Mortality|32187349|White|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32335465|White|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|32449078|White|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.1|17|Mortality|32522098|White|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32578661|White|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|32666378|White|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|0.0|0.0|0.0|45|Mortality|164045464|White|Male|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|32710351|White|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|32781426|White|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|32907095|White|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|32980214|White|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|0.0|0.1|0.1|24|Mortality|32187349|White|Male|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|32335465|White|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32449078|White|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|0.0|0.1|0.1|17|Mortality|32522098|White|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|32578661|White|Male|Kidney and Renal Pelvis|2003|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|32666378|White|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.1|89|Mortality|164045464|White|Male|Kidney and Renal Pelvis|2004-2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32710351|White|Male|Kidney and Renal Pelvis|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32781426|White|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32907095|White|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.0|0.1|0.1|18|Mortality|32980214|White|Male|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.8|1.0|0.9|296|Mortality|32187349|White|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.2|1.1|343|Mortality|32335465|White|Male|Leukemia|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|321|Mortality|32449078|White|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.1|0.9|310|Mortality|32522098|White|Male|Leukemia|2002|0.9|1.1|1.0
0-19|0.9|1.1|1.0|335|Mortality|32578661|White|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.8|1.1|0.9|310|Mortality|32666378|White|Male|Leukemia|2004|0.8|1.1|0.9
0-19|0.8|0.9|0.9|1432|Mortality|164045464|White|Male|Leukemia|2004-2008|0.8|0.9|0.9
0-19|0.8|1.0|0.9|302|Mortality|32710351|White|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|1.0|0.9|284|Mortality|32781426|White|Male|Leukemia|2006|0.8|1.0|0.9
0-19|0.8|1.0|0.9|289|Mortality|32907095|White|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.7|0.8|0.7|247|Mortality|32980214|White|Male|Leukemia|2008|0.7|0.8|0.7
0-19|0.1|0.2|0.2|53|Mortality|32187349|White|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.3|0.2|66|Mortality|32335465|White|Male|Non-Hodgkin Lymphoma|2000|0.2|0.3|0.2
0-19|0.1|0.2|0.2|56|Mortality|32449078|White|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32522098|White|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.1|48|Mortality|32578661|White|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|32666378|White|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|269|Mortality|164045464|White|Male|Non-Hodgkin Lymphoma|2004-2008|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32710351|White|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|54|Mortality|32781426|White|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|45|Mortality|32907095|White|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.2|55|Mortality|32980214|White|Male|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.2
0-19|0.5|0.7|0.6|203|Mortality|32187349|White|Male|Other|1999|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32335465|White|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|187|Mortality|32449078|White|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|214|Mortality|32522098|White|Male|Other|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|200|Mortality|32578661|White|Male|Other|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|205|Mortality|32666378|White|Male|Other|2004|0.5|0.7|0.6
0-19|0.5|0.6|0.6|947|Mortality|164045464|White|Male|Other|2004-2008|0.5|0.6|0.6
0-19|0.5|0.7|0.6|208|Mortality|32710351|White|Male|Other|2005|0.6|0.7|0.6
0-19|0.4|0.6|0.5|168|Mortality|32781426|White|Male|Other|2006|0.4|0.6|0.5
0-19|0.5|0.7|0.6|190|Mortality|32907095|White|Male|Other|2007|0.5|0.7|0.6
0-19|0.5|0.6|0.5|176|Mortality|32980214|White|Male|Other|2008|0.5|0.6|0.5
0-19|0.2|0.3|0.2|73|Mortality|32187349|White|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32335465|White|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|65|Mortality|32449078|White|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.1|0.2|0.2|59|Mortality|32522098|White|Male|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.3|0.2|70|Mortality|32578661|White|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32666378|White|Male|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.2|0.2|314|Mortality|164045464|White|Male|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.1|0.2|0.2|57|Mortality|32710351|White|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.3|0.2|67|Mortality|32781426|White|Male|Soft Tissue|2006|0.2|0.3|0.2
0-19|0.1|0.2|0.2|57|Mortality|32907095|White|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.3|0.2|71|Mortality|32980214|White|Male|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.3|0.4|0.4|236|Mortality|62644958|White|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.5|284|Mortality|62928282|White|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.5
0-19|0.4|0.5|0.4|253|Mortality|63138448|White|Male and Female|Acute Lymphocytic|2001|0.4|0.5|0.4
0-19|0.4|0.5|0.4|273|Mortality|63295581|White|Male and Female|Acute Lymphocytic|2002|0.4|0.5|0.4
0-19|0.4|0.5|0.4|281|Mortality|63438313|White|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.4|0.5|0.4|254|Mortality|63632973|White|Male and Female|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.3|0.4|0.4|1162|Mortality|319688972|White|Male and Female|Acute Lymphocytic|2004-2008|0.3|0.4|0.4
0-19|0.3|0.4|0.4|230|Mortality|63734250|White|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.4
0-19|0.3|0.4|0.4|225|Mortality|63884713|White|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.3|0.4|0.4|248|Mortality|64140678|White|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.3|0.4|0.3|205|Mortality|64296358|White|Male and Female|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.2|0.3|0.3|158|Mortality|62644958|White|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|171|Mortality|62928282|White|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|183|Mortality|63138448|White|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|162|Mortality|63295581|White|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63438313|White|Male and Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|155|Mortality|63632973|White|Male and Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.2|0.2|744|Mortality|319688972|White|Male and Female|Acute Myeloid|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|158|Mortality|63734250|White|Male and Female|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|151|Mortality|63884713|White|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|142|Mortality|64140678|White|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|138|Mortality|64296358|White|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|2.7|2.9|2.8|1754|Mortality|62644958|White|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|3.0|2.9|1799|Mortality|62928282|White|Male and Female|All Cancer Sites Combined|2000|2.7|3.0|2.9
0-19|2.7|2.9|2.8|1774|Mortality|63138448|White|Male and Female|All Cancer Sites Combined|2001|2.7|2.9|2.8
0-19|2.7|2.9|2.8|1782|Mortality|63295581|White|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.7|3.0|2.8|1797|Mortality|63438313|White|Male and Female|All Cancer Sites Combined|2003|2.7|3.0|2.8
0-19|2.6|2.9|2.7|1748|Mortality|63632973|White|Male and Female|All Cancer Sites Combined|2004|2.6|2.9|2.7
0-19|2.5|2.7|2.6|8342|Mortality|319688972|White|Male and Female|All Cancer Sites Combined|2004-2008|2.6|2.7|2.6
0-19|2.6|2.8|2.7|1734|Mortality|63734250|White|Male and Female|All Cancer Sites Combined|2005|2.6|2.9|2.7
0-19|2.4|2.6|2.5|1601|Mortality|63884713|White|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.4|2.7|2.6|1649|Mortality|64140678|White|Male and Female|All Cancer Sites Combined|2007|2.4|2.7|2.6
0-19|2.4|2.6|2.5|1610|Mortality|64296358|White|Male and Female|All Cancer Sites Combined|2008|2.4|2.6|2.5
0-19|0.2|0.3|0.3|168|Mortality|62644958|White|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|144|Mortality|62928282|White|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|159|Mortality|63138448|White|Male and Female|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63295581|White|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|156|Mortality|63438313|White|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|147|Mortality|63632973|White|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|759|Mortality|319688972|White|Male and Female|Bones and Joints|2004-2008|0.2|0.3|0.2
0-19|0.2|0.3|0.3|175|Mortality|63734250|White|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|138|Mortality|63884713|White|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|145|Mortality|64140678|White|Male and Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|154|Mortality|64296358|White|Male and Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.6|0.8|0.7|431|Mortality|62644958|White|Male and Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|437|Mortality|62928282|White|Male and Female|Brain and Other Nervous System|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.7|428|Mortality|63138448|White|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|440|Mortality|63295581|White|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|470|Mortality|63438313|White|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|440|Mortality|63632973|White|Male and Female|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.7|0.7|0.7|2165|Mortality|319688972|White|Male and Female|Brain and Other Nervous System|2004-2008|0.6|0.7|0.7
0-19|0.6|0.8|0.7|438|Mortality|63734250|White|Male and Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|415|Mortality|63884713|White|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|439|Mortality|64140678|White|Male and Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.6|0.7|0.7|433|Mortality|64296358|White|Male and Female|Brain and Other Nervous System|2008|0.6|0.7|0.7
0-19|0.0|0.1|0.1|34|Mortality|62644958|White|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|22|Mortality|62928282|White|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63138448|White|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63295581|White|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|20|Mortality|63438313|White|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|20|Mortality|63632973|White|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|80|Mortality|319688972|White|Male and Female|Hodgkin Lymphoma|2004-2008|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63734250|White|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63884713|White|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|64140678|White|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|64296358|White|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.1|0.1|0.1|44|Mortality|62644958|White|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|35|Mortality|62928282|White|Male and Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63138448|White|Male and Female|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63295581|White|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|53|Mortality|63438313|White|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|48|Mortality|63632973|White|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|201|Mortality|319688972|White|Male and Female|Kidney and Renal Pelvis|2004-2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|45|Mortality|63734250|White|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63884713|White|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|31|Mortality|64140678|White|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.0|0.1|0.1|36|Mortality|64296358|White|Male and Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.8|0.9|0.9|534|Mortality|62644958|White|Male and Female|Leukemia|1999|0.8|0.9|0.9
0-19|0.9|1.0|0.9|596|Mortality|62928282|White|Male and Female|Leukemia|2000|0.9|1.0|0.9
0-19|0.9|1.0|0.9|586|Mortality|63138448|White|Male and Female|Leukemia|2001|0.9|1.0|0.9
0-19|0.8|0.9|0.9|546|Mortality|63295581|White|Male and Female|Leukemia|2002|0.8|0.9|0.9
0-19|0.8|1.0|0.9|562|Mortality|63438313|White|Male and Female|Leukemia|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|532|Mortality|63632973|White|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.8|0.8|0.8|2517|Mortality|319688972|White|Male and Female|Leukemia|2004-2008|0.8|0.8|0.8
0-19|0.7|0.9|0.8|508|Mortality|63734250|White|Male and Female|Leukemia|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.8|500|Mortality|63884713|White|Male and Female|Leukemia|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|509|Mortality|64140678|White|Male and Female|Leukemia|2007|0.7|0.9|0.8
0-19|0.7|0.8|0.7|468|Mortality|64296358|White|Male and Female|Leukemia|2008|0.7|0.8|0.7
0-19|0.1|0.2|0.1|75|Mortality|62644958|White|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|90|Mortality|62928282|White|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|78|Mortality|63138448|White|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|88|Mortality|63295581|White|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.1|0.1|74|Mortality|63438313|White|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.2|0.1|79|Mortality|63632973|White|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.1|0.1|369|Mortality|319688972|White|Male and Female|Non-Hodgkin Lymphoma|2004-2008|0.1|0.1|0.1
0-19|0.1|0.2|0.1|83|Mortality|63734250|White|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|67|Mortality|63884713|White|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|68|Mortality|64140678|White|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|72|Mortality|64296358|White|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.1|0.1
0-19|0.5|0.6|0.6|352|Mortality|62644958|White|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|359|Mortality|62928282|White|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|341|Mortality|63138448|White|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.5|0.7|0.6|372|Mortality|63295581|White|Male and Female|Other|2002|0.5|0.7|0.6
0-19|0.5|0.6|0.5|341|Mortality|63438313|White|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.6|362|Mortality|63632973|White|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.5|0.5|1651|Mortality|319688972|White|Male and Female|Other|2004-2008|0.5|0.5|0.5
0-19|0.5|0.6|0.5|336|Mortality|63734250|White|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.4|0.5|0.5|310|Mortality|63884713|White|Male and Female|Other|2006|0.4|0.5|0.5
0-19|0.5|0.6|0.5|333|Mortality|64140678|White|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.4|0.5|0.5|310|Mortality|64296358|White|Male and Female|Other|2008|0.4|0.5|0.5
0-19|0.2|0.2|0.2|116|Mortality|62644958|White|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|116|Mortality|62928282|White|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|115|Mortality|63138448|White|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|118|Mortality|63295581|White|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|121|Mortality|63438313|White|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|120|Mortality|63632973|White|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|600|Mortality|319688972|White|Male and Female|Soft Tissue|2004-2008|0.2|0.2|0.2
0-19|0.2|0.2|0.2|130|Mortality|63734250|White|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|111|Mortality|63884713|White|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|112|Mortality|64140678|White|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.2|0.2|127|Mortality|64296358|White|Male and Female|Soft Tissue|2008|0.2|0.2|0.2
